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ABSTRACT
Albumins Redhill and Warwick-2 are monomeric, 
slow albumin variants discovered serendipitously in sera 
obtained from two unrelated families living in the U.K.
Albumin Redhill was purified both by chromato- 
focusing and preparative polyacrylamide gel electrophoresis 
whereas albumin Warwick-2 was obtained exclusively by the 
latter technique. Following isolation, selective cleavage 
at methionine and tryptophan residues using specific 
chemical reagents was employed to examine the primary 
structure of each variant compared to the structure of 
normal albumin.
Albumin Redhill is a proalbumin; the intracellular 
precursor of albumin. An amino acid substitution within 
the N-terminal propeptide has prevented normal cleavage 
of the additional residues in vivo. A second mutation 
lies in the C-terminal region of the sequence, probably 
between residues 503 and 585. This mutation is unusual 
in that it appears to involve the insertion of a short 
sequence, corresponding to approximately ten to twelve 
amino acids. The N-terminal residue is L-arginine;
L-leucine was identified as the C-terminal end group.
Albumin Warwick-2 contains an amino acid substitution 
in the N-terminal region of the sequence, between residues 
1 and 87. This variant is not a proalbumin, having 
L-aspartic acid in the N-terminal position. The C-terminal 
residue is L-leucine.
The isoelectric point of albumin Redhill is 
more acidic than that of albumin A, at pH 4.74-4.75, 
whereas albumin Warwick-2 becomes isoelectric on the 
basic side of albumin A, at pH 5.0-5.02.
Both variants share a common antigenicity with 
albumin A and are present in a lesser quantity than the 
normal allotype in the serum. Albumin Redhill shows 
a reduced binding capacity for copper and nickel
while albumin Warwick-2 binds these two metals normally.
Both albumins show decreased binding for bilirubin and 
differential binding towards a series of organic 
dyes, but bind palmitate similarly to albumin A.
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1CHAPTER 1
NORMAL SERUM ALBUMIN
1. 1 FUNCTIONS OF ALBUMIN
Albumin is a versatile, multifunctional protein 
important in many aspects of physiology, chemistry and 
clinical diagnosis. It is the most abundant protein in 
the blood, constituting approximately 60% of the total 
plasma protein and is normally present at a concentration 
of 42 g/litre, although this value may fluctuate during 
disease.
One of the main functions is to bind large 
organic anions normally insoluble in aqueous fluids 
and transport them to the liver for detoxification.
These include drugs, dyes, fatty acids, metabolites, 
steroid hormones, bilirubin, organic toxins, tryptophan 
and heavy metal ions. Albumin also acts as an overflow 
depot for thyroxine and cortisol when the capacities 
of their more specific binding proteins, thyroxine - 
and cortisol binding globulin are exceeded.
Since albumin is too large to be lost 
extensively through the capillaries, a second major 
physiological role is the maintenance of plasma 
colloidal osmotic pressure, of which it provides 80% 
and hence contributes to the regulation of fluid 
exchange in the tissues. In addition, breakdown 
into amino acids provides nutrition for the peripheral
tissues.
Owing to its high stability and solubility, 
albumin is often used as a model protein for protein 
chemistry and metabolic studies, and in immunology 
as a model antigen and hapten carrier. Since it is one 
of the few readily available carbohydrate-free proteins, 
albumin is widely used as a reference standard in protein 
assays.
For clinicians, blood albumin concentration is 
of greater diagnostic value than the measurement of total 
plasma protein. Albumin levels fall during disease: 
oedema, heart attacks, cirrhosis, nephritis, bronchitis, 
haemorrhage and gastrointestinal disease, or is lost 
through the skin after surgery, burns, dermatitis and 
accidental injury. Albumin levels are especially 
valuable as an index of the severity of protein 
malnutrition in children.
1.2 THE STRUCTURE OF SERUM ALBUMIN
1.2.1 The Primary Structure of Human Serum
Albumin (HSA)
The albumin molecule consists of a single 
polypeptide chain comprising 585 amino acid residues.
The complete primary sequence has been determined by 
Behrens et al. (1975) and Meloun et al. (1975) using 
conventional protein sequencing methods. There are 
several discrepancies between the two sequences, 
generally involving the structure around cysteine
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Fig. 1.1 The primary structure of human serum albumin: nucleotide 
sequence of USA mRNA as determined from cloned cDNA 
(Dugaiczyk et al., 1982).
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residues, particularly the 17th and 18th cysteines, 
since the presence (Behrens: cys-lys-glu-pro-cys) or 
absence (Meloun) of intervening amino acids affects the 
nature of the loops created by disulphide bridges.
More recently, Dugaiczyk et al. (1982) used 
an alternative approach and evaluated the nucleotide 
sequence of HSA mRNA from recombinant cDNA clones. This 
sequence agrees well with that of Meloun but Behrens' 
report is less comparable.
However, some disagreements between the former 
two sequences still remain. These are detailed below 
with the sequence determined by Meloun in brackets:
94-gln(glu), 95-glu(gln), 97-gly(glu)
170-gln(glu) , 464-his (glu) , 465-glu(his)
501-glu(gln) and residues
364-370-ala-asp-pro-his-glu-cys-tyr are specified as 
(his-asp-pro-tyr-glu-cys-ala).
In addition, the latest sequence has verified 
the absence of amino acids between cys27g and cys279, thereby 
establishing the near perfect homology in the triplet 
domain structure of the molecule. Fig. 1.1 shows the 
primary structure according to Dugaiczyk et al.
1.2.2 The Secondary Structure of Serum Albumin
The distribution of secondary structure in
bovine serum albumin (BSA) is shown in Fig. 1.2.
5Fig. 1.2 Distribution of secondary structure in BSA 
(Peters and Reed, 1977).
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Peters and Reed (1977) calculated the loci of 
6-turns, 8-pleated sheet, a-helix and random coil using 
the revised sequence of BSA (Brown, 1977). The arrange­
ment consists of long loops of a-helix modified with 
8—sheet and B-turn conformations, particularly in loops 
1, 3, 6 and 7. The helix is predicted to extend to
the short ends of some loops but model building 
demonstrates that it cannot continue for more than 
two residues beyond the cys-cys bond into these tight 
loops. Disturbance of the helices occurs at the apices 
of the loops, eight of which are formed into 6-turns. 
Seven of the turns contain cystine residues and one 
includes the single thiol at cys^.
An alternative structure proposed by Brown
6(1977) and based on model building, comprises six 
uniform helical regions. The helices are joined 
at the end of each long loop by invariant proline 
residues (at 146, 222, 337, 414 and 530), and by 
disulphide bridges elsewhere (Fig. 1.3).
Further estimates employing model building 
and the amino acid sequence demonstrate a total of 
46% o-helix and 16% B-pleated sheet. This compares 
well with 50-55% a-helix and 15-18% B-pleated sheet 
derived from optical measurements (Peters, 1975) 
although McLachlan and Walker (1977) suggest as much 
as 75% a-helix.
1.2.3 The Tertiary Structure of Serum Albumin
The regular occurrence of adjacent cys-cys 
sequences is paramount in the three dimensional organisa­
tion of the albumin molecule. Disulphide bridges formed 
between the 34 half-cystine residues form the molecule 
into three repeat units or domains, encompassing residues
1-190, 191-382 and 383-585 (Brown, 1975). Each domain 
consists of a large double loop, a short connecting 
segment, a small double loop, a long connecting 
segment, another large double loop and a connecting 
segment to the next repeat unit. Overall, the system 
involves a regular series of nine loops arranged to 
form the domains such that loops 1-3, 4-6 and 7-9 
constitute domains I, II and III respectively.
There is no closure of the large loop
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Fig. 1.3 The tertiary structure of bovine serum albumin 
(Brown, 1977).
between residues 8 and 54. Brown (1977a) believes that 
cysteine residues were once located at positions 8 
and 54 but were lost during evolution.
Fig. 1.3 shows the triple domain structure 
and great internal homology of BSA according to Brown 
(1977). The absence of amino acids between cys2 g^ and 
cys279 brin9s the structure of domain II closer to the 
structures of the other two domains. The locations of 
all 35 cysteine residues in both Meloun's and Dugaiczyk's 
sequence of HSA and Brown's sequence of BSA are exactly 
the same, consequently, the published tertiary arrangements 
are all identical.
There are considerable differences in composition 
among the domains which make the molecule asymmetrical.
The frequency of tyrosine residues decreases from domain I 
to II to III. Tyrosine is particularly abundant in loops 
3 and 6 whereas histidine is concentrated in loops 1 and 
2. Each domain has a similar number of arginine and 
lysine residues but fewer aspartic acid and glutamic 
acid residues exist in domain III, hence, the C-terminal 
end is less negative than the N-terminal end of the 
molecule. Asymmetry of charges also occurs within 
individual loops. There is a tendency for basic residues 
to be positioned at the long ends of loops while acidic 
residues are situated at the short ends (Peters and 
Reed, 1977) .
Each domain consists of two subdomains A-B and 
C containing a long loop and a hinge region. Each 
subdomain can be further subdivided into 3 helices X, Y
9and Z (Fig. 1.3).
The loop and link arrangement accounts for the 
flexibility and stability of albumin under conditions 
detrimental to other proteins: resistance to heat and 
to hydrogen bond disrupting agents (urea, guanidinium 
chloride), and the formation of isomeric forms as a 
result of expansion in acid or base. Local segments are 
maintained in near alignment by the disulphide bridges and 
isolated fragments containing disulphides retain most of 
their secondary structure and the ability to bind ligands 
whereas fragments without disulphide bonds do not 
(Reed et at., 1975).
pH isomerisation (Zurawski and Foster, 1974) 
ranges from simple, reversible expansion to irreversible 
disulphide rearrangement. The normal 'N'-form predominates 
at pH 5-7. An expanded, faster migrating 'F'-form 
appears below pH 4, the expansion increasing below pH 3 
to expose tyrosine and other hydrophobic residues.
Near pH 8, particularly if calcium ions are present, 
a second type of expansion occurs to yield the 'B'-form 
in which hydrogen atoms become accessible for exchange.
The mobility of the thiol group is increased and some 
of the helical conformation is lost. Above pH 8, 
a transformation to the slower moving 'A'-form 
prevails (Nikkei and Foster, 1971; Stroupe and Foster, 
1973). This change involves disulphide bond rearrange­
ment and becomes irreversible near pH 10.
Isolated and denatured fragments can regain 
their native disulphide pattern independently from the
10
remainder of the molecule. Intact albumin does so more 
slowly (Teale and Benjamin, 1976).
1.3 CONFORMATION
The general shape of monomeric albumin can 
be represented by a prolate ellipse of dimensions 
141 x 42 8 (Wright and Thompson, 1975) . X-ray studies 
have further defined this structure as a linear arrange­
ment of three spheres, 38-53-38 8 in diameter (Bloomfield, 
1966) or more recently, fragmentation of native albumin 
has revealed a possible arrangement of four segments 
of unequal size with a small arm projecting from the N- 
terminal end of the first segment (Peters, 1970), Fig. 1.4.
The albumin dimer is a side-to-side aggregation 
of the monomer with an approximate overlap of 50%
(Squire et al., 1968).
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Fig. 1.4 The conformation of albumin (Peters, 1970).
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EVOLUTION1.4
The point during evolution at which albumin 
appeared is difficult to estimate. Proteins corresponding 
to human serum albumin have been observed inconsistently 
in the plasma of fish and amphibians (Cohen and Stickler, 
1958; Engle et al., 1958; Woods et al. , 1958), and 
Masat and Dessauer (1968) identified albumin in 15 species 
from the four major reptilian orders: turtles, crocodiles, 
lizards and snakes. Avian and mammalian albumins compare 
closely with HSA in solubility, size, charge and amino 
acid composition. Detailed interspecies comparisons 
using immunochemical methods have shown that albumin 
has evolved at a steady rate (Sarich and Wilson, 1967), 
through "neutral" (non-functional) amino acid changes 
(Peters, 1977).
Brown (1976) has proposed that the protein 
was built up to its present size by a nine-fold 
replication of a primordial subdomain structure comprising 
about 78 residues and 2 disulphide bridges. The 
greater similarity between domains I and II (domains I and
II show 25% identity, II and III 21% identity and I and
III only 18%identity) implies that the primitive gene 
corresponding to a single domain was duplicated to 
give the ancestral gene of domains II and III (about 
156 residues). After sufficient time had elapsed to 
allow for divergence of these domains, a tandem half­
gene duplication added domain I resulting in the triple 
domain structure reminiscent of present-day albumin.
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Formation of the subdomains arose by triplica­
tion of a primordial subdomain gene corresponding 
approximately to the sequence 504-581, resulting in 
three large loops with long connecting segments (about 
22 residues). Later, a deletion of about 40 residues near 
the middle of the sequence resulted in the large-small- 
large double loop pattern characteristic of the basic 
single domain (Brown, 1976a; 1977).
Brown (1977) proposed that the primordial 
subdomain probably arose from a gene fragment of a 
primitive globin about 1.1 billion years ago. However, 
statistical analysis performed on the sequence homology 
between the domains suggested rather, that the primordial 
double loop had the ability to dimerise and subsequent 
gene duplication allowed similar paired structures to 
form many times within a single, long chain, thereafter 
evolving its helical structure independently (McLachlan 
and Walker, 1977).
The approximate age of the triple domain structure 
is 700 million years. The evolutionary pathway of 
albumin as proposed by Brown (1977) is shown in Fig. 1.5.
1.5 PHYSICAL AND CHEMICAL PROPERTIES
Serum albumin is distinguishable from the 
majority of other plasma proteins by its smaller size, 
greater total charge, net charge at blood pH, greater 
symmetry, lower viscosity and higher solubility and 
stability (Cohn, 1941). It contains only 0.08%
carbohydrate,0.02% trace metals and 0.8% fatty acids 
(calculated as oleic acid and equivalent to 1.8 moles/ 
mole of albumin) (Goodman, 1957). Chen (1967) recognised 
from 1.8 to 2.5 moles per mole of protein in some preparations. 
Albumin is thus a simple protein consisting almost exclusively 
of amino acids.
The high content of glutamic acid, lysine and 
histidine is responsible for the high charge, polarity 
and ability to bind small molecules. The high proportion 
of cysteine provides 17 disulphide bridges per molecule. 
Comparatively low levels of glycine and tryptophan 
partially compensate for the surplus of these four amino 
acids.
Albumin is highly soluble in aqueous solutions 
at neutral pH (compared to the globulins) and more soluble 
than most other proteins at high salt concentrations.
A unique feature is its solubility in mild organic 
solvents, e.g. 40% methanol at neutral pH.
At blood pH, the net charge on the molecule 
is -19 which renders albumin the most rapidly anodic 
migrating protein of the major plasma components. At 
this pH, 181 groups are ionised, 81 positively and 100 
negatively. The ionisable groups comprise 102 
carboxyls (pK 4.1), 15 imidazoles (pK 6.3), 1 a-amino 
group (pK 7.8), 56 e-amino groups (pK 9.5), 17 phenolic 
residues (pK 10.2) and 23 guanidines (pK > 12) (Alberty,
1953).
The molar absorptivity of albumin is one 
of the lowest of the serum proteins at 5.3, due to
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there being only one tryptophan in the sequence. Spectral 
perturbation by large solvent molecules (sucrose, 
polyethylene glycol) shows that one third of the 17 
tyrosine residues lie near the surface between pH 4.2 and 
8 (Herskovits and Laskowski, 1962). One of the surface 
tyrosines and the single tryptophan are situated in an 
exposed location near the single sulphydryl group (Ohkubo,
1969). Acidification exposes 3-5 more residues from the 
hydrophobic interior as the molecule expands, although 
complete dénaturation is required to expose all the 
aromatic amino acids.
1.6 HETEROGENEITY
The heterogeneity of commercial albumin 
preparations arises through the presence of protein 
contaminants, non-protein contaminants and factors 
inherent in the albumin molecule itself.
Traces of heavy metals and some fatty acids have 
proven difficult to remove and some samples have been found 
to contain citrate, pyruvate, lactate, aspartate and 
a-ketoglutarate ions (Janatova, 1974). Electrophoretic 
techniques can detect contamination by transferrin, 
a-globulins, genetic variants, bisalbumins induced by 
bound ligands, pH isomers and proalbumins. Other 
proteinaceous impurities include insulin, proteolytic 
enzymes, antihaemophilic factor (Barrow et al., 1972) 
and bacterial endotoxin (Philip et al., 1966). Artefacts 
may also arise through glycosylation of the E-amino
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groups of lysine residues, in particular lys525 
(Garlick and Mazer, 1983). Glycosylated albumin 
accounts for 6-15% of total serum albumin in healthy 
adults (Day et al. , 1979).
The distribution of free sulphydryl groups 
is invariably fractional, typically 0.6-0.7 mol/mole 
of albumin (Simpson and Saroff, 1958) as a result of 
non-mercaptalbumin formation. Non-mercaptalbumin 
arises via mixed disulphide bonding between the free 
sulphydryl group at cys34 and either cysteine or gluta­
thione in the plasma (Andersson, 1966). Alternatively, 
the free sulphydryl group can exist in higher oxidation 
states such as the sulphonic acid (Noel and Hunter, 1972).
The care taken during isolation and storage of 
albumin strongly influences the final extent of hetero­
geneity in a preparation. Dimers and higher oligomers 
form spontaneously upon storage of plasma. New plasma 
contains only 5-8% dimers and other aggregates 
(Hartley et al. , 1962). Irreversible loss of reactive 
sulphydryl groups occurs with storage and freeze drying. 
This loss is not compensated for by molecular aggregation 
and is attributed to non-mercaptalbumin monomers.
Further intrinsic variations result from 
'molecular aging' or modification of functional side 
groups without peptide bond breakage (Wong and Foster, 
1969). Common reactions include deamidation of 
asparagine and glutamine (Robinson et al., 1970), 
acetylation of amino groups by aspirin (Hawkins et al. , 
1969) and oxidation of the sulphydryl group, all of
17
which may occur during prolonged storage of plasma or 
as a consequence of rigorous isolation procedures.
1.7 LIGAND BINDING SITES
1.7.1 Introduction
Fig. 1.6 summarises the locations of binding
sites for particular ligands. These sites either lie 
on the surface of the molecule or are accessible to the 
surface and can be categorised as follows:
(A) hydrophobic, non-covalent sites for
(i) primary long chain fatty acids
(ii) bilirubin and certain drugs
(iii) indole compounds and certain other drugs
(B) covalent attachment sites for organic ligands 
including the thiol group
(C) chelation sites for divalent metals.
A large majority of the binding sites have
been characterised to a greater or lesser extent but 
for reasons of space, detailed discussion as to the 
mode and position of binding will be limited to those 
ligands relevant to this work.
1.7.2 The Binding of Fatty Acids
1.7.2.1 Introduction
The plasma free fatty acid (FFA) is composed 
primarily of long chain fatty acids (FA) (C16 and C^g) 
released from adipose tissue, the predominant species
18
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Fig. 1.6 The main ligand binding sites on HSA.
being oleate, stearate, linoleate, arachidonate and 
palmitate (Spector, 1971). Over two thirds are 
unsaturated and they are maintained in solution by 
non-covalent complexation of the anion monomers with 
albumin (Spector, 1975). Albumin can carry up to 
2 moles of FFA without appreciably reducing its 
ability to bind other compounds.
Albumin functions to increase the availability 
of FFA to the cell membrane. It serves as a reservoir, 
effectively concentrating the FFA at the cell surface.
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The formation of complexes permits maximum solubility 
and hence enhanced utilisation of FFA.
The binding of FA anions in the physiological 
range is accompanied by subtle conformational changes, 
namely an increase in volume (Soetewey et al., 1972).
The phenomenon of configurational adaptability (Karush, 
1954) is related to the pliability of albumin binding 
sites and their ability to change conformation. The 
altered site is stabilised when occupied by an organic 
anion. Concomitant disruption of the weak intrahelical 
attractions permits the amino acid side chains to 
change orientation, thus exposing new, modified sites as 
the helices separate.
The Karush model accounts for cooperativity in 
binding and is more consistent with the mode of fatty acid 
binding than the Scatchard model which assumes a fixed 
number of pre-existing sites competing independently 
for the available ligand (Scatchard, 1949).
Such structural alterations are studied by 
analysing the perturbation of the fluorescence spectrum 
(Spector, 1968). The binding sites are mapped relative 
to the position of the single tryptophan residue. 
Alternatively, changes in the emission spectra of 
fluorescent probes: 8-anilino-l-naphthalenesulphonic 
acid (ANS) (Santos and Spector, 1974) and 5-(dimethylamino) 
naphthalene-1-sulphonic acid (DNS) (Doody et al. , 1982) 
have been used to investigate fatty acid binding sites.
The presence of fatty acid anions stabilises 
albumin against the action of pepsin, trypsin, chymotrypsin
and other proteases (Kondo, 1962), against dénaturation 
by heat, urea and guanidinium chloride (Boyer et al. ,
1946; 1946a), and also facilitates realignment of the
secondary structure during reoxidation of the completely 
reduced molecule (Andersson, 1969). Conversely, defatting 
increases the susceptibility of albumin to digestion by 
pepsin (Klapper and Cann, 1964).
1.7.2.2 Binding Models
Scatchard plots obtained for the binding of 
biologically important fatty acids show that a single 
albumin molecule possesses multiple sites for the 
accommodation of fatty acid anions. The plots are non­
linear indicating that several types of site exist.
A number of binding models have been suggested 
(Klotz et al., 1946; Goodman, 1958; Arvidsson et al.,
1971; Laiken and Nemethy, 1971). These have been 
superceded by a generalised model (Spector and Fletcher,
1977) based upon stepwise addition of the ligand. No 
assumptions are made as to the pre-existence or 
independence of binding sites and configurational 
adaptibility, positive or negative co-operativity, site-site 
and ligand-ligand interactions are taken into account.
The new scheme indicates that there are 6 high affinity 
and approximately 30 low affinity sites.
1.7.2.3 Structure of the Binding Sites
The sites themselves comprise two parts, a 
pocket lined with non-polar amino acid side groups and
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a cationic group located at the surface (Swaney and 
Klotz, 1970). The same authors demonstrated that one 
of the high affinity sites contains the sequence: 
lys-ala-trp-ala-val-ala-arg where the five non-polar 
side chains form the hydrophobic pocket and a cationic 
group is present at both ends.
Location is probably restricted to the 
hydrophobic clefts between adjacent globular domains.
The single tryptophan residue is thought to reside in 
the cleft between the first and second domains (Brown,
1976a) and changes in the tryptophan emission spectrum 
induced by small quantities of FFA verify that one or 
more of the high affinity sites occur in this region 
(Santos and Spector, 1974).
The primary site for medium chain FFA’s lies 
between residues 124-297 and 298-585. The secondary 
site is in the same general region (Lee and McMenemy,
1980) .
1.7.2.4 Mechanism of Binding
Hydrophobic interactions between the fatty 
acid hydrocarbon chains and the non-polar amino acid 
side groups lining the binding site feature more 
prominently than electrostatic attraction or hydrogen 
bonding involving the carboxylate groups. The latter 
ionic interactions have been implicated in a minor 
capacity at the high affinity sites (Morrisett et al. ,
1975).
The strongest hydrophobic interactions occur along 
the hydrocarbon chain, but the terminus, which penetrates
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furthest into the site, is not held firmly in place 
(Muller and Mead, 1973). Furthermore, the positioning 
of the hydrocarbon moiety is not consolidated by 
electrostatic attractions. At physiological concentrations 
only one mole of organic acid is contained within each 
binding site.
The association constants increase with 
increasing chain length: laurate < myristate < palmitate 
< stearate (Ashbrook et al. , 1975) and range from
2.4 x 10® to 2.6 x 10® M 1 for the primary sites and
3.5 x 10® to 3.9 x 105 M 1 for the weaker sites.
Insertion of one cis-double bond increases the binding 
strength but a second double bond reduces affinity 
below that of the corresponding saturated fatty acid.
1.7.2.5 Palmitate
Palmitate has been used as a model for fatty 
acid binding and fragmentation studies have revealed a 
single, high affinity locus in or near loop 7 (Reed 
et al., 1975). Further examination located the primary 
site to residues 377-503 (Ka 2 x 107 M-1), the second 
site to residues 239-306 (Ka = 8 x 10® M-1) and the 
third site to the sequence 307-377 (Ka = 2 x 10® M-1).
1.7.2.6 Competition by other Ligands
Competition for binding has been observed with 
methyl orange (Cogin and Davis, 1951), ANS (Santos and 
Spector, 1972), bilirubin (Thiessen et al., 1972), 
thyroxine (Tabachnick, 1964), and salicylates (Dawkins
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et al., 1970) in the face of high concentrations of FFA.
Drugs show little or no competition (Rudman et al., 1971).
1.7.3 The Binding of Bilirubin
1.7.3.1 Introduction
Bilirubin features among the substances most 
tightly bound by albumin. Failure of albumin to bind this 
ligand in the plasma leads to hyperbilirubinaemia, the 
excess bilirubin being deposited in the extremities as 
jaundice takes effect. The condition is more serious 
in neonates in whom the immature blood-brain barrier 
lacks resistance to the passage of appreciable quantities 
of bilirubin, which subsequently becomes concentrated in 
the basal ganglia, causing kernicterus and possible 
lasting brain damage.
1.7.3.2 Location of the Binding Sites
The initial quantitative work concerning the 
interaction between bilirubin and albumin was carried 
out by Jacobsen (1969) who demonstrated that at least 
three moles of bilirubin were bound reversibly per
9mole of albumin at one high affinity site (Ka = 7 x 10 M 
and two equivalent low affinity sites (Kq = 2 x  106 M 1).
1 mole of ligand bound at the primary site and 2 moles 
were detected within the weaker sites.
Fragmentation studies have enabled the binding 
sites to be located more exactly. Binding of bilirubin 
to large peptic (Geisow and Beaven, 1977) and small
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tryptic (Reed et al., 1975) albumin fragments indicates
that the primary site lies within the segment containing
residues 186-238. This sequence approximately constitutes
loop 4 of the tertiary conformation. However, photoactivated
covalent binding of (^H]-bilirubin to HSA located the
primary site within the sequence 1-124 and a secondary
site between residues 125-297 (Hutchinson and Mutopo,
1979). A second weak site was identified in the
fragment 446-547 (Gitzelmann-Cumarasamy et al., 1976).
In a physiological environment, the association
7 8 “1constant for the primary site is in the order of 10-10 M
and that of the secondary sites in the order of 10^ M 1
(Levine, 1977; Brodersen, 1979). However, Beaven et al.
(1973) demonstrated that three sites exist at low ionic
strength, namely one high affinity site (Ka = 1.4 to
2 x 107 M 1) and two sites of lower affinity (Ka = 3.3
to 10 x 10^ M 1 and 3.3 to 5 x 10^ M *) whereas at high
salt concentrations only two sites remain active, one
7 -1strong site (Ka = 1.5 x 10 M ) and one weak site 
(Ka = 3.3 x 106 M_1).
1.7.3.3 Structure of the Binding Sites
Chemical modification of certain amino acid 
residues of HSA have shown that arginine, tyrosine and 
histidine lie close to or are located within the 
high affinity site. Carboxyl, cysteinyl, and tryptophanyl 
groups are not involved (Jacobsen, 1972). Affinity 
labelling using reagents specific for the e-amino 
groups of lysine suggest that two amino groups also
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form part of the primary site (Jacobsen, 1975), one 
of these being later localised to lysine2 4 Q (Jacobsen,
1978) .
Even if the tryptophan in loop 4 is not 
directly involved in binding, its environment is affected 
since attachment of the ligand quenches the intrinsic 
fluorescence of albumin. All mammalian albumins contain 
tryptophan near residue 214 (Feldhoff and Peters, 1976) 
although chicken albumin which has no tryptophan binds 
bilirubin equally strongly (Blauer et at., 1977).
The role of tryptophan in bilirubin binding as yet remains 
unclarified.
1.7.3.4 Mechanism of Binding
At physiological pH, bilirubin binds as 
the dianion (Hansen et al., 1979; Jacoben and Brodersen,
1983). Lysine2 4 Q is probably bound to one of the carboxylate 
groups by electrostatic attraction whereas a similar salt 
bridge to another lysine or the guanidinium group of an 
arginine may secure the second carboxylate function. 
Hydrophobic interactions have less influence on the 
stability of the bilirubin-albumin complex (Jacobsen,
1977) .
1.7.3.5 Competition by other Ligands
Numerous anions compete with bilirubin and 
decrease the effective binding capacity of albumin.
Among these are fatty acids, bile salts, haeraatin, 
acetamide and a number of drugs and azo dyes (Peters,
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1970). Apart from long chain fatty acids, the affinity 
is generally lower than that for bilirubin.
Amongst the drugs, sulphonamides show widely 
differing displacement effects. Several analgesics, 
anticoagulants and antiinflammatory compounds including 
salicylates and food additives such as saccharin and 
antibacterial preservatives are also bilirubin displacers 
whereas benzodiazepines (Librium, valium), most antibiotics, 
antihistamines, diuretics, general anaesthetics and 
hormones show little competition. Drugs carrying a net 
positive charge are not displacing (Brodersen, 1977) .
Long chain (Cjg and above) and short chain 
(C^q and below) fatty acids in excess of 4 moles/mole of 
albumin compete stongly for the primary bilirubin site. 
Conversely, the binding affinity is enhanced in the 
presence of medium chain fatty acids, e.g. laurate (C^) 
and myristate (Cl4) at a concentration of 2 molar. This 
positive co-operative effect is limited to a chain 
length of 12 to 14 carbon atoms (Brodersen, 1977a).
1.7.4 The Binding of Metals
1.7.4.1 Introduction
Albumin is a scavenger of heavy metal ions 
and prevents them from damaging the enzyme systems 
of the mitochondria. Metals interact with the free protein 
thiol groups in the organelle membrane (Verity and 
Gambe11, 1968).
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1.7.4.2 Copper
The binding of copper to albumin in the 
serum was first demonstrated by Bearn and Kunkel 
(1954). They showed that albumin was the immediate 
transporter of copper in the blood plasma following 
ingestion but later relinquished about 70% of it to 
the caeruloplasmin.
Copper binds at several sites along the 
albumin molecule. The primary site is located in the 
N-terminal tripeptide (Nl^-asp-ala-his) and involves 
four nitrogen ligands: the a-amino nitrogen, two 
intervening peptide bond nitrogens, and the imidazole 
nitrogen of the adjacent histidyl residue such that a 
square planar complex is formed. It has also been 
suggested that the side chain carboxyl group participates 
in the complexation of copper at this site (Sarkar, 1980) 
resulting in the penta-coordinated structure shown in 
Fig. 1.7.
P R O U I N  C H A I N  AWvWM/\_coo-
(ii)Fig. 1.7 The primary copper 
(Sarkar, 1980).
transport site of USA
The identity of the first two amino acids is not 
restrictive since bovine and rat serum albumins bind 
copper equally well. Their tripeptide sequences are 
NH2-asp-thr-his and NH2-glu-ala-his respectively.
However, the requirement of a histidine residue in the 
third position is illustrated by the relative failure 
of dog albumin (tripeptide sequence NHj-glu-ala-tyr) 
to bind copper at the primary site (Appleton and Sarkar,
1971).
The association constant for the primary 
8 “1site is 10 M (Breslow, 1964). The second equivalent 
of copper binds at the single sulphydryl group with a 
reduced affinity and can illicit the formation of albumin- 
S-Cu-S-albumin dimers analogous to the mercury dimer.
The 4th to 9th binding sites have association constants of 
only 104 M-1 (Lai, 1959).
The major inhibitor of copper binding is the 
sulphide ion (Cartwright et al., 1954). Cupric sulphide 
is insoluble and renders the copper unavailable for the 
formation of complexes.
1.7.4.3 Nickel
Peters (1977) demonstrated that nickel 
can sterically fit the primary copper binding site 
of albumin. The chelation mechanism is similar to 
that operating for copper although the protein accommo­
dates the larger ion with a reduced affinity, K =a
7.5 x 10^ M  1 (Rao, 1962). Histidine in the third 
position is also mandatory for nickel complexation.
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1.7.4.4 Other Metals
The reaction of albumin with metal ions other 
than the first one or two ions of copper, nickel 
and mercury are more electrostatic in nature and of
but being monovalent, it cannot cause dimérisation.
Metal binding is minimal below the isoelectric 
point of albumin and increases with pH. The number of
is small (Perkins, 1961), the principal groups involved 
being imidazoles (Gurd and Wilcox, 1956). Guthans and
(Gurd and Murry, 1954; Irons and Perkins, 1962).
1.7.5.1 Binding Sites
Albumin binds a multitude of synthetic and 
exogenous anions including many organic dyes and pH 
indicator substances. In general, associations are 
weaker than those observed for bilirubin and fatty 
acids and the number of binding sites varies according 
to the dye.
Competitive binding studies indicate that
lower affinity. Silver ( I ) binds with high affinity
sites available for binding zinc (II) and cadmium (II)
Morgan (1982) showed that 2-3 moles of Zn*11*, Ni*11* 
and Cd*11* are bound per mole of albumin with 
association constants in the range 10^ M 1 and relative
and magnesium*11* bind at a complex of carboxyl groups
1.7.5 The Binding of Dyes
several dyes, particularly the phenolsulphonephthalien
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group, e.g. phenol red, bind to a region common to the 
primary bilirubin binding site (Kragh-Hansen et al.,
1974). Phenol red and the tetrabromo-derivative bromophenol 
blue are bound with high affinity at 5 common sites, the 
association constants being approximately 100-1000-fold 
smaller for phenol red than for bromophenol blue.
binding site distinct from the site of interaction of 
indocyanine green, bromocresol green and rose bengal.
The former shows a greater preference for the secondary 
bilirubin sites whereas the latter dyes associate more 
strongly with the primary site (Kamisaka et al. , 1974). 
Bromocresol green was observed to bind to albumin fragments 
(Reed et al., 1975). Binding was proportional to 
fragment size but occurred to the greatest extent in 
the region of bilirubin binding.
binding is dependant upon albumin concentration (Bowmer 
and Lindup, 1980). Both the association constants and 
number of high affinity sites decrease with increasing 
protein concentration although the secondary sites remain 
largely unaffected. This anomaly could not be adequately 
explained by the presence of impurities, by aggregation 
or by competition with other ligands. Inhibition by 
chloride ions was also observed, however, none of these 
conditions influenced the uptake of bromocresol green 
or methyl orange.
Sulphobromophthalien interacts at a bilirubin
2-(4'-Hydroxybenzeneazo)benzoic acid (HABA)
The naphthalenesulphonic acids, Trypan blue
Evans blue and Congo red are tightly bound (Flanagan and 
Ainsworth, 1968) as are the azobenzoates such as
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methyl red (Burkhard et at., 1961). The mode of 
m-methyl red interaction differs from that of o- and p- 
methyl red. The isomers do not compete among themselves 
for sites, suggesting non-identical binding loci.
Trypan blue binds to a maximum of three sites but as 
saturation approaches, two primary sites are replaced 
by three weaker sites, possibly as a result of competition 
by the functional groups of the dye.
Like other ligands, dyes cause configurational 
changes in the albumin which stabilise it towards 
denaturation and proteolytic digestion (Markus et at., 1967).
1.7.5.2 Competition by other Ligands
ANS, dodecylsulphate and dodecylsulphonate 
displace phenol red competitively from the high 
affinity sites. ANS competes at 4-5 sites. Bilirubin 
inhibits binding at equimolar concentrations. Palmitate 
and oleate show modest competition above a four-fold 
molar ratio and iopanoate shares a mutual high affinity 
site with bromophenol blue (Kragh-Hansen, 1981).
1.7.6 The Binding of Antigen
1.7.6.1 Introduction
Antigenic sites on albumin are specific 
binding loci, whereby the antibody is regarded as the 
macromolecule and the albumin site as the ligand. These 
sites have been located through fragmentation studies 
and immunologically active fragments have been isolated
32
from different parts of the albumin molecule.
1.7.6.2 Location of Binding Sites
The amount of antigenic activity is directly 
related to the size of the fragments. Isolated and 
reduced domains are able to refold independently of 
the remainder of the polypeptide chain to reform the 
native antigenic structure, the third domain regaining 
its native conformation more rapidly than the first 
domain (Teale and Benjamin, 1976). In addition,the 
two halves of BSA can recombine to regenerate a complete 
antigen (Peters and Reed, 1977).
Peters et at. (1977) studied the antigenic 
behaviour of 14 fragments of BSA and predicted at least 
6 antigenic determinants distributed fairly uniformly 
along the entire length of the molecule, with the site 
of greatest antibody affinity situated in the C-terminal 
region. Likewise, Bellon and Lapresle (1975) demonstrated 
the presence of two strong sites in loop 9 of HSA. By 
correlating available information Peters and Reed (1977) 
assigned the antigenic sites to residues 1-49, 50-184, 
185-306, 307-385, 386-504 and 505-582.
1.7.6.3 Characterisation of the Binding Sites
The nature of the antigenic sites is unclear. 
Habeeb and Atassi (1976) proposed that native albumin 
carries identical, repeating sites based upon the loop- 
and link structure of albumin. However, Peters et al. 
(1977), although confirming the existence of multiple,
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homologous sites which react with the same populations 
of antibodies, found evidence for unique determinants 
which combine selectively with an exclusive antibody 
population, and further suggested that each half of 
albumin has its own characteristic sites which do not 
react with antibody to the other half.
Doyen et al. (1982) presented a compromise 
view. Using CNBr fragments of HSA, they observed that 
antibodies not only combined strongly with the fragments 
from which they were derived (homologous), but also showed 
a weak cross-reactivity with the other fragments (heterologous), 
the latter reaction resulting from the homology inherent 
in the albumin molecule.
The antigenic sites appear to be negatively charged. 
Neither intact tertiary structure, nor amino, phenolic or 
sulphydryl groups are essential but free carboxyl groups 
are a certain requirement (Sri Ram et al., 1962).
Antibodies may bind to homologous sites if the residues 
therein are similar in size and charge and the difference 
between homologous and identical sites may merely be a 
question of affinity.
1.7.7 Other Ligands
Kragh-Hansen (1981) proposed the existence 
of at least 6 binding regions on albumin. A general 
feature of albumin-ligand interactions is the presence 
of one or two high affinity sites accompanied by a variable 
number of weaker sites, depending on the ligand. Further,
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at high ligand to albumin ratios, several additional 
ligand molecules can associate weakly in a non­
specific manner. Some ligands, e.g. dodecylsulphate 
and ANS bind with equal affinity at several sites, 8 for 
dodecylsulphate (Ray et al., 1966) and 4 for ANS (Kolb
and Weber, 1975).
Apart from the binding regions shown in Fig. 1.6, 
other regions as yet uncharacterised are of major importance 
in the transport of negatively charged and electrically 
neutral drugs such as warfarin, phenylbutazone, indomethacin 
and paracetamol. Positively charged drugs, quinine, 
procaine and the antimalarial compound pamaquine associate 
with comparable strength but at different locations.
Low concentrations of steroids bind tightly 
to the globulins but associate mainly with albumin when 
present at high levels. Progesterone and testosterone 
interact with secondary fatty acid binding sites and 
several steroids can bind to the primary bilirubin site.
1.8 ALLOALBUMINAEMIA
1.8.1 Introduction
Alloalbuminaemia may be defined as the 
presence of either two allomorphs - or one variant 
form of albumin in body fluids, the most frequent 
observations being made in the serum. On electrophoresis, 
the former heterozygous type appears as two bands showing 
varying degrees of separation, one corresponding to the
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common albumin A and the second migrating either ahead 
of (the so-called fast or anodic variants) or behind 
the normal component (the so-called slower,cathodic 
albumins, appearing between albumin A and aj-globulin). 
Homozygote patterns are extremely rare and difficult 
to detect unless the normal allotype is run in parallel 
for comparison. Careful scrutiny and constancy in 
sample application is required for these.
The difference in electrophoretic mobility is 
brought about by a difference in net charge between the 
two forms.
Albumin variants fall into three categories:
(A)
(i)
(ii)
( B )
(C)
Congenital, hereditary alloalbuminaemia 
Structural alloalbuminaemia - arising from a 
small change within the amino acid sequence. 
Dimers - monomeric variants with an increased 
tendency to dimerise.
Acquired, transitory bisalbuminaemia - due to 
the binding of small organic ligands or as a 
consequence of enzyme action during pancreatic 
disease.
Analbuminaemia
1.8.2 Congenital, Hereditary Alloalbuminaemia
1.8.2.1 Introduction
A true, hereditary alloalbumin should be 
distinguished from transient variants, dimers formed
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upon prolonged storage of serum, pH isomers ('F'-, 'A'- 
and 'B'-forms), electrophoretic bands split by protein- 
buffer interactions (Cann, 1966), prealbumin, a-fetoprotein 
and a^globulin which runs close to albumin on filter 
paper.
Numerous analyses concerning the pedigrees of 
families with alloalbuminaemic members have shown that 
the albumin phenotype is transmitted by two co-dominant 
alleles. The trait is not sex-linked. The propositus 
is usually heterozygous for the condition although a number 
of homozygotes are known. No incidences of heterozygotes 
for two different variants have as yet been found.
1.8.2.2 Mechanism of Mutation
Available structural information indicates that 
albumin variants arise through a single amino acid 
change at some position in the sequence.
Single point mutations result from a single 
base change within the gene. In transitional mutations, one 
purine-pyrimidine base pair is replaced by another. 
Transversional mutations occur when a purine-pyrimidine 
pair is substituted for a pyrimidine-purine pair. Both 
types of mutation can occur spontaneously and are 
relatively benign since only one amino acid is altered 
without affecting the remainder of the sequence. The 
defective protein is usually still functional.
Certain amino acid substitutions require more 
than one base change and are therefore less likely to 
occur, e.g. asp -* gly is more likely than asp -*• met,
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■* phe or •+■ leu.
Only the following substitutions have been 
identified:
(i) Albumin B (Oliphant) (Winter et al. , 1972)
glutamic acid (GAA, GAG) -*• lysine (AAA, AAG)
(ii) Albumin Mexico-2 (Franklin et al., 1980)
aspartic acid (GAU, GAC) •* glycine (GGU, GGC,
GGA, GGG)
(iii) Proalbumin Christchurch (Brennan and Carrell, 1978)
arginine (CGU, CGC, CGA, CGG, AGA, AGG) -*• 
glutamine (CAA, CAG)
(iv) Proalbumin Lille (Abdo et al., 1981)
arginine -* histidine (CAU, CAC)
Gentou and Plazonnet (1978) observed a 
substitution of 10 glutamic acid and/or glutamine 
residues by an equal number of lysine residues and of 
5 alanines by prolines in an un-named slow variant.
They attributed the change to an inversion of a cistron 
segment GAA (glutamic acid) -*• AAG (lysine) and GCC (alanine)
-*■ CCG (proline) .
1.8.2.3 Linkage to other Loci
Pedigree data have been investigated for 
possible linkages between the albumin locus and other 
genetic systems. Weitkamp et al. (1966); (1968) and
Kaarsalo et al. (1967) recognised an association between 
the albumin and the Gc (group specific component 
(Hirschfeld, 1962)) loci. The probability of linkage 
with hereditary methaemoglobinaemia (Scott and Wright,
138
1969), haptoglobin and transferrin (Kaarsalo et al., 1967) 
loci is small but Keuppers et al. (1969) tentatively 
suggested a relationship with the a-chain of haptoglobin. 
Apart from these connections, albumin variants appear to 
arise independently of other genetic variations in proteins.
1.8.2.4 Alloalbuminaemia in Man and other Animals
1.8.2.4.1 Presence in Animals Controlled genetic 
studies in animals have confirmed that albumin alleles are 
autosomal and co-dominant. Alloalbuminaemia occurs in 
cattle (Ashton, 1964), sheep (Tucker, 1968), pigs 
(Kristjansson, 1966), horses (Stormont and Suzuki, 1963), 
turkeys (Quinteros et al. , 1964), chickens (Mclndoe, 1962),
quail (Haley, 1965) and doves (Miller, 1967). Hybrid 
crosses between domestic fowl show that three phenotypes 
are possible, one heterozygous and two homozygous forms.
In horses and sheep, three co-dominant alleles 
A, B and C can be demonstrated. Appropriate crosses can 
yield three heterozygous (AB, AC, BC) or three homozygous 
(AA, BB, CC) progeny.
In pigs the 0 allele controls no detectable 
albumin synthesis so that animals with the OO genotype 
are analbuminaemic and heterozygous AO and BO animals 
had albumin levels decreased to about half those with the 
AA, AB or BB genotypes.
A high degree of albumin polymorphism is 
detectable in toads (Guttman and Wilson, 1973).
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1.8.2.4.2 Presence in Man The first case of allo- 
albuminaemia was reported by Scheurlen (1955) in a Swiss- 
German diabetic patient. The appearance of two albumins 
in the serum coincided with the onset of a diabetic 
coma, the electrophoretic pattern returning to normal 
once the illness had stabilised. Two years later,
Knedel (1957) and Nennstiel and Becht (1967) simultaneously 
recognised the hereditary nature of the condition, through 
studies of slow and fast variants of German origin.
Following these observations, Wuhrmann (1959) reinvestigated 
Scheurlen's patient. Her double albumin pattern had 
become permanent and was present in other members of her 
family. These findings substantiated the previous evidence 
for a hereditary phenomenon. The failure to detect the 
albumin variant during periods of stability was probably due 
to the lack of resolution inherent in filter paper 
electrophoresis.
Earle et al. (1959) described a slow variant,
the original albumin B, in a Norwegian-Araerican family.
The anomaly was present in 25 out of 43 members of the 
family. From several immunological studies, they concluded 
that the alloalbumin B was antigenically indistinguishable 
from the normal form. The new protein described by 
Fraser et al. (1959) was probably the first dimeric 
variant to be found.
The genetic hypothesis gained support as additional 
cases of uncommon albumin bands were reported. Apart from 
those of German origin, slow-moving variants (albumins B) 
were found in Europeans from several countries including
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France (Sandor et al., 1965), Italy (Sarcione and Aungst, 
1962), the U.K. (Franglen et al. , 1960; Cooke et al. ,
1961), Sweden, Norway (Efremov and Braend, 1964) and 
Denmark (Drachmann et al., 1965) and in the United 
States (Robbins et al., 1963).
Two fast albumins were discovered in European 
families, albumin Gent (Wieme, 1960) in a Belgian family 
and albumin Reading in a Welsh/English family (Tarnoky 
and Lestas, 1964).
The first non-European variant was discovered by 
Melartin and Blumberg (1966). This fast alloalbumin was 
found among American Indians and was termed albumin Naskapi.
It differed from those previously reported both in 
electrophoretic mobility and the relatively high frequency 
at which it occurred. Albumin Naskapi was also the first 
observation of an individual homozygous for a variant 
albumin.
By 1967, a sizeable literature concerning 
albumin variation had accumulated and was reviewed by Melartin 
(1967). Since then, the number of incidences reported has 
increased greatly due to the application of straightforward 
electrophoretic screening techniques to sera in many parts 
of the world, and the subject has been reviewed more 
recently by Tarnoky (1980).
New variants have been found among the 
Japanese (Fukunaga et al., 1973; Nishimukai et al., 1982), 
Malaysians (Lie-Injo et al., 1971; Welch and Lie-Injo,
1972), Indonesians (Lie-Injo et al., 1974), Indo-Dravidians 
(Tarnoky and Dowding, 1969; Bradwell et al., 1975;
Frohlich et al., 1978) and South Americans (Weitkamp 
and Chagnon, 1968; Arends et al., 1970; Salzano et al., 
1974) .
The distribution of albumin variants appears 
to be world wide. However, only two cases of 
alloalbuminaemia in individuals of African ancestry have 
been observed (Cohen, 1965; Weitkamp et al., 1969).
This can probably be explained by the paucity of 
observations in this region.
1.8.2.5 Nomenclature
The terms 'split'- or 'double'-albumin and 
'iso'-, 'para'- or 'bisalbuminaemia' have all been used 
in early attempts to describe albumin variants. These 
have been superseded by the term 'alloalbumin' for 
forms other than the normal allotype.
The first notations distinguished only two 
albumins, the normal albumin A or Aj^ and the variant 
type called fast, slow, A2 or B, later expanded to 
include faster and very fast in attempts to classify the 
increasing confusion of variants. The accepted notation 
is that proposed by Melartin (1967) whereby normal 
albumin is designated albumin A (gene symbol A1 ) and 
variants are named after their ethnic, geographical or 
laboratory origin with the exception of albumin B 
which is retained exclusively for the Norwegian-American 
slow albumin described by Earle et al. (1959).
The normal genotype becomes A1A/A1^. Similarly, 
the genotypes for heterozygotes, e.g. albumin Redhill
are AlA/AlRd and for homozygotes, e.g. albumin Naskapi, 
AlNa/AlNa. Italian cases are described by laboratory 
location followed by the family's place of origin; the 
letters are taken from car number plates.
1.8.2.6 Classification of Variants
The majority of cases of alloalbuminaemia are 
discovered in hospital laboratories during routine 
electrophoresis of sera at pH 8.6. Others are 
especially looked for in an experimental capacity by 
electrophoretic screening of selected populations or 
racial groups. Several methods for the characterisation 
of variants have been devised.
1.8.2.7 Classification of Variants by Electrophoresis
Electrophoretic analysis is the most commonly
used criterion for establishing the nature of variants.
Variants migrating in close proximity to 
Albumin A may show up merely as widened bands and serum 
dilution may be necessary. Where the alloalbumin has 
arisen via an amino acid substitution involving no net 
change in charge, its mobility remains that of albumin A.
Such electrophoretically silent variants require 
alternative procedures, such as peptide mapning, for their 
detection.
There are two standard procedures for classification 
by electrophoresis: the starch gel system of Weitkamp 
et al. (1973) at three pH levels, and the Royal Berkshire 
Hospital (RBH) test schedule (Tarnoky, 1980) which involves
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dye binding and electrophoresis on six media, all 
at alkaline pH.
1.8.2.7.1 Starch Gel Electrophoresis (Weitkamp et al.,
1973) Variants are compared in three vertical starch gel 
systems: acetate-EDTA at pH 5.0, iris-lithium-succinate-
citrate at pH 6.0 and tris-EDTA-borate at pH 6.9. Of these, 
the pH 5.0 separation is superior for distinguishing fast 
variants whereas the pH 6.0 and 6.9 systems are valuable 
for slow types.
this pH range leading in some cases to actual reversal 
in mobility of variants relative to each other in different 
buffer systems (Weitkamp and Chagnon, 1968; Weitkamp 
et al. , 1969). Alterations in electrophoretic conditions, 
e.g. extended running time, has a marked effect on the 
differential mobility of variants, possibly due to a 
changing environment within a discontinuous buffer system.
the number of distinguishable types: no more than 12-15 
variants are recognisable on any one system, whereas the 
combination of all three systems has realised some 28 
allotypes.
1.8.2.7.2 The RBH Test Schedule (Tarnoky, 1980) Variant 
sera are subjected to electrophoresis on the following 
six media:
Relative mobilities differ appreciably over
The use of several buffer pH's has increased
(i) Whatman 3 MM filter paper in barbitone buffer
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Br Br Br Br
bromocresol green
Na° 3 s —
Ponceau S
Congo Red
(4 Hydroxybenzeneazo)benzoic acid
Classification of variants by dye binding: structures 
of the RBII test dyes.
Fig. 1.8
— H?y ‘^ ^ • s .a
s- OH (ii) Cellulose acetate (Shandon Celagram cellulose
^ B r
acetate strips) in barbitone Oxoid buffer 
(0.1 M, pH 8.6).
N a (iii) Helena Titan III Zip Zone cellulose acetate 
plates in barbitone buffer (0.05 M, pH 8.8)
(iv) Agar (1%) in barbitone buffer (0.05 M, pH 8.6) 
(Izquierdo et al. , 1971).
(v) Agarose (1%) containing sucrose (5%), EDTA 
(0.035%) and barbital (0.065 M, pH 8.6) in 
barbitone buffer (0.1 M, pH 8.6), using the 
Corning ACI electrophoresis system.
(vi) Disc-polyacrylamide (7%) in a tris-glycine 
discontinuous buffer system (pH 8.3 -*■ 8.9 •+
8.3) (Tarnoky and Dowding, 1967).
Relative mobility is expressed on a 0-100 
scale, where 0 is the cathodic trailing edge of the serum 
pattern and 100 is the leading edge of albumin A (Tarnoky 
et al. , 1970).
— OH
1.8.2.8 Dye Bindinq
Qualitative tests based on transport function 
are carried out by incubating variant sera with a panel 
of six ligands: bromophenol blue, bromocresol green, 
Ponceau S, Congo red, HABA and bilirubin prior to 
electrophoresis on six media. The resultant dye uptake 
is a combination of interactions between the dye, protein
ieazo)benzoic
and support medium and is estimated visually. All dyes
acid
are added to an excess of albumin except for HABA.
ttures
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1.8.2.9 Critique of Ligand Binding Methods
Variation between results depends upon the 
uniform availability of free binding sites on the 
albumin molecule. Binding tests use non-defatted 
albumin so that pre-existing ligands such as drugs, 
fatty acids and bilirubin may compete for or already 
occupy the dye binding sites to a greater or lesser 
extent.
However, the tertiary integrity of the 
undefatted structure outweighs the advantage of a more 
standardised form, depleted of stabilising ions and with 
possible deformed binding sites. Preliminary defatting 
followed by reconstitution to an agreed fatty acid 
content would ensure comparability in testing. The 
IFCC criterion for standardisation of albumin 
preparations is 1-2 moles of fatty acid per mole of 
albumin and a polymer content below 1% (Tarnoky, 1981).
Dye binding is reversible and as electrophoresis 
proceeds, the ligand becomes detached and migrates more 
rapidly than albumin to the anode. Dye detached from the 
slow component would be temporarily rebound by the fast 
band so that this band would seem to bind more ligand.
This can be remedied by using a standard running length 
and field strength and specified media.
The differential binding of dyes to alloalbumins 
is valuable for establishing differences, but it cannot 
prove identities.
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1.8.2
1.8.2
(i)
(ii)
1 . 8 . 2
(i)
.10 Additional Methods of Classification 
.10.1 Ligand Binding 
Thyroxine
[1^1I]-Thyroxine uptake by variants is quanti­
fied either by scintillation counting, auto­
radiography or scanning (Sarcione and Aungst, 
1962; Yamamoto et al., 1977). Lallozet al.
(1983) reported a silent variant with a 20-fold 
affinity for thyroxine over albumin A. However, 
interpretation of results is complicated by 
albumin acting only as an overflow depot for 
this hormone.
Radioactive Ligands (Cavalli-Sforza et al., 1977) 
Plasma proteins were screened using a panel 
of 63 physiologically important radioactive 
ligands including vitamins, hormones, metal ions, 
drugs, amino acids, purines, pyrimidines, fatty 
acids and carbohydrates. Comparative binding 
ability was assessed by PAGE-autoradiography.
.10.2 Tests of Stability
Low Temperature Storage
Some alloalbumins gradually merge into 
albumin A after prolonged storage in the cold. 
This phenomenon is possibly a return to an 
electrophoretically silent variant. Although 
the amino acid substitution does not involve 
a change in net charge, it may promote other 
changes which cause an alteration in mobility
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such as the binding of ligands only to the 
variant. These ligands become detached during 
storage so that the variant reverts to its 
original mobility. Two such cases are 
albumin Paris (Lie-Injo et al., 1971)and 
the equivalent albumin Gombak (Weitkamp 
et al. , 1973).
(ii) Freezing and Thawing
Sera are subjected to two-, ten-, and 
thirty-five-fold freezing (-20°C) and thawing 
(37°C) followed by electrophoresis against 
control sera. This procedure removes lipid from 
albumin and the instability of albumin Luarca 
(Izquierdo et al., 1971) to this treatment was 
manifested by a decrease in the relative 
proportion of the allotype from 44% to 35%.
(iii) Thermal Stability
This procedure identifies dimeric variants.
Sera are heated at 56° for 30 minutes and 2 hours. 
Under these conditions, dimers are dissociated and 
the mobility of the allotype reverts to that of 
albumin A. The dimeric character of albumin 
Warao was uncovered in this manner (Arends 
et al. , 1969).
1.8.2.10.3 Molecular Weight
The monomeric or dimeric nature of variants
is reliably determined by gradient-PAGE.
1.8.2.10.4 Proportion of Normal:Variant Albumins
Most variants constitute just under 50% of
the total sérum 
exceptions.
Table 1.1
albumin. Table 1.1 denotes some
Variant Normal : Variant Reference
Cuneo/Belluno 79% 21% Vacca et al. (1974)
Genova/Catania 90% 10% Porta et al. (1974)
RI H 64% 36% Chapman et al .(1978)
Stirling 59%-66% 4l%-33% Curnow et al. (1978)
Vancouver 35% 65% Frohlich et al. (1978
The relative proportions of dimeric variants 
are usually low, e.g. albumin Warao comprises only 30% 
of the total serum albumin (Arends et al. , 1969).
1.8.2.10.5 Isoelectric Points
The determination of isoelectric points is 
potentially useful in the classification of variants but 
this parameter has rarely been determined. One objection 
is that artefacts may arise through the binding of 
ampholytes to native albumin (Foster, 1977; Wallevik, 
1973) and even normal albumin shows multiple bands 
(Kaplan and Foster, 1971; Spencer and King, 1971) and 
has several published isoelectric points: pi 4.8 
(Evenson and Deutsch, 1978), pi 4.7-5.3 (Valmet, 1969), 
pi 5.2 (Carlsson and Perlmann, 1969) and pi 4.78 and
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4.84 (Giuliani et al., 1978) for non-defatted HSA.
Successful application of isoelectric focusing would 
require standardisation of experimental conditions.
Sudaka et al. (1976) used isoelectric 
focusing in the pH range 4-6 to measure the isoelectric 
points of albumins Pollibauer (pi 5.84) and Gainesville 
(pi 5.65).
Bradley and Hornbeck (1974) used pH-gradient 
elution on the strongly anionic ion-exchanger QAE- 
Sephadex to determine the isoelectric points of 
several fast and slow variants. However, reproducible 
pH gradients are difficult to achieve and some variants 
are sufficiently similar to albumin A as to prevent 
separation.
1.8.2.10.6 Immunological Character
The antigenic behaviour of albumin variants 
has been tested by reaction against anti-albumin A and 
by reaction of albumin A against anti-albumin variant.
These tests have indicated that alloalbumins are antigenically 
identical to albumin A.
This observed similarity arises from several 
features. Albumin is believed to possess similar 
repeating antigenic sites (Section 1.7.6) so that a 
single amino acid substitution would be unlikely to 
alter the overall immunological character. The site of 
mutation may not be involved with the antigenic nature 
of the molecule, moreover, binding of the antibody to 
only a few sites could be sufficient for precipitation.
Also, the techniques employed may not be sufficiently
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sensitive to detect minute differences in the sequence 
and the heterogeneous antibody preparations obtained by 
immunisation are relatively undiscerning, thereby 
allowing sufficient reactivity to fcrm a precipitate.
There are however, two exceptions. Robbins 
et al. (1963) reported no distinction between the slow
and normal albumin components in undiluted serum but 
two separate precipitin arcs were formed after a 1:30 
dilution. This was attributed to a secondary precipitation 
with excess antibody (Payne and Dickinson, 1967), bearing 
in mind the possible existence of a unique antigenic 
determinant. Margni et al. (1970) found albumin A to 
be antigenically deficient relative to a slow alloalbumin.
A far more definitive method would be the use
of monoclonal antibodies. Micheel et al. (1982) used 
125I-labelled and fluoresceinisothiocyanate (FITC)-labelled 
normal HSA to measure the antibody activity of anti-HSA 
hybridoma antibodies. These monoclonal antibodies 
detected antigenic determinants containing tyrosine 
or lysine as an essential part.
1.8.2.10.7 Structural Studies
The ultimate means by which variants 
can be distinguished is by amino acid sequencing.
So far, the primary structure of only a few variants 
has been investigated: albumin B (Winter et al. , 1972), 
albumin Mexico-2 (Franklin et al., 1980), albumin 
Naskapi (Franklin et al., 1980a), proalbumin Christchurch 
(Brennan and Carrell, 1978), proalbumin Lille (Abdo et al.,
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1981), ‘the un-named variant of Gentou and Plazonnet 
(1978) and the partial structures of albumin Gainesville 
(Lapresle, 1977) and albumin Adana (Franklin et al.,
1980a).
1.8.2.11 Population Distribution of Variants
At present, it is difficult to determine the 
exact number of variants. Out of about 80 variants 
named, approximately 28 have been distinguished from 
each other (Weitkamp, 1973). This discrepancy is due 
to the use of several names to apply to a smaller 
number of variants. The table compiled by Schell 
and Blumberg (1977) includes variants which were not 
named by their discoverers, variants which may be rediscoveries 
of previously identified variants and variants which appear 
in comparative studies but which have not been described 
in the literature individually. The result of these 
practises is a proliferation of variant names, many 
of which are not commonly used or recognised.
Variants may be either rare or polymorphic 
depending on whether they occur with a frequency of 
1% or more. These two classes may be subdivided on 
the basis of their distribution.
There are three classes of rare variants:
(i) unique or private variants which have been
seen only in the family in which they were 
discovered;
(ii) restricted rare variants which occur in a
small number of unrelated individuals of
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Table >.2 Population distribution of some alloalbumins (adapted from Weitkamp . t a l .  
(1973) and Schell and Blumberg (1977)
Race
Caucasian
Negroid
Mongoloid
Unknown
Variant Type Distribution Origin
Pollibauer Slow Unique Austrian
D (SO/C2) Slow Rare, restricted Various European
Roma Slow - Italian
Gainesville Slow Rare, restricted Irish
Paris (Gombak) Slow (silent) Rare, unrestricted French
SO/BS Slow - Italian
Cartago Slow - Spanish
Reading (New Guinea, Syracuse) Fast Rare, unrestricted Welsh
Gent (Fast) Fast Rare, restricted Belgian
R1H Slow - Norwegian
'Dimer' Slow - Welsh, Swedish
Stirling Slow - Scottish
Yorkshire Slow - English
Amsterdam Slow - German
Cayemite Slow Unique Haitian Negro
Uinba Slow Unique Native New Guinea
New Guinea (Reading, Syracuse) Fast Rare, unrestricted Native New Guinea
'Dimer' Slow “ Negro (U.S.A.)
Gombak (Paris) Slow Rare, unrestricted Native Malaysian
Kashmir (Afghanistan) Slow Rare, restricted Indian
Pushtoon Slow - Indian
Mexico Slow Polymorphic, dispersed American Indian
Medan Rare, restricted Chinese Malaysian
Maku (Makiritare-2) Fast Rare, restricted Native South American
Makiritare-3 Fast Unique Native South American
Makiritare-1 (Warao) Dimer Polymorphic, restricted Native South American
Naskapi (Mersin) Fast Polymorphic, dispersed American Indian
Yanomama Dimer Rare, restricted Venezuela
Yanomama-2 Slow Polymorphic, restricted Native South American
Xavante Slow - Native South American
Jaffna Slow (silent) - Sri Lanka
Vancouver Slow - Indian (Fiji)
Birmingham Slow Unique Indian (Punjab)
Santa Ana Slow Unique Mexican
Belem I Slow Unique Brazilian
Belem II (Mexico) Slow Polymorphic, dispersed Brazilian
Belem III (Maku) Fast Rare, restricted Brazilian
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one ethnic group; and
(iii) unrestricted rare variants which occur in a
small number of unrelated individuals of 
different ethnic groups.
Polymorphic variants may be restricted to 
one ethnic group and locality or dispersed among several 
groups and localities. Table 1.2 shows the population 
distribution of some alloalbumins, adapted from 
Weitkamp et al. (1973) and Schell and Blumberg (1977).
1.8.2.12 Albumin B
Albumin B is a broad classification of the 
rare variants most frequently found in Europeans. It 
has a wide distribution with an incidence of heterozygotes 
of 1:1000-1:10,000. This variant was designated ’very 
slow1 by Weitkamp et al. (1969). Similarity between all 
the albumins B has not been proved but there is evidence 
to suggest that some of them may be the same variant.
By studying electrophoretic separation in the 
pH range 3.0-12.3, Earle et al. (1959) concluded that 
a carboxyl group had been substituted by tyrosine, 
cysteine or lysine. Later, Gitlin et al. (1961) demonstrated 
that between pH 4.00 and 8.43, albumin B possesses a net 
charge of +2 greater than albumin A, in accordance with 
a change from a single carboxyl group to a single lysine 
residue.
The strongest evidence for similarity between 
albumins B came from sequence analysis of albumins Oliphant 
and Ann Arbor, of German and Danish descent respectively.
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Peptide mapping revealed a novel peptide having the 
sequence ala-lys-glu-gly-lvs-lvs-leu instead of the 
usual ala-glu-glu-gly-lys-lys-leu. Subsequent CNBr 
fragmentation localised the anomaly to the C—terminal 
end of the molecule. The point mutation corresponds to 
a substitution of a lysine residue for glutamic acid^^g. 
These findings are analogous to those concerning the 
earlier B albumin. Furthermore, albumins Ann Arbor 
and Oliphant were proved to be identical.
Several B-type albumins have been found in France, 
including albumin Paris (Fine et al. , 1976). Albumins 
Paris and Gainesville have been subtyped B" and B'
(Ott, 1974) in a similar manner to a group of non-identical 
B albumins reported around Stuttgart amongst which, a 
homozygote, albumin B Schönaich was discovered (Ott et al., 
1973).
The C-terminal CNBr fragment of albumin B 
migrates faster than the corresponding fragments of 
albumins A and Mexico-2 at pH 3.0, consistent with the 
glu -*• lys substitution (Franklin et al., 1980).
1.8.2.13 Albumin Mexico
Albumin Mexico is a polymorphic variant occurring 
in several widely separated geographical areas. It was 
initially reported in several non-related sera in 
Mexico (Melartin et al., 1967) but has since been 
discovered in American Indians from Middle America 
and as far south as Guatemala. A consideration of the 
distribution and high gene frequency is a useful indicator
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of past cultural influences, linguistic similarities, 
migrations and relationships among the native American 
populations. At pH 8.6, the variant migrates midway 
between albumins A and B.
analysis of CNBr peptides in an acid-urea-non-ionic
detergent gel system, Franklin et al. (1980) have resolved
two species of the variant, normally indistinguishable by
conventional electrophoresis. These have been named
albumins Mexico-1 and Mexico-2, but because all surveys have
so far employed conventional methods, the proportion
of each variant in a population is impossible to calculate.
Albumin Mexico-2 arises through a substitution
of aspartic acid by a glycine residue. The resultant loss 550
of one negative charge accounts for the slower mobility of 
the native protein at pH 8.6 and the faster mobility of 
the associated CNBr peptide at pH 3.0.
could be obtained for albumin Mexico-1 since all 
the CNBr peptides migrate identically to those of 
Albumin A in this system. This indicates that an acidic 
residue may be replaced by a neutral one or that the asp -*■ 
gly change is present but is obscured by a second 
substitution.
palmitate binding site. The change between the helix- 
indifferent aspartic acid and the helix-breaker 
glycine is sufficient to cause a gap in the helix of 
about four residues. This may influence the binding of
Using a new screening procedure involving the
In contrast, no such structural information
The mutation lies in the region of the primary
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long chain fatty acids. Haemoglobin and thyroxine bind 
normally (Melartin, 1967) but bromophenol blue and 
warfarin bind less readily (Wilding et al. , 1977).
The clinical implication of decreased binding is an increase 
in pharmacologically active free ligand leading to an enhanced 
response and possible toxicity. However, all homozygotes 
for the trait appear to be healthy.
1.8.2.14 Albumins Naskapi, Mersin and Adana
Together with albumin Mexico, albumins Naskapi 
and Mersin are the only widely distributed variants 
occurring at polymorphic frequencies. Albumin Naskapi 
was discovered by Melartin and Blumberg (1966) among 
the Naskapi and Montagnais Indians of Quebec and is 
found predominantly in the Indian populations of 
North America, Alaska and Canada. It occasionally co­
exists with albumin Mexico in the south-west. Where 
this occurs, the proportions of the two variants relative 
to albumin A and to each other differ between each 
Indian group.
Apart from very low frequencies observed 
in Eskimos of mixed ancestry (Melartin et al., 1968), 
albumin Naskapi was thought to be exclusive to American 
Indians. However, a similar variant, albumin Mersin 
has recently been identified among Eti Turks in southeastern 
Turkey (Franklin et al., 1980a). Albumin Mersin migrates 
identically to albumin Naskapi at pH 8.6 and may be the 
same variant. Both are fast alloalbumins.
The site of mutation in both albumins has
been localised to residues 373-389. The relevant CNBr 
peptide (residues 330-446) migrates more slowly at 
pH 3.0 than its normal counterpart which suggests a 
change from a basic residue, although the exact 
substitution site has not been identified.
Albumin Naskapi binds haemoglobin and thyroxine 
normally but shows a diminished affinity for warfarin. 
Conversely, bromophenol blue binding is increased.
Albumin Adana, also found among the Eti Turks 
and migrating similarly to albumin B, differs from 
the latter and albumin A by a substitution between 
residues 447-548.
1.8.2.15 Proalbumins Christchurch and Lille
Human proalbumin differs from albumin A in 
that it possesses an additional N-terminal hexapeptide 
with the sequence arg-gly-val-phe-arg-arg. Proalbumin 
is the intracellular precursor of albumin, and has been 
well characterised (Russel and Geller, 1975; Judah and 
Quinn, 1976). The propeptide contains an excess of 
positively charged groups and terminates with an arginyl 
residue at the site of cleavage, therefore being cleavable 
by intracellular serine proteases with a specificity 
similar to that of trypsin. Proalbumin can, in fact, 
be converted to albumin in vitro by mild treatment 
with trypsin (Judah et al. , 1973; Quinn et at., 1975; 
Brennan and Carrell, 1980). The presence of the basic 
propeptide also causes the 'pro'-form of albumin to be 
more positively charged than the active form, permitting
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separation of the two forms by electrophoresis.
In size, proalbumin is indistinguishable from 
albumin and no immunological differences are detectable 
upon double diffusion in agar against anti-albumin 
(Russel and Geller, 1973). The conversion of proalbumin 
into the active form occurs in the Golgi apparatus, 
probably by non-specific tryptic-like proteolysis.
However, the discovery of proalbumins Christchurch 
and Lille has provided additional evidence concerning 
the mode of cleavage of the propeptide. The C-terminal 
basic arginyl residue of the proalbumin Christchurch 
propeptide has undergone a point mutation to a neutral 
glutamine, whereas the penultimate residue in that of 
proalbumin Lille has changed from arginine to the basic 
histidine. Both proalbumins are readily cleaved in vitro 
by trypsin but remain uncleaved in vivo, which strongly 
suggests that cleavage occurs by specific proteolysis with 
paired arginine residues being a prerequisite. This fits 
the proposal that cleavage is effected by a specific 
protease, possibly Cathepsin B (Judah and Quinn, 1978).
Both proalbumins constitute approximately 
50% of the total serum albumin. At pH 5.0, proalbumin 
Lille migrates more slowly than proalbumin Christchurch.
Proalbumin Christchurch has lost the high 
affinity copper and nickel binding site since
the attachment of the propeptide has blocked the a-amino 
nitrogen essential for metal binding (Brennan and Carrell, 
1980). It hasn't, however, altered the conformation 
of albumin since palmitate, bilirubin, ANS and bromocresol
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green are all bound normally (Reed at al. , 1980).
1.8.2.16 Albumin Gainesville
This slow, monomeric variant occurs exclusively 
in European populations (Weitkamp et al., 1973a) and 
was originally discovered in an American family of 
Irish descent (Lau et al., 1969). It is a rare variant, 
occurring with a frequency of less than 1 in 1000 and has 
been characterised by Weitkamp et al.,(1969a).
Fragmentation by CNBr has enabled a partial local­
isation of the mutation (Lapresle, 1977). The change lies 
within the first 122 residues from the N-terminal end.
1*8.3 Non-Hereditary, Transient Bisalbuminaemia
1.8.3.1 Introduction
True, acquired transitory bisalbuminaemia was 
initially discovered in an 11-year old boy with ascites 
by Gabl and Huber (1964). The condition is rare, with 
only 64 reported cases from 1948 to 1976. All cases show 
common features: the transient bisalbumin appears 
during an acute, probably viral infection and only persists 
for a short while, disappearing sometimes even before 
the illness has completely subsided.
Transients can be formed through the binding of 
ligands, acute illness or may constitute their own type. 
Simultaneous familial investigations rule out the possibility 
that the trait is hereditary. In inherited alloalbumin- 
aemia, the two components are usually present in equal
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proportions whereas the proportion of a transient bis- 
albumin is markedly less than that of albumin A. Also, 
drug and enzyme-induced forms do not always show two 
distinct bands unlike inherited variants. Both albumins 
are usually immunologically similar.
Porta et al. (1980) reviewed 19 cases of
transient bisalbuminaemia, including 57 bisalbumins 
induced by drugs, 5 probably due to pancreatic disease and 
7 with an unidentifiable aetiology.
Dye binding has been employed by Porta et al. (1980)
as a means of distinguishing induced bisalbuminaemia 
from hereditary alloalbuminaemia. Bisalbumins have less 
affinity for bromocresol green and bilirubin than normal 
albumin and alloalbumins. Enzymatic digestion also 
reduces the dye binding capacity.
1.8.3.2 Ligand Effects
The binding of some small ligands to albumin 
gives rise to two bands on electrophoresis, one due to 
free albumin, and a faster migrating band containing the 
albumin-ligand complex. Their proportions depend upon 
the quantity of ligand present.
The most noticeable binding effect is that 
of penicillin, discovered by Arvan et al. (1968) in
patients receiving large intravenous doses of Penicillin 
G and related drugs. Patients developed a fast 
albumin component which disappeared upon cessation of 
therapy. In vitro experiments using normal sera, 
heterozygous alloalbuminaemic sera (albumins B
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and Naskapi), and purified albumin solutions showed that 
the phenomenon is related to the concentration of 
antibiotic in the serum. The binding of Penicillin G 
and Cephalothin induced the formation of four bands 
in the variant sera. The increase in mobility is due 
to the additional negative charge conferred upon 
the molecule by the carboxylic acid group of the drug.
The rapid form was not observed when Penicillin 
G was inactivated with penicillinase prior to binding.
The consequent opening of the B-lactam ring renders the 
drug non-functional. However, penicillinase had no 
apparent effect on pre-existing penicillin-induced 
bisalbuminaemia, indicating that binding to albumin 
offers protection to the immobilised B-lactam ring.
I I X * '
R - C - N H - C H — CH
i i
O I C -------N —
’n . - C H ,
penicillinase
n
R - C - N H - C H — CH
- C H - C O O H
Iore
OH
N-
v _^CH3 
<PCH3 
C H - C O O H
Penicillin G Penicilloic acid
Penicillin G-related drugs: Penicillin 0, 
Methicillin, Nafcillin and Ampicillin were similarly 
effective but streptomycin and Chloromycetin were 
less successful.
Gibaud et al. (1973) reported 12 cases of
transient bisalbuminaemia induced by heavy doses of
6-lactam antibiotics.
1.8.3.3 Transient Bisalbuminaemia Associated with
Pancreatic Disorders
A limited number of cases concerning the 
presence of a fast albumin in relation to pancreatitis 
have been reported. Shashaty and Atamer (1972) described 
two cases where the fast components were immunologically 
albumins, their proportions being directly related to 
serum amylase levels, but remaining well below 50% of 
the total albumin, even during hyperamylasaemia.
Lamotte-Barillon et al. (1975) observed a 
case of a different nature. The patient was suffering 
from chronic pancreatitis and ascites and the fast band 
was present continually, irrespective of amylase 
concentration. Since the electrophoretic pattern could 
be reproduced by partial digestion of albumin with 
trypsin in vitro, it was concluded that the fast component 
was an enzymic breakdown product of albumin.
Rousseaux et al. (1976) discovered transient
bisalbumins in the serum, ascitic fluid and pleural 
fluid of three patients. Structural analysis of the 
fast component revealed that the C-terminal end of 
the molecule differed from normal albumin and attributed 
this to limited enzymatic degradation by the proteolytic 
enzymes of the pancreas: chymotrypsin or elastase, 
followed by the action of carboxypeptidases A and B.
Gastard et al. (1976) demonstrated the clinical 
importance of finding a bisalbumin. Appearance in a
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patient with ascites suggests a pancreatic disorder, 
whereas a pancreatic fistula may be suspected should it 
be observed during chronic pancreatitis. In addition, 
possible overdosage may be prevented in patients with 
renal insufficiency undergoing intensive drug therapy 
(Bismuth et al., 1976).
A rare combination of pancreatic disease and 
hereditary slow alloalbuminaemia gave rise to accidental 
trisalbuminaemia (Tarnoky, 1982). The shortened 
albumin A molecule formed a fast band while the degraded 
slow variant migrated inside the unchanged albumin A 
band.
1.8.4 Analbuminaemia
Analbuminaemia is the absence or near absence 
of albumin in an individual. Plasma albumin concentration 
may be less than 0.5 g/litre (typically 1 mg to 100 mg %).
In man, the term seems to describe two separate abnormalities. 
Christen and Franglen (1972) liberated a large quantity 
of previously undetectable albumin from a macroglobulin 
complex, suggesting that one form of the disorder may 
be a hereditary masking of plasma albumin. Alternatively, 
the illness is generally associated with a deficiency in 
albumin synthesis.
The trait is rare and assumed to be an inheritable, 
autosomal recessive abnormality since patients are often 
the offspring of consanguineous marriages (Ott, 1974a).
Only 18 unrelated cases have been reported. Detection
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is usually delayed into adolescence but incidence in 
babies has been observed (Cormode ot al. , 1975; Goulle 
et al., 1976).
The lack of albumin is partly balanced by an 
increase in the other serum proteins: globulins, haptoglobulins, 
a antitrypsin, caeruloplasmin, aj-macroglobulin, IgM, 
transferrin, 6-lipoprotein and fibrinogen. Some of the 
transport functions are taken over by other proteins. 
Alternative fatty acid transport is efficient, less so 
for bilirubin.
The small quantity of albumin present has a 
prolonged half-life: 40-110 days compared to the normal 
turnover rate of 20 days. The survival time of transferrin 
is also extended. The catabolic rate for both proteins 
may or may not return to normal after restoration of 
albumin levels by infusion (Gitlin and Gitlin, 1975) 
which in itself suggests two forms of the defect, possibly 
also a defect in albumin catabolism. However, Waldmann 
(1977), is critical of this notion since the studies 
were carried out at different times after infusion.
Despite the absence of a functionally 
important protein, sufferers complain of only mild 
symptoms: occasional fatique, fainting, some oedema
andanaemia. Renal function is affected, low blood 
pressure and low capillary pressure are balanced by 
a low extravascular osmotic pressure. Circulating 
unbound bilirubin is a potential cause of jaundice and 
skin changes (11% of total body albumin is contained 
within the skin) such as eczema and dermatitis are
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occasionally presented.
Analbuminaemia is generally detected by 
immunological techniques and its existence, apart from 
being clinically important, leads to some speculation 
about the necessity and normal functions of albumin.
1.8.5 Effects of Variant Albumins
Few diseases can be linked with certainty to 
alloalbuminaemia. The main cause for concern lies 
with the altered binding properties of the variant albumin 
for drugs and bilirubin. Dosage calculations based only 
on the performance of normal albumin may lead to overdosage 
or undertreatment. The former is especially applicable to 
analbuminaemia. Reduced bilirubin binding may increase 
the risk of kernicterus in infants.
The reasons for variant polymorphism in 
American Indians as opposed to Europeans and other 
non-Indian populations is unclear. Blumberg (1969) 
speculated on the advantages of possible altered binding 
properties, particularly in relation to drugs. The 
retention of the AlNa and AlMe genes may be a result of 
natural selection although the evolutionary forces which 
maintain the trait are not known. A likely explanation 
is interbreeding between populations during several 
generations.
Neel (1973) estimated that the mutation rates for 
blood proteins in South American Indians could reach 
eight times those assumed for other populations, a
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feature attributable to a high degree of chromosome breakage, 
high serum mercury levels, extensive viral disease and 
the use of hallucinogens.
The influence of environmental factors on 
mutation rates is well demonstrated in Japan where the 
incidence of heterozygotes of 1:6000 in most regions of 
the country contrasts considerably with 1:400 in 
Hiroshima and Nagasaki.
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CHAPTER 2
2.1 INTRODUCTION
Routine hospital cellulose acetate electro­
phoresis at pH 8.6 revealed two non-identical variant 
albumins of the slow type.
The first incidence was discovered at Redhill 
General Hospital, in the sera of an English mother and 
son living in the neighbourhood of Redhill, Surrey, U.K. 
The variant was designated albumin Redhill after the place 
of origin.
The second alloalbumin migrates more slowly 
than albumin Redhill at pH 8.6. It was identified in 1981 
at Warwick Hospital in the serum of an unrelated Indian 
woman living in Warwick, U.K., and was termed albumin 
Warwick-2.
Fig. 2.1 shows the serum patterns of all three 
patients on polyacrylamide gel electrophoresis (PAGE) 
(Davis, 1964) .
2.2 OBJECTIVES
Hereditary alloalbuminaemia is the rare occurrence 
of an amino acid substitution (s) in the primary sequence 
of normal serum albumin, giving rise to a second albumin 
having either a faster, slower or equivalent electrophoretic
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Fig. 2.1 Polyacrylamide gel electrophoresis of variant 
sera. A and H - normal serum, B, C, E and 
F- albumin Redhill, D and G- albumin Warwick-2.
mobility (Section 1.8.2).
The main objective of the research was to 
isolate the variant albumins, identify the aberrant amino 
acids and finally to locate the substitution in the primary 
structure.
2.3 EXPERIMENTAL STAGES
The research was performed in 6 stages. The 
initial step involved the characterisation of albumins 
Redhill and Warwick-2 using standard methods of 
classification (Section 1.8.2.7 and Section 1.8.2.8).
The second stage was the isolation of the variant
albumins from serum, free from albumin A and other
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Fig. 2.1 Polyacrylamide gel electrophoresis of variant 
sera. A and H - normal serum, B, C, E and 
F- albumin Redhill, D and G- albumin Warwick-2.
mobility (Section 1.8.2).
The main objective of the research was to 
isolate the variant albumins, identify the aberrant amino 
acids and finally to locate the substitution in the primary 
structure.
2.3 EXPERIMENTAL STAGES
The research was performed in 6 stages. The 
initial step involved the characterisation of albumins 
Redhill and Warwick-2 using standard methods of 
classification (Section 1.8.2.7 and Section 1.8.2.8).
The second stage was the isolation of the variant
albumins from serum, free from albumin A and other
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contaminants. This condition was stringent so that 
any anomalies observed while comparing peptide maps 
with those of normal HSA could be attributed solely 
to the abnormal peptides.
Sequence analysis in the third phase involved 
fragmentation of the variant albumins into relatively 
large and readily accountable peptides. To this end, 
the sites of cleavage were aimed at those amino acids 
which occur only rarely in HSA, namely the six 
methionines and the lone tryptophan.
The fourth stage was the identification of the 
novel peptides by peptide mapping. This technique enabled 
the localisation of the anomalous peptides within the 
sequence.
Stage five encompassed various ligand binding 
studies, employed either to confirm or to give further 
information regarding the position of the amino acid 
aberration.
The final stage was not completed due to 
insufficient time. It was to have involved amino acid 
sequencing of the purified abnormal peptides in order to 
obtain a positive identification of the mutant residues.
CHAPTER 3
CHARACTERISATION OF ALBUMINS REDHILL 
AND WARWICK-2
3.1 INTRODUCTION
The variant albumins were classified
according to the following parameters:
(i) Total protein in the serum.
(ii) Total albumin in the serum.
(iii) Electrophoretic mobility on six media.
(iv) Ligand binding capacities of normal and 
variant albumins visualised on the same 
six media.
(v) Relative proportions of normal and variant 
albumins in the serum.
(Vi) Thermal stability.
( vii ) Resistance to freezing and thawing.
(viii) Molecular weight.
(ix) Detection of a possible pro-peptide.
(X) Isoelectric point.
(xi) Immunological character.
Dr.A. L. Tarnoky at the Royal Berkshire
Hospital kindly classified albumins Redhill and
Warwick-2 for us by carrying out the electrophoretic 
mobility and ligand binding tests.
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3.2 EXPERIMENTAL
3.2.1 Determination of Total Protein in Serum
The total protein contained in the variant
sera was measured according to the Biuret procedure 
of Gornall et al. (1949). The Biuret reagent comprised 
copper sulphate (CuSO^.5H20) (1.5 g), sodium potassium
tartrate (NaKC4H^0g.4H20) (6.0 g), NaOH (10% w/v, 300 ml)
and potassium iodide (KI) (1.0 g) per litre.
3.2.1.1 Preparation of Standards
The standard protein used was Sigma normal HSA, 
Fraction V, essentially free from fatty acids with a 
purity of 96-99%.
Biuret reagent (4.0 ml) was added to the 
albumin solutions (1.0 ml) containing 1-14 mg of protein. 
The latter figure was corrected for water content by 
spectrophotometric measurement at 280 nm and the actual 
weight of protein present calculated using
3.2.1.2 Preparation of Serum Samples
The sera were diluted 1:20 with water and 
lipid was removed by adding diethyl ether (1 vol. ether:
3 vol. serum). After mixing for 30 seconds, the two 
layers were separated by centrifugation in sealed vessels.
Lipid was removed into the organic phase and Biuret reagent was
5.31
(Hunter and McDuffie, 1959)
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added to the clarified aqueous layer.
The absorption of standards and samples was 
measured at 540 nm after 30 minutes at room temperature.
3.2.2 Determination of Total Albumin in Serum
The total albumin present in both sera was 
evaluated using the specifically binding dye bromocresol 
green (Doumas et al., 1971; Gustaffson, 1976).
Undiluted serum or standard normal HSA solutions 
(Section 3.2. 1.1) (10 gl) were added to 2.0 ml of the
dye solution: bromocresol green (0.15 mM), sodium 
succinate (75 mM), and 'Brij 35' surfactant (30% w/v,
4.0 ml) per litre, pH 4.20 + 0.05.
Mixing and timing began simultaneously and the 
absorbance of the albumin-dye complex was monitored at 
629 nm, commencing at 10 seconds after mixing and 
continuing for 2-3 minutes.
Albumin values were obtained by extrapolating 
the absorbance curves back to time = 0.
The standard solutions ranged from 1-10 g 
albumin/dl, corrected for water content.
3.2.3 Electrophoretic Mobility
Table 3.1 gives a summary of the conditions 
employed for the evaluation of electrophoretic mobility. 
The scheme originates from the Royal Berkshire Hospital 
test schecule (Tarnoky, 1980).
3.2.3.1 Staining
All electrophoretograms except for filter paper 
were stained with Ponceau S (0.2% w/v in TCA 3% w/v) and 
destained in acetic acid (7% v/v). The albumins were 
located on filter paper by drying the paper at 110°C 
for 10 minutes and then staining with bromophenol blue 
(1% w/v in 95% ethanol saturated with mercuric chloride), 
and destained in tap water.
3.2.4 Ligand Binding
For all electrophoretic methods except for 
disc-PAGE, serum (0.1 ml) was incubated with 50 pi of 0.05% 
aqueous solutions of each of the following dyes: bromophenol 
blue, bromocresol green, Ponceau S, Congo red, HABA and 
bilirubin, at 37°C for 10 minutes. The molar ratio of 
albumin:dye was approximately 2:1 except for HABA, in 
which case the ratio was 1:2.
For disc-PAGE, serum-sucrose (0.3 ml) was 
similarly incubated with 50 pi of each dye solution and 
the complete 350 pi loaded over the spacer gel.
The behaviour of the albumin-dye complexes was 
then observed by electrophoresis on the same six media as 
indicated in Table 3.1.
At the end of each run, the final appearance 
of the electrophoretograms was noted before staining.
The number and positions of the albumin bands were marked 
and quantitative estimations of the extent of ligand 
binding were made visually. The positions of unbound
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ligand were also acknowledged. The patterns were then 
stained and the positions of the albumins confirmed after 
destaining.
3.2.5 Estimation of the Relative Proportions 
of Albumins in Serum
The albumins were separated by cellulose 
acetate electrophoresis in barbitone buffer (0.075 M, 
pH 8.6). Location of the bands was effected by extended 
staining in Ponceau S (0.9 g), TCA (13.4 g), sulphosali- 
cylic acid (13.4 g)/litre to ensure complete penetration 
of the dye.
The background was destained in acetic acid
(5% v/v) and the acid subsequently removed by thorough
washing in distilled water.
The individual bands were excised and the dye
eluted with NaOH (1.0 ml, 0.4 M) by agitation for
several hours. The red colour was restored upon the
addition of acetic acid (40%, 0.1 ml), and the cellulose
acetate fragments were removed by centrifugation.
The absorbance of each eluate was measured at
X = 512 nm. max
3.2.6 Tests of Stability
3.2.6.1 Thermal Stability (Arends et al., 1969)
Sera were heated at 56°C for 30 minutes and
2 hours.
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3.2.6.2 Resistance to Freezing and Thawing
(Izquierdo et al., 1971)
Sera were twice frozen to -20°C and thawed at 
37°C a few hours later. Sera were also frozen at -20°C, 
thawed at 37°C and immediately re-frozen, 10 times. In 
addition, rapid freezing and thawing was conducted 
30-35 times over a time course of several days.
For both sets of tests, the resultant mobility 
and proportion of albumins Redhill and Warwick-2 were 
examined by cellulose acetate electrophoresis against the 
untreated variant sera.
3.2.7 Determination of Molecular Weight by SDS-PAGE
The molecular weight of normal and variant 
albumins was measured using isolated, defatted mixed albumins 
and sera diluted 10 times in water. As an aid to 
calculation, commercial molecular weight markers (BDH) 
spanning the range 12,300-78,000 were run alongside the 
albumin samples on each gel.
The gel system was based upon the discontinuous 
trie-buffer system of Laemmli (1970), employing a 12% 
separating gel containing tris-HCl (0.375 M), SDS (0.1% w/v), 
pH 8.9, and a 3% stacking gel, 0.125 M in trie-HCl and 0.1% in 
SDS, pH 6.8. This gel contained sucrose (40%) to increase 
mechanical strength. The electrophoresis buffer comprised 
trio (0.05 M), glycine (0.384 M) and SDS (0.1% w/v), final 
pH 8.3.
Samples were prepared for electrophoresis in the 
following buffer: trio-HCl (0.0625 M), glycerol (10% v/v) ,
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SDS (2% w/v), 2-mercaptoethanol (5% v/v) and bromophenol 
blue (0.01% w/v) as detailed in the manufacturers 
instructions (BDH Chemicals Ltd., England "Molecular 
weight markers for SDS-PAGE")- 10-20 yg of protein was 
applied per sample well and gels (16 x 16 x 0.15 cm) were 
electrophoresed at 60 V for 30 minutes, and then at 
120 V until the tracker dye had reached the base of the 
gel (6-7 hours).
Gels were simultaneously fixed and stained 
in PAGE Blue G-90 (0.25% w/v in methanol (45% v/v) and
acetic acid (10% v/v)). Destaining was performed at 
40°C in methanol (5% v/v), acetic acid (7.5% v/v)
(Weber et al. , 1972).
3.2.8 Detection of Proalbumins by Limited
Tryptic Digestion
The possibility that albumins Redhill and 
Warwick-2 may have N-terminal propeptides was investigated 
by digestion with trypsin under mild conditions.
3.2.8.1 With Purified Mixed Albumins (Quinn et al., 1975;
Brennan and Carrell, 1980)
The mixed albumins (10-15 mg) were chromatographed 
on a column (1.5 x 62 cm) of Ultrogel AcA 34 eluted with 
sodium phosphate-HCl buffer (0.01 M, pH 7.5) containing 
NaCl (0.1 M) . This procedure removed any contaminating 
dj-macroglobulin which acts as a trypsin inhibitor 
(Brennan and Carrell, 1980). Elution was at 18 ml/hour
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and the albumin fractions were pooled, dialysed against 
distilled water at 4°C and lyophilised.
The mixed albumins (5 mg) were dissolved in 
sodium phosphate-HCl buffer (1.0 ml, 50 mM, pH 7.5) 
containing calcium chloride (50 pM). Trypsin-TPCK 
(N-tosy1-L-phenylalanyl chloromethyl ketone) (1 pg) was 
added and digestion followed for 1 hour at 22°C. The 
reaction was stopped with soya bean trypsin inhibitor 
(2 pg) and the solution fractionated on a column (1 x 43 cm) 
of Sephadex G-50 eluted with sodium phosphate-HCl (10 mM, 
pH 7.5) at a flow rate of 14 ml/hour. The albumin peak 
was dialysed against water and lyophilised. Any conversion 
of albumins Redhill or Warwick-2 into albumin A was 
assessed by non-denaturing disc-PAGE (Davis, 1964).
3.2.8.2 With Serum (Rousseaux et al. , 1982)
Trypsin-TPCK (10 pi, 5 mg/ml) in ammonium 
bicarbonate buffer (0.1 M, pH 8) containing calcium 
chloride (0.1 mM) was added to variant sera (100 pi) and 
the mixture incubated at 37°C for 2 hours, 4 hours and 
6 hours. Digestion was stopped with soya bean trypsin 
inhibitor and cellulose acetate electrophoresis was 
carried out immediately at two pH levels: at pH 8.6 in 
barbitone buffer (0.075 M) and at pH 5.0 in sodium 
acetate buffer (0.031 M) containing EDTA (0.004 M) at 
8 V/cm for 2-3 hours using untreated sera as standards.
80
3.2.9 Isoelectric Points
The isoelectric points of normal and abnormal 
albumins were determined by isoelectric focusing (IEF) 
either in gel tubes or in thin layers of gel on both 
polyacrylamide and agarose media. Approximate pi 
values were obtained by focusing the proteins in a broad 
pH range. Subsequently, a more accurate determination 
was possible in a narrow pH range.
3.2.9.1 Analytical IEF in Polyacrylamide Gel Tubes 
(T = 5%. C = 3%)
3.2.9.1.1 Focusing
The gels (9 x 0.6 cm i.d.) containing 
Pharmalyte pH 4-6.5, were prepared as detailed in the 
book entitled "Polyacrylamide Gel Electrophoresis", 
supplied by Pharmacia (Great Britain) Ltd. After 
prefocusing for 30 minutes at 1 mA/gel, non-defatted 
albumin (10-20 yg) was applied to each gel and focusing 
was continued at 1-2 mA/gel, constant current for 3.5- 
4 hours. All gels were water-cooled to about 10°C.
The anode buffer consisted of (DL) glutamic 
acid (0.01 M) with L-histidine (0.01 M) at the cathode.
3.2.9.1.2 Fixing, Staining and Destaining
After focusing was complete, the proteins 
were fixed overnight in TCA (11.5% w/v) / sulphosalicylic 
acid (3.45% w/v)/ methanol (30% v/v), and then stained 
in PAGE Blue G-90 (0.115% w/v) dissolved in destaining
solution: ethanol (25%v/v)/acetic acid (8% v/v).
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Destaining was at 40°C.
3.2.9.1.3 Measurement of the pH Gradient
Commercially available pi markers (Pharmacia 
(Great Britain) Ltd.) were used for accurate isoelectric 
point determination. The particular set of markers 
applicable in this instance were contained in the Low 
pi Calibration Kit (pH 2.5-6.5) and were prepared 
according to the manufacturers'instructions. In the 
final, stained gels, four markers were visible: glucose 
oxidase (pi 4.15) soya bean trypsin inhibitor (pi 4.55), 
B-lactoglobulin A (pi 5.20) and bovine carbonic anhydrase 
B (pi 5.85).
3.2.9.2 Analytical IEF in Thin Laver Polyacrylamide
Gels (T = 5%, C = 3%)
Gels were cast onto thin, silanised glass 
plates (25 x 12.5 cm). Pre-treatment of the glass with 
Silane A174 enables the gel to become chemically bonded 
to the plate by means of covalent linkages. Therefore, 
adhesion of the gel to the glass plate is ensured 
throughout the long fixing, staining and destaining 
processes. In addition, gel damage due to tearing and 
problems of gel distortion through shrinkage and swelling 
are minimised.
3.2.9.2.1 Focusing
The gels (11 x 11 x 0.15 cm) were cast by 
following a combination of instructions described in 
the book entitled "Isoelectric Focusing-Principles and
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Methods" by Pharmacia, and in LKB Application Note 250.
Gels incorporating the pH 3-10 range Pharmalyte were 
focused at 15 watts constant power with 25 mA maximum 
current and 1000 V maximum voltage. Under these conditions, 
the focusing time was 1.75 hours.
Gels containing the pH 4-6.5 range Pharmalyte 
were focused at 12 watts constant power with 15 mA 
maximum current and 750 V maximum voltage. Focusing 
was complete after 3 hours.
Before application of the samples, gels were 
prefocused for 30 minutes to remove persulphate and any 
contaminating acrylic acid which may cause gradient drift.
All gels were cooled to 10°C.
The electrolytes were as follows:
pH Range Anolyte (+) Catholyte (-)
3-10 H3P04 (0.1 M) NaOH (1.0M)
4-6.5 (DL) glutamic 
(0.01 M)
acid L-histidine 
(0.01 M)
3.2.9.2.2 Fixing, Staining and Destaining
After completion of focusing, gels were 
fixed for 1 hour in TCA (10% w/v)/ sulphosalicyclic acid 
(5% w/v). The gels were freed from ampholytes by 
immersing in destaining solution, methanol:acetic acid: 
water (3:1:6) for 30 minutes, after which time they 
were stained for 3-6 hours in PAGE Blue G-90 (0.2% w/v) 
dissolved in destaining solution. Destaining was at 40°C.
*■% '. ~f-fr
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3.2.9.2.3 Measurement of the pH Gradient
For both pH ranges, the Low pi Calibration 
Kit was used to measure the resultant gradient. In the 
pH 3-10 range, the following markers were visible: 
amyloglucosidase (pi 3.50), glucose oxidase (pi 4.15) 
soybean trypsin inhibitor (pi 4.55), 6-lactoglobulin A 
(pi 5.20), bovine carbonic anhydrase B (pi 5.85), and 
human carbonic anhydrase B (pi 6.55).
3.2.9.3 Analytical Agarose IEF
3.2.9.3.1 Focusing
were prepared by adding Agarose IEF (0.1815 g) and 
sorbitol (99+% pure) (2.178 g) to distilled water 
(16.34 ml) and heating at 100°C until dissolved. The
Pharmalyte pH 3-10 or pH 4-6.5 (1.15 ml) was added.
The gel was quickly cast into Gel Bond film as described 
by Pharmacia, and left for 1 hour at 4°C in a humidity 
chamber to harden.
at 7 watts constant power with 75 mA maximum current and 
750 V maximum voltage. Focusing required 1.5 hours under 
these conditions at 10°C. The anode solution comprised 
H2S04 (0.05 M) with NaOH (1.0 M) at the cathode, for
both ranges.
The pH gradient was measured using pi standards 
as detailed for PAG-IEF.
Fixing, staining and destaining utilised the 
same solutions and followed the same sequence as for
Thin layer agarose gels (11 x 11 x 0.15 cm)
solution was allowed to cool to about 70°C and
Gels incorporating both pH ranges were focused
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thin-layer PAG-IEF.
3.2.10 Immunological Character
The immunological properties of albumins 
Redhill and Warwick-2 were examined by two methods.
(i) The double immunodiffusion procedure of
Ouchterlony.
(ii) Immunoelectrophoresis.
The extent of immunological similarity to 
albumin A was determined by reacting variant sera and 
purified normal and abnormal albumins with goat anti­
albumin A.
3.2.10.1 ftuchterlony Double Diffusion (Ouchterlony, 1949)
3.2.10.1.1 Preparation of the Agar Gel (Clausen, 1981)
Agar Noble (electrophoretic grade) was
de-fined in distilled water. NaCl (0.83% w/v) and sodium 
azide (0.1% w/v) in water were added to the agar (1.5% 
w/v). Dissolution was aided by heating at 100°C in a 
flask loosely stoppered by an inverted 5 ml volumetric 
flask .
Alcohol-washed microscope slides were covered with 
molten agar (4.0 ml) and left to set at room temperature.
Wells (lOyl approximate volume) were cut in 
the agar with a truncated Pasteur pipette using a 
template for guidance, such that 8 wells were 
situated circularly around a central well. The radius 
of the circle was 7.5 mm and the well contents were
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removed with a needle.
3.2.10.1.2 Determination of a Balanced Antigen:
Antibody System
Initial trials to fix a balanced proportion 
between antigen and antibody were done by performing 
immunodiffusion in 2 series:
(i) A fixed quantity of the antigen diffusing
against a series of antibody dilutions.
Pure albumin A (10 yl, 1 mg/ml) was applied 
to the centre well. Antiserum (10 ill) was 
applied to the surrounding wells after the 
following dilutions in water: undiluted,
1 in 2, 1 in 3, 1 in 4, 1 in 5, 1 in 10,
1 in 15 and 1 in 20.
(ii) A fixed quantity of the antibody diffusing
against a series of antigen dilutions.
Undiluted antiserum (10 yl) was applied to 
the centre well and pure albumin A (10 yl,
1 mg/ml) diluted in water as above, applied 
to the surrounding wells.
The slides were placed in a humidity chamber 
at 4°C and diffusion was allowed to proceed for 16 hours.
3.2.10.1.3 Preservation of the Slides
The gels were washed for 24 hours in 
phosphate buffered saline, (0.05 M phosphate, pH 7.0) 
containing NaCl (0.8% w/v) to remove unreacted antigen 
and antibody and to stop diffusion. The agar was then 
washed free of NaCl with distilled water for several 
hours and the immunoprecipitates subsequently stained with
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Amido Schwartz 10B (0.1% w/v in acetic acid (5.4% v/v) , 
sodium acetate (0.72% w/v) and glycerol (1% v/v)) for 
10 minutes. Slides were detained in acetic acid (5% v/v) 
for 2 hours.
Gels were dried by overlaying them with 
filter paper (Whatman 542) being careful to exclude air 
bubbles, and drying under vacuum at 37°C (about 12 hours) 
or 60°C (about 2 hours). Alternatively, if left open 
to the air at room temperature, complete drying required 
48 hours.
3.2.10.1.4 Immunoprécipitation of Albumins Redhill 
and Warwick-2
The centre wells contained undiluted antiserum 
(10 pi) and surrounding wells contained solutions (10 pi,
1 mg/ml) of pure albumin A, pure albumins Redhill and 
Warwick-2, and pure albumin A isolated from the variant 
sera, all diluted 1 in 5. Diffusion, preservation and 
staining of slides was as previously described (Section 
3.2.10.1.3).
3.2.10.2 Immunoelectrophoresis (Scheidegger, 1955) 
3.2.10.2.1 Preparation of the Agar Gel (Clausen, 1981)
(i) For Immunoelectrophoresis of serum
Agar noble (electrophoretic grade, 1% w/v) 
was dissolved in sodium veronal-HCl buffer (0.05 M, 
pH 8.4) containing sodium azide (0.1% w/v) by 
heating at 100°C. Alcohol-washed microscope slides 
were covered with the molten, buffered agar (2.0 ml)
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and set aside to harden.
Two wells (capacity about 5 pi) were cut in 
parallel approximately 2 cm from one end of the slide and 
filled with serum (2 pi). Electrophoresis was performed in 
sodium veronal-HCl buffer (0.05 M, pH 8.4) at 10 V/cm 
for 3.5 hours.
longitudinal channel of width 1 mm was cut equidistant 
between the sample wells, using two razor blades 
secured in parallel. Antiserum (40 pi) was spread in the 
channel and immunodiffusion was allowed to proceed at 4°C 
in a humidity chamber for 16 hours.
(ii) For immunoelectrophoresis of pure variant albumins
of the pure albumins Redhill and Warwick-2 (1 mg/ml, 15-20 pi) 
were used to fill more capacious wells cut as described 
previously. The proteins were electrophoresed in sodium 
veronal-HCl buffer (0.05 M, pH 8.4) at 10 V/cm for 6 hours. 
Antiserum (60 pi) was used to fill the central channel 
and immunodiffusion took place in a similar manner to that 
stated for serum.
3.2.10.2.2 Washing, staining and preservation of slides 
Gels were washed and the immuno-precipitation 
lines stained following the procedures for Ouchterlony diffusion
(Section 3.2.10.1.3). Slides were dried under vacuum at 
37°C.
The slide was removed from the tank and a
4.0 ml of agar was poured per slide and solutions
Slides of serum were also stained after the
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electrophoresis stage to show the extent of separation of 
the albumins before the diffusion step.
3.3 RESULTS AND DISCUSSION
The total concentration of serum proteins in the 
subject carrying albumin Redhill was 68 g/litre. This 
figure is well within the normal range of 60-80 g/litre.
The total protein concentration of serum containing 
albumin Warwick-2 was considerably higher, at 102 g/litre.
The total albumin levels of both sera were within 
the normal range of 35-50 g/litre. Albumin A/albumin 
Redhill constituted 39 g/litre whereas albumin A/albumin 
Warwick-2 comprised 40 g/litre of serum. Figures 3.1 and 3.2 
show the standard curves obtained for total protein (Biuret) 
and total albumin (bromocresol green) determinations 
respectively.
The relative proportion of albumin Redhill: 
albumin A in the serum is 40%:60% while albumin Warwick-2 
constituted 45% of the total albumin against 55% of 
albumin A. Albumin Redhill, therefore, constitutes
15.6 g/litre with the level of albumin Warwick-2 at 
18.0 g/litre of serum. Albumin variants usually comprise 
approximately half of the total serum albumin, with a 
slight preponderance of the normal allotype (Section 1.8.2.10.4). 
Albumin Warwick-2 also falls into this category but albumin 
Redhill may be slightly anomalous in this respect, with 
only 40% of the variant present. However, it is 
appreciated that these relative values are only approximations
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Fig. 3.2 Total albumin:bromocresol green standard curve.
since differential binding of Ponceau S by normal and 
variant albumins due to the altered primary structure 
of the variants, may obscure the true relationship 
between the concentrations of each albumin.
The relative mobilities on cellulose acetate 
electrophoresis, and the concentrations of both variants 
remained unchanged after repeated freezing and thawing 
and by heating at 56°C. This shows that both albumins
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Redhill and Warwick-2 are monomeric variants and that 
the altered electrophoretic mobility is not brought about 
by the binding of small ligands which should have been 
detached during these procedures. The character of the 
variant albumins was similarly unaltered after prolonged 
storage at -20°C. Furthermore, the hereditary nature 
of albumin Redhill is certain since this variant is 
present in more than one member of the same family. 
Although a closer familial investigation of albumin 
Warwick-2 has not been possible, the results of these 
tests strongly suggest that albumin Warwick-2 is not 
a transient variant.
SDS—PAGE revealed that albumin Warwick-2 has a 
similar molecular weight to albumin A. The two albumins 
cannot be distinguished on this basis by conventional 
SDS-PAGE. In contrast, however, the molecular weight of 
albumin Redhill is greater than that of albumin A by 
about 2,200. Fig. 3.3 shows the molecular weight gel of 
albumin A/albumin Redhill. This is very unusual since 
other monomeric variants, where this parameter has been 
measured, show no molecular weight differences to 
albumin A. Moreover, a substitution of only one amino 
acid by another would be unlikely to cause an identifiable 
change in mass since even the molecular weight of 
proalbumin, which has an additional hexapeptide, is 
indistinguishable from the molecular weight of albumin 
(Section 1.8.2.15). This indicates that albumin Redhill 
has undergone more than a single base change and has 
therefore not arisen merely as a result of a single amino
I Fig. 3.3 Molecular weight determination of albumin Redhill by SDS—PAGE (Laemrali, 1970).
A and C, albumin A/albumin Redhill;
B and D, standard molecular weight markers.
acid mutation, whereas albumin Warwick-2 would appear to 
be a more 'conventional' variant. The molecular weights 
calculated using commercial standards are: albumin A, 
65,400, albumin Warwick-2, 65,400, albumin Redhill, 
67,600. Fig. 3.4 shows a sample standard molecular 
weight curve (albumin A). These calculations confirm 
that both variants are monomeric.
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A B C D
Fig. 3.3 Molecular weight determination of albumin Redhill 
by SDS—PAGE (Laemrali, 1970).
A and C, albumin A/albumin Redhill;
B and D, standard molecular weight markers.
acid mutation, whereas albumin Warwick-2 would appear to 
be a more 'conventional' variant. The molecular weights 
calculated using commercial standards are: albumin A, 
65,400, albumin Warwick-2, 65,400, albumin Redhill, 
67,600. Fig. 3.4 shows a sample standard molecular 
weight curve (albumin A). These calculations confirm 
that both variants are monomeric.
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Fig. 3.4 Standard molecular weight curve (albumin A).
The method of limited tryptic digestion used to 
establish whether or not the variants are proalbumins 
proved to be inconclusive when applied to albumin Redhill. 
Digestion of both the serum and purified mixed albumins 
gave similar results. The electrophoretic mobility of the 
variant was unaltered at both pH 8.6 and 5.0. Albumin 
Redhill is indistinguishable from albumin A at pH 5.0, 
both before and after treatment with trypsin. However,
the unchanged mobility cannot disprove that albumin Redhill 
is not a proalbumin: the degree of difference between the 
molecular weights of albumin Redhill and albumin A is too 
large to account only for the increase in size associated 
with an additional six residues; the molecular weight of 
the normal propeptide is approximately 880. Therefore, 
if albumin Redhill is a proalbumin, the expected change 
in electrophoretic mobility would be obscured by the 
remaining mutant residues which must exist at some other 
position in the sequence and lead to a further weight increase 
of approximately 1,300, corresponding to about ten to twelve 
additional amino acids. This change alone is likely to 
account for a retarded electrophoretic mobility. Consequently, 
an N-terminal propeptide cleaved off by trypsin may be 
undetectable by this method.
Alternatively, albumin Redhill may not be a 
proalbumin since the loss of a basic region of the 
sequence is likely to cause some change in electrophoretic 
mobility. However, further evidence obtained from metal 
binding studies (Chapter 7) and end group determination 
(Chapter 5) support the proposal that this variant is a 
proalbumin.
Albumin Warwick-2 is not a proalbumin. The 
electrophoretic mobility of the variant was unchanged at 
pH 8.6 and 5.0 after digestion with trypsin. Unlike 
albumin Redhill, albumin Warwick-2 is distinguishable from 
albumin A at pH 5.0, migrating more slowly at both pH 
levels. Since there is no uncharacteristic mutation to 
obscure the propeptide in this variant, it can be
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concluded that albumin Warwick-2 does not possess an additional 
N-terminal hexapeptide.
Under similar conditions, the pro-peptides of 
Proalfc>iimins Christchurch and Lille were cleaved and the 
electrophoretic mobility of the variants reverted to that 
of albumin A (Section 1.8.2.15).
The isoelectric points of albumins A, Redhill and 
Warwick-2 are detailed in Table 3.2.
Non-defatted albumin A showed one band and 
mixed albumin A/albumin Redhill and albumin A/albumin 
Warwick-2 showed two well-defined bands in gel cylinders 
in the pH range 4-6.5. In the pH 3-10 range on both 
polyacrylamide and agarose thin layer gels each albumin 
focused as a single band. However, in the pH 4-6.5 
range on both media, an additional, minor band with a 
pi of 4.65 was present in all albumin samples. This extra 
band is probably due to the established heterogeneity of 
albumin preparations (Section 1.6) and is a manifestation 
of differential fatty acid binding by all the molecules 
in a sample. This low pi band is not visible in the pH 3-10 
range which is too broad to be able to resolve the hetero­
geneous forms.
The pi values for albumin A obtained in gel 
cylinders are slightly higher than those calculated using 
the thin layer technique. This is probably due to the 
difficulty in reproducibly measuring and casting individual 
gels.
The pi of albumin Redhill is lower than the pi 
of albumin A, while albumin Warwick-2 has a higher pi.
■ ■ ■
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Since both variants are of the slow type it was expected 
that their pi's would fall on the basic side of albumin A, 
since slow albumins are more positively charged and hence 
should require less protonation to reach electrical 
neutrality. While albumin Warwick-2 conforms to this 
pattern, albumin Redhill does not. Isoelectric focusing 
suggests that this variant has an overall more negative 
charge than albumin A whereas non-denaturing electrophoresis 
suggests a more positive net charge. A contributary factor 
to this anomalous behaviour may be the increased molecular 
size which retards the variant behind albumin A on 
conventional electrophoresis, obscuring an overall more 
negative charge than the usual allotype.
Fig. 3.5 shows the stained immunoprecipitates 
after fiuchterlony immunodiffusion. From preliminary 
investigations, the optimum conditions for the formation
- V„
I
Fig. 3.5 fluchterlony immunodiffusion of albumins A,
Redhill and Warwick-2. A, E, I and M, albumin A 
from pooled human serum» B, C and D, albumin A 
from serum containing albumin Redhill» F, G and 
H, albumin Redhill» J, K and L, albumin A from 
serum containing albumin Warwick-2» N, 0 and P, 
albumin Warwick-2.
of a precipi-tation line occurred between undiluted 
antiserum and albumin solutions (1 mg/ml) diluted
97
Since both variants are of the slow type it was expected 
that their pi's would fall on the basic side of albumin A, 
since slow albumins are more positively charged and hence 
should require less protonation to reach electrical 
neutrality. While albumin Warwick-2 conforms to this 
pattern, albumin Redhill does not. Isoelectric focusing 
suggests that this variant has an overall more negative 
charge than albumin A whereas non-denaturing electrophoresis 
suggests a more positive net charge. A contributary factor 
to this anomalous behaviour may be the increased molecular 
size which retards the variant behind albumin A on 
conventional electrophoresis, obscuring an overall more 
negative charge than the usual allotype.
investigations, the optimum conditions for the formation
Redhill and Warwick-2. A, E, I and M, albumin A 
from pooled human serum; B, C and D, albumin A 
from serum containing albumin Redhill; F, G and 
H, albumin Redhill; J, K and L, albumin A from 
serum containing albumin Warwick-2; N ,  O and P ,  
albumin Warwick-2.
Fig. 3.5 shows the stained immunoprecipitates 
after fiuchterlony immunodiffusion. From preliminary
1 y a
j  '  h b
(2 ) k 9 (2 )o c
n 1m c
Fig. 3.5 fiuchterlony immunodiffusion of albumins A,
of a precipitation line occurred between undiluted 
antiserum and albumin solutions (1 mg/ml) diluted
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1 in 5. The immunoprecipitates fused completely in the 
central area indicating that both albumins Redhill and 
Warwick-2 possess a similar antigenic make-up to albumin A. 
The immunological behaviour of the variant albumins is 
indistinguishable from that of albumin A by this technique.
Fig. 3.6 shows the immunoelectrophoretic 
patterns of both variant sera. Gels stained after
(a )  albumin Warwick -  2
( b )  albumin W a r w i c k  -  2
electrophoresis of serum revealed that albumin Warwick-2 
was visibly distinct from albumin A whereas albumin Redhill 
and albumin A remained inseparable. The morphology of the 
immunoprecipitates associated with Immunoelectrophoresis 
is influenced by the mobility of the antigens (Hirschfeld, 
1960) so that for the albumin fraction, albumin A/ 
albumin Warwick-2 shows two arcs fused in the centre 
reminiscent of one antigen with two main electrophoretic 
mobilities but with similar immunological properties.
The albumin fraction containing albumin Redhill shows
only one arc located alongside the electrophoretic zone.
Fig. 3.6 Immunoelectrophoresis of sera containing albumins
Redhill and Warwick-2 after:
(a) electrophoresis only
(b) electrophoresis followed by immunodiffusion.
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Both pure albumins Redhill and Warwick-2 gave a single pre­
cipitation arc with anti-albumin A. Hence, immunoelectro- 
phoresis confirms the antigenic similarity of both variants 
to albumin A. However, these seemingly complete immunogenic 
reactions cannot prove total antigenic similarity to 
albumin A since the methods and antibody preparations used 
may not be selective enough to detect minute changes in 
primary structure. Polyclonal antibodies like the goat 
anti-albumin A used in this study are heterogeneous since 
they consist of antibodies which cross react with 
different parts of the albumin molecule. Monoclonal 
antibodies are required if a single amino acid mutation 
is to be detected. Lapresle and Doyen (1983) have 
recently reported two monoclonal antibodies to HSA which 
can detect the glutamic acid,-70 to lysine substitution in 
albumin B.
The electrophoretic mobility tests show that 
both albumins Redhill and Warwick-2 are slow variants. 
Albumin Warwick-2 migrates more slowly than albumin Redhill 
at pH 8.6. Table 3.3 shows the combined results from the 
relative mobility and ligand binding tests for both 
variants.
Both sets of tests distinguish albumin Redhill 
from four other European variants classified under 
similar conditions: albumin RIH (Chapman et al. , 1978), 
albumin Amsterdam (Sanders et al. , 1979)*, albumin Stirling 
and albumin Yorkshire (Curnow et al., 1978)*. Albumin
*Curnow, J. V. , Fraser, G. P. and Tarnoky, A. L. (1978)
I.R.C.S. Med. Soi., 6, 525Sanders, G. T . B., Curnow, J. V. and Tarnoky, A. L . (1979)
I.R.C.S. Med. Soi., 7, 581
Redhill migrates more closely to albumin A at pH 8.6 
than any of these variants.
Comparing the dye binding properties, albumin 
Redhill binds bromophenol blue and Ponceau S similarly 
to albumin Amsterdam, bromophenol blue, Ponceau S, 
bilirubin and Congo red similarly to albumin Stirling, 
bromophenol blue, bilirubin and Congo red similarly to 
albumin Yorkshire but showed no common binding properties 
to albumin RIH on cellulose acetate, Helena, disc-PAGE 
and agarose. The other ligands are bound differently 
on one or more of the various media. However, it is not 
possible to make an absolute comparison since at the time 
of testing, the carrier of albumin Redhill was taking a 
variety of drugs and had previously undergone a succession 
of drug treatments over several years. Dye uptake by 
the albumins may be affected by the blocking action of 
bound drugs, as observed in albumins Stirling and 
Yorkshire.
Albumin Warwick-2 differs from several Indian 
variants available for comparison: albumin Warwick-1 
(Tarnoky, private communication), albumin Jaffna 
(Bayliss et al., 1983)*, albumin Vancouver (Frohlich 
et al. , 1978), albumin Birmingham (Bradwell et al. , 1975), 
albumin Kashmir (Tarnoky and Dowding, 1969), and 
albumin Hussain (Tarnoky, private communication).
Albumin Warwick-2 binds bromophenol blue and Ponceau S 
similarly to albumin Jaffna, bromophenol blue similarly 
to albumins Warwick-1 and Kashmir but shows no common dye
‘Bayliss, V. M., Curnow, J. V., Tillyer, C. R. and 
Tarnoky, A. L. (1983) I.R.C.S. Med. Soi., 1J , 250-251
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binding characteristics to albumins Vancouver and 
Hussain on cellulose acetate, Helena, disc-PAGE, 
agar and agarose media. The relative electrophoretic 
mobility is slower than any of these variants on all 
five media except for a faster mobility than albumin 
Vancouver on Helena and agarose, and than albumin 
Hussain on agarose.
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Table 4.1 Some methods used in the purification of albumin variants
Variant Separation Method Final Purity Reference 1
Albumin D Starch block electrophoresis 85-95% Gitlin at a l .  (1961)veronal buffer (0.1 M, 
pll 8.6)
Albumin Oliphant DEAE-Sephadex
sodium phosphate (0.2 M ,
pH 5.75)
> 95% winter e t  a l .  (1972)
idl
Albumin Gainesville DEAE-Sephodex
sodium phosphate (0.15 M, Laprcsle (1977) si J
pH 5.75)
byl
Albumin Birmingham DEAE-Cellulose Bradwell e t  a l .  (1975)
by Jsodium phosphate (0.02 M, pH 7.0)
incorporating a linear 
salt gradient prl
wi J
Albumin Kashmir Chromatofocusing 
pH range 4-5
90% Ti1Iyer a t  a l .  (1982)
all
Proalbumin Christ- DEAE-Sephadcx Brennan and Carrcll in 1church sodium acetate (0.025 M, 
pH 5.1-4.6) (1978) iol
Proalbumin Lille Preparative cellulose acetate 
electrophoresis
> 95% Abdo a t  a l .  (1981) and
tris-veronal buffer (pH 8.6) usd
Un-named fast and QAE-Sephadex A-50 Bradley and Hornbockslow variants sodium acetate (0.1 M , 
pH 5. 1-4.6) (1974) by J
Transient DEAE-Sephadcx A-50 Rousseaux at a l .  (1976) el J(pancreatitis) sodium phosphate (0.4 M, 
pH 5.75)
by I
Transient DEAE-Sephadex Laprcslc and Wal (1979) be j(penicillin) sodium phosphate (0.15 M, 
pH 5.75)
prd
red
tha
dyd
s ta
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CHAPTER 4
PURIFICATION OF ALBUMINS REDHILL 
AND WARWICK-2
rence
al.  ( 1 9 6 1 ) 4.1 INTRODUCTION
at. ( 1 9 7 2 ) Albumin variants, for the most part have almost 
identical molecular weights to albumin A, as well as
( 1 9 7 7 ) similar immunological properties. The only obvious means
ft al. ( 1 9 7 5 )
by which they differ from their normal counterpart are 
by charge and isoelectric points. The latter two 
properties have been exploited in various forms by workers
! al. ( 1 9 8 2 )
wishing to isolate pure samples of either fast or slow 
alloalbumins in order to carry out subsequent structural
id Carrcll investigations. To date, separations have involved 
ion-exchange chromatography, preparative electrophoresis
. ( 1 9 8 1 ) and chromatofocusing. Table 4.1 summarises the methods 
used to purify some albumin variants.
d Hornbeck Samples of pure albumin Redhill were obtained both 
by chromatofocusing and preparative polyacrylamide gel
a t  al. ( 1 9 7 6 ) electrophoresis. Albumin Warwick-2 was purified exclusively 
by preparative-PAGE, since this latter method proved to
hd W a l  0  9 7 9 ) be less time consuming and less expensive although no 
preference is expressed over the final preparation 
resulting from either technique.
Albumin A was purified from pooled human serum.
the final stage being either chromatofocusing or 
dye-affinity chromatography. The initial purification 
stages for all the albumins followed the same route,
namely, ammonium sulphate precipitation and gel filtration.
4.1.1 Chromatofocusing
4.1.1.1 Introduction
Chromatofocusing is a relatively new technique.
A pH gradient is generated on an ion-exchange resin by 
taking advantage of the buffering action of the charged 
groups within it. Proteins are separated according to 
their isoelectric points.
The method gives high resolution, has a high 
capacity and is easy to operate.
4.1. 1.2 Principle
The pH interval is chosen such that the 
isoelectric points fall roughly in the middle of the 
ensuing pH gradient. The appropriate Polybuffer 
exchanger is equilibrated with the starting buffer, the 
pH of which is set slightly above the upper limit of 
the pH gradient, whilst the pH of the eluant, Polybuffer, 
is adjusted to the pH value chosen for the lower limit.
The pH gradient forms automatically as the charged groups 
on the exchanger are titrated with the large number of 
differently charged species which comprise the eluant, 
and the proteins emerge from the column in order of 
decreasing isoelectric point.
4 . 1 . 1.3 Behaviour of Proteins on the Column
A protein migrating down the column is
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continually attached and detached from the ion~exchanger 
depending on the pH of the environment and the charge on 
the protein at any particular instant.
When the pH of the eluting buffer is below 
the pi of the protein, the protein is positively 
charged and so does not bind to the anion exchanger.
The pH of the buffer increases with distance from the 
point of origin and when the changing pH rises above 
the pi, further down the column, the protein reverses 
its charge and becomes bound to the exchanger, where it 
remains until the gradient causes the pH to fall below 
the pi, releasing the protein again. This process is 
repeated throughout the length of the column until 
the protein emerges at its pi.
4.1. 1.4 The Focusing Effect
A protein applied to the column migrates in the 
eluant as far as its isoelectric point, whereupon it 
travels more slowly until it elutes. If a similar protein 
sample is applied some time after the first sample, it 
descends at the same speed as the eluant until it catches 
up with the slower-moving sample. The proteins then proceed 
down the column at the same speed until they co-elute.
This effect increases the resolution of the method.
4.2 EXPERIMENTAL
4.2.1 Ammonium Sulphate Precipitation (McMenemy
et al. , 1971)
Blood was collected from patients without
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the addition of anticoagulant. A crude preparation of 
albumin was first obtained by adding solid ammonium 
sulphate to sera with slow stirring at 0°C until 
45% saturated (277 g/litre, pH 6.5). After about 20 
minutes, the precipitate was removed by centrifugation at 
7,000 r.p.m. at 4°C for 30 minutes. The aranonium sulphate 
saturation of the supernatant was increased to 75%
(516 g/litre, pH 4.5) and the precipitate spun down at 
15,000-18,000 r.p.m. for 30-60 minutes at 4°C.
4.2.2 Gel Filtration and Desalting
The second precipitate was retained and redissolved 
in the minimum volume of trie-HC1 buffer (0.01 M, pH 7.0) 
containing NaCl (0.05 M) . A suitable volume of this 
solution (the product from about 5-6 ml of original serum) 
was applied to a column (1.5 x 95 cm) of Sephadex G-100 
equilibrated with the trie-buffer previously described.
The column was eluted with the same buffer at a flow rate 
of 15 ml/hr. The albumin closely followed a turbid 
region of high lipid content and was easily recognisable 
owing to the yellow colour of protein-bound bilirubin.
The albumin fractions were pooled, dialysed exhaustively 
against distilled water at 4°C and lyophilised.
It was convenient at this point to defat 
the albumin although chromatofocusing experiments were 
performed using the non-defatted protein. Albumins were 
defatted before preparative PAGE.
4.2.3 Defatting (Chen, 1967)
The charcoal treatment of Chen is a very mild 
technique and the native conformation of proteins remains 
undisturbed. Other bound ligands, particularly bilirubin 
are also removed.
Activated charcoal was washed with distilled 
water, filtered by suction and allowed to dry at room 
temperature.
Albumin was dissolved at room temperature in 
distilled water and charcoal (half the weight of protein) 
was mixed in. The pH of the solution was lowered 
to pH 3.0 with HC1 (0.1 M) and the mixture stirred 
magnetically for 1 hour on an ice bath. The charcoal 
was removed by centrifugation at 2°C and the clarified 
solution brought to neutrality by the addition of NaOH 
(0.1 M).
The defatted albumin was dialysed against 
distilled water at 4°C and lyophilised
4.2.4 Chromatofocusing
4.2.4.1 Separation of the Albumins
The chosen pH range was pH 6-4. All gels 
and buffers were degassed before use to prevent 
irregularities in the pH gradient caused by dissolved 
atmospheric CC^- This phenomenon occurs between pH 5.5 
and 6.5 and may cause a pH plateau in this region.
A column (1 x 26 cm) of Polybuffer exchanger
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(PBE) 94 was equilibrated with the starting buffer, 
histidine-HCl (0.025 M, pH 6.2). The column packing 
was checked by following the progress of cytochrome C 
(horse heart type IIA) which has a strongly basic pi.
A small volume of eluting buffer, Polybuffer 
74-HC1 (5-10 ml, 0.0094 mmol/pH unit/ml, pH 4.0) was
allowed to run into the column prior to sample application 
to begin the gradient. The albumin samples (non-defatted, 
salt-free), either Albumin A or combined albumin A/ 
albumin Redhill (25 mg) dissolved in the starting buffer 
(3.0 ml), were applied to the column. Elution was at 
10 ml/hour and fraction volumes were small (1.65 ml).
At least 9 column volumes of eluant were required to 
generate the complete gradient.
4.2.4.2 Removal of Polybuffer
The individual albumin peaks were lyophilised and 
freed from Polybuffer by gel filtration on Sephadex G-100 
in trts-HCl buffer (0.01 M, pH 7.0) containing NaCl 
(0.05 M). The albumin fractions were then dialysed 
against distilled water at 4°C and lyophilised.
Albumin Redhill eluted after albumin A during 
chromatofocusing. The relevant peak was rechromatographed 
under similar conditions to remove contaminating albumin 
A.
In later experiments, it was more productive to 
use large PBE 94 columns (1 x 40 cm) to enable greater 
quantities of albumin to be processed (up to 100 mg).
Also, to save time, the dialysis step
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required after removing the Polybuffer from albumins 
separated by the first round of chromatofocusing was 
replaced by direct buffer exchange from tris-HCl/NaCl 
to histidine-HCl on Sephadex G-25 before the second 
separation.
4.2.5 Preparative Polyacrylamide Gel Electrophoresis
4.2.5.1 Separation of the Albumins
The mixed albumins were separated in non-denaturing 
slab gels (16 x 16 x 0.3 cm) (Davis, 1964, Laemmli, 1970), 
using a discontinuous trfs-buffer system.
The separating gel (T = 7.5%, C = 2.7%) 
contained tris-HCl (0.375 M, pH 8.9) and the stacking 
gel (T = 3%, C = 2.7%), trfs-HCl (0.125 M, pH 6.8).
The gels were pre-electrophoresed for 30 minutes at 60 V 
constant voltage using tria-HC1 (0.05 M, pH 8.3) as 
electrolyte, to remove persulphate ions from the 
immediate environment of the proteins.
Mixed albumin A/albumin Redhill (10 mg) or 
albumin A/albumin Warwick-2 (15 mg) were applied to the 
gels dissolved in a sucrose solution and the albumins 
were separated by electrophoresis at 60 V for 1 hour 
followed by 120 V constant voltage at 4°C with tria- 
(0.05 M)-glycine (0.38 M), final pH 8.3, as the electrode 
buf fer.
An additional small well was made alongside the 
main sample well in each gel in order to apply a small 
volume of bromophenol blue in sucrose solution, necessary
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for following the progress of electrophoresis. Albumin Warwick-2 
was better separated from albumin A than albumin Redhill, 
therefore it was possible to apply a greater weight of 
this protein per gel .
4.2.5.2 Location of the Albumin Bands
In order to avoid binding unwanted ligands, 
the following detection method was devised.
After separation, the gels were removed from the 
glass plates and transferred onto clingfilm. The gel was 
placed directly over a fluorescent silica gel TLC plate 
(Kieselgel 60 F254' Merc^» Darmstadt). Viewing directly 
under ultra-violet light, the albumins showed up as dark 
bands on a fluorescent background and were excised with 
a razor blade.
4.2.5.3 Electrophoretic Elution of the Albumins
(Otto and Snejdarkova, 1981; Mendel-Hartvig,
1982)
The elution gel consisted of a support gel in 
running buffer, the gel strip to be eluted (sample gel) and 
a stacking gel.
The support gel comprised acrylamide (T = 7.5%,
C = 2.7%) in fcrts-(0.05 M)-glycine (0.38 M), pH 8.3. 
Pre-electrophoresis was carried out for 3 hours at 
120 V before use. The sample gel was placed on top 
of the support gel and fixed in position by overlaying 
with a stacking gel (T = 3%, C = 2.7%) containing 
trte-HCl (0.125M, pH 6.8) approximately 2 cm in height.
Reverse polarity electrophoresis was at 20 mA constant
in
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current. Under these conditions, the albumin concentrated 
in and eluted through the stacking gel, and with no staining 
was readily visible as a sharp, refractile line.
Just before the albumin left the gel, an overlay 
(3-4 ml) of glycerol (50% v/v) in stacking gel buffer 
was added which in turn was overlain with NaCl (2.0 M) . 
Electrophoresis was continued until elution into the 
glycerol layer was complete, after which time, the 
NaCl was removed and the albumin-containing layer was 
dialysed exhaustively against distilled water at 4°C 
and lyophilised.
4.2.6 Analysis of the Albumin Preparations
The purity of the final albumin preparations was 
determined by:
(i) Cellulose Acetate Electrophoresis
Electrophoresis was carried out at 8 V/cm 
in barbitone buffer (0.075 M, pH 8.6) for 
2 hours. Electrophoretograms were stained 
in Ponceau S and destained in dilute 
acetic acid (Section 3.2.5).
(ii) Non-denaturing PAGE (Davis, 1964)
Analytical disc-PAGE without SDS was used to 
determine the extent of contamination by 
albumin A. The separating gel was 7.5% (C = 2.7%) 
and the stacking gel, 3% (C = 2.7%) in 
acrylamide.
(iii) Denaturing PAGE (Weber and Osborn, 1975)
SDS-disc PAGE was used to evaluate the 
overall purity of the albumins. The 
acrylamide concentrations in the separating 
and stacking gels were as for non-denaturing 
PAGE. Gels and electrophoresis buffer 
contained 0.1% SDS.
4.2.7 Purification of Albumin A by Dye-affinity
Chromatography
Blue Sepharose CL-6B contains the dye Cibacron 
Blue F3G-A which selectively removes albumin from solution.
The gel was regenerated by washing cycles of 
alternate high and low pH. The column (1.9 x 24.5 cm) was 
washed with 10 column volumes of tris-HC1 buffer (0.1 M, 
pH 8.5) containing NaCl (0.5 M), followed by 10 column 
volumes of sodium acetate buffer (0.1 M, pH 4.5) containing 
NaCl (0.5M) and then re-equilibrated with eluting buffer, 
tris-HCl (0.05 M, pH 7.0) containing NaCl (0.1 M).
Impure albumin A was dissolved in eluant and 
applied to the column at a very slow flow rate. Elution 
was ceased for 2 hours to facilitate binding to the 
dye. Unbound components were then removed by washing 
with 10 column volumes of eluting buffer and the albumin 
subsequently desorped with fcrts-HCl (0.05 M, pH 7.0) 
containing NaCl (1.5 M). The albumin fraction was 
dialysed against distilled water at 4°C and lyophilised.
Purity was assessed by SDS-disc PAGE (Weber
and Osborn, 1975).
4.3 RESULTS AND DISCUSSION
All sera gave a similar elution profile during 
gel filtration on Sephadex G-100 of the fraction 
obtained after precipitation with 75% saturated ammonium 
sulphate. A typical example is shown in Fig. 4.1 which 
denotes the fractionation of albumin Redhill from an 
original 6.2 ml of serum. The small peak eluting after 
albumin contained large quantities of ammonium sulphate 
as detected by barium sulphate precipitation.
V O L U M E  I m i )
Fig. 4.1 Gel filtration of albumin Redhill on Sephadex 
G-100. Eluant is tris-HCl (0.01 M, pH 7.0) 
containing NaCl (0.05 M).
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1
Fig. 4.2 Chromatofocusing of albumin A/albumin Redhill in the 
pH range 6-4.
A B C D
Fig. 4.3 Analysis of the albumin peaks after chromatofocusing
of albumin A/albumin Redhill, by disc-PAGE (Davis, 1964). 
A - peak 3» B - peak 2; C - peak 1( D - normal HSA.
The progress of purification was followed by 
analysing the products from each stage by discontinuous- 
PAGE (Davis, 1964), using normal, whole serum for 
comparison. Precipitation with ammonium sulphate at 45% 
saturation removed B-l-lipoprotein, the haptoglobulins, 
y-globulins, some transferrin and some o^-macroglobulin.
The supernatant after 75% ammonium sulphate saturation 
contained some albumin, some a^-macroglobulin, prealbumin 
and some transferrin. After gel filtration of the second, 
albumin-containing precipitate, the only visible contaminant 
was a small quantity of transferrin.
Chromatofocusing in the pH range 6-4 proved to be 
an effective final stage in the preparation of pure albumin 
Redhill. Fig. 4.2 shows the elution profile after the 
first fractionation by this technique. The mixed albumins 
eluted as three well-defined peaks although baseline 
separation was not achieved. Analytical isoelectric focusing 
(Section 3.2.9) demonstrated that albumin Redhill has a more 
acidic isoelectric point than albumin A and, in agreement 
with this, albumin Redhill eluted after albumin A from 
the chromatofocusing column.
Fig. 4.3 shows disc-PAGE analysis of the three 
peaks obtained after the first round of chromatofocusing 
of albumin Redhill. Normal HSA was used as a standard.
Peak 1 contained mostly albumin A with a small quantity 
of albumin Redhill. Peak 2 was an almost equal mixture 
of albumin Redhill and albumin A but with a slight 
preponderance of the variant albumin, whereas the last 
peak consisted almost exclusively of albumin Redhill with
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a trace of albumin A. All fractions were contaminated 
slightly with transferrin.
Following the removal of Polybuffer and salts, 
the albumin Redhill fraction underwent a second separation 
to remove residual albumin A. The elution pattern again 
showed three peaks, and although resolution was rather 
poor, disc-PAGE analysis of the final peak revealed the 
pure variant. Gels showed no visible contamination with 
albumin A or transferrin.
Although this method finally yielded the variant 
albumin in a very pure form, its quantitative efficiency 
was rather low with only 25% recovery of the pure protein 
being attained. Washing the PBE column with strong salt 
solution indicated that the albumins had not been retained 
on the column and there are no other sources where 
appreciable losses would occur.
Evaluation of the analytical gels and the 
elution profiles indicates that the major factor responsible 
for the low yield is that the technique does not discriminate 
sufficiently between the isoelectric points of the two 
albumins to allow complete separation. Although some albumin 
Redhill elutes as a separate peak, the remainder always 
remains unresolved from albumin A. Hence, the overall 
process is not so much a complete separation, but a gradual 
"leaching out" of the variant albumin from the original 
mixed sample. Isolating large quantities of abnormal albumin 
by this technique would prove costly and time consuming 
although only very mild conditions are involved in the 
procedure.
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Fig. 4.4 Purification of normal HSA by chromatofocusing in 
the pH range 6-4.
Figure 4.4 shows the elution profile of normal 
albumin after chromatofocusing. Electrophoresis revealed 
the albumin to be pure and free from transferrin (pi 5.9). 
Purification of albumin A by affinity chromatography using 
Cibacron Blue F3G-A gave a similarly pure albumin 
preparation. Albumin eluted as a single peak.
Preparative PAGE was the most efficient method 
for purifying both albumins Redhill and Warwick-2 
rapidly and cheaply and in high yield. During the 
electrophoresis stage, albumin Redhill did not separate
r
from albumin A as well as albumin Warwick-2, so that less 
of this variant could be purified at one time. Both 
variants were separated well enough to enable them to be 
excised from the gel as distinct bands. The final 
preparations of each variant were free of albumin A and 
other contaminants as judged by electrophoresis. In 
addition, the resultant preparations of albumin A from 
each of the sera were free of the variant albumin.
Therefore, losses of the variants could not be attributed to 
lack of resolution in this method.
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CHAPTER 5
FRAGMENTATION STUDIES ON 
ALBUMINS REDHILL AND WARWICK-2
5.1 INTRODUCTION
This chapter describes the methods used for 
determining the N- and C-terminal end groups, and for 
chemical fragmentation of albumins Redhill and Warwick-2 
at the methionine and tryptophan residues.
The N-terminal residue was identified by labelling 
with dansyl chloride. The C-terminal residue was determined 
by reaction with carboxypeptidase Y.
The methionine-specific reagent, cyanogen bromide 
and the tryptophan-specific o-iodosobenzoic acid and 
N-chlorosuccinimide were used to cleave the albumins 
into relatively large peptides. Before fragmentation, 
albumin was defatted and denatured, either by oxidation 
with performic acid or by reduction and S-carboxymethylation, 
except for reaction with carboxypeptidase and N-chloro­
succinimide where native albumin was used.
The fragmentation patterns were analysed by 
polyacrylamide gel electrophoresis, the details of which 
are described in the following chapter.
5.1.1 Performic Acid Oxidation (Hirs, 1967; Croft and
Waley, 1971)
This procedure was used to denature albumin
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prior to reaction with dansyl chloride. The resultant 
protein is resistant to cleavage by CNBr since methionine is 
oxidised to methionine sulphone. Cysteine and cystine 
are converted to cysteic acid while tryptophan undergoes 
multiple transformations leading to the formation of 
N-formylkynurenine in which the indole ring is opened.
The destruction of tryptophan prevents the use of 
tryptophan-specific reagents for fragmentation studies.
A large excess of reagent (at least 10-fold) is 
required. This is removed under mild conditions to prevent 
over-oxidation of the protein (phenolic and hydroxyl groups).
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Fig. 5.1 Oxidative cleavage of disulphide cross-linkages 
by performic acid.
5>1-2 Reduction and S-Carboxvmethylatlon
Disulphide bond reduction followed by blocking 
of the sulphydry1 groups is a commonly used denaturing 
procedure which does not usually lead to the destruction
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of amino acids. The most satisfacotry reducing agents 
are B-mercaptoethanol (Hirs, 1967) or dithiothreitol/ 
dithioerythritol (Cleland, 1964). The reduction is 
performed in the absence of oxygen with a large excess 
of reagent at alkaline pH. Dénaturants such as urea or 
guanidinium chloride ensure complete unfolding of the 
protein. Carbamylation of amino groups by ammonium 
cyanate which accumulates in aqueous solutions of urea 
is minimised by the use of amines for pH control, 
particularly tris and methylamine. Cyanate reacts more 
favourably with these buffer amines.
The sulphydryl groups were blocked with iodo- 
acetic acid. Excess reagent may modify other amino acids, 
namely methionine, histidine, lysine and tyrosine. 
S-carboxymethylation increases the negative charge on 
the protein (Gurd, 1972).
Reduced, alkylated proteins are generally 
insoluble in dilute, aqueous solutions.
Protein-SH + ICH2COOH --------------- Protein - S - C H 2COOH + HI
iodoacetic acid
Fig. 5.2 S-carboxymethylation of cysteine with iodoacetic 
acid.
5.1.3 Determination of the N-Terminal Residue
Several methods have been documented for the 
determination of the amino terminal residues in peptides 
and proteins including reactions with fluorodinitro-
123
benzene (Sanger, 1945), phenylisothiocyanate (Edman,
1950), cyanate (Stark, 1972a), dansyl chloride (Gray,
1972) and 4-dimethylaminoazobenzene-4'-isothiocyanate 
(Dabitc)(Chang et al., 1976). Enzymic digestion with 
leucine aminopeptidase and aminopeptidase M have also 
been used (Light, 1972).
The N-terminal residues of albumins Redhill 
and Warwick-2 were identified using 'dansyl' (5-dimethyl- 
aminonaphthalene-l-sulphonyl) chloride, (DNS-C1), chosen due 
to the simplicity of methodology and high sensitivity.
The limits of detection exceed 10  ^ pmoles of DNS-amino 
acid using the polyamide layer system of identification 
and only 1-5 nmoles of original protein are required.
DNS-C1 reacts with N-terminal primary and 
secondary amines. Reactive side chain functions include 
thiol (cysteine), phenolic hydroxyl (tyrosine), amino 
(lysine) and imidazole (histidine) in decreasing order 
of reactivity. Amino groups only react as the free 
base (R-NH2 ) and not as the conjugate acid (R -NH^+) 
so that successful labelling only occurs at alkaline pH, 
usually between pH 9 and 11. Excess DNS-C1 is hydrolysed 
to l-dimethylaminonaphthalene-5-sulphonic acid (DNS-OH, 
dansic acid) by water and hydroxyl ions this being 
visible as a large blue fluorescent spot on the chromato­
gram.
5.1.3.1 Principle of the Method
The protein amino groups are labelled with 
DNS-C1 to give yellow/green fluorescent sulphonamide
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derivatives followed by hydrolysis of the peptide bonds 
and identification of the fluorescent DNS—amino acid 
derived from the N-terminus.
hydrolysis. Cysteine and histidine sulphonamides are 
degraded to DNS-OH and the original group and the 
hydrolysis time must be limited if DNS-proline is 
suspected. DNS-serine, DNS-threonine and DNS-cysteine 
break down with the elimination of DNS-NH2 (1-dimethyl- 
aminonaphthalene-l-sulphonamide) and DNS-tryptophan is 
destroyed.
chnj /CH, CHj c^h,
Dansyl derivatives are generally stable to
N N
R, R'I I
HjNCHCO —NHCMCO--
SOjCI SOj-NHCHCO-NHCHCO-----I L
dansyl
chloride
N
I
so2- nhchcoohI
fig. 5.3 Labelling the N-terminal residue of a protein 
with dansyl chloride.
5.1.4 Determination of the C-Terminal Residue
The methods available for C-terminal end group
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identification are more limited and less satisfactory 
than those for the determination of N-terminal residues.
Some of the methods in use include hydrazinolysis (Schroeder, 
1972), C-terminal selective tritium labelling (Matsuo 
et al., 1966), 'subtractive' C-terminal determination 
(Parham and Loudon, 1978), hydantoin formation (Stark,
1972b) and digestion with carboxypeptidases A and B 
(Ambler, 1972), C (Tschesche, 1977) or Y (Hayashi, 1977).
The method of choice was partial hydrolysis 
with carboxypeptidase Y due to its convenience, 
reliability and specificity. Carboxypeptidase reacts 
with peptides and proteins to release amino acids 
possessing a free a-carboxyl group.
Carboxypeptidase Y is isolated from bakers yeast 
and has a broad specificity. All C-terminal amino acids 
are removed, including proline. Hydrophobic residues are 
released more rapidly than charged residues. Glycine 
in the penultimate position slows the release of the 
terminal amino acid. The enzyme does not usually react 
with native proteins, although albumin dénaturation was 
found to be unnecessary. The C-terminal sequence is 
evaluated either by studying the kinetic release of amino 
acids after enzyme addition, or by thin layer 
chromatography.
5.1.5 Cleavage at Methionine with CNBr
Cyanogen bromide was introduced by Gross 
and Witkop (1961) and has proved to be the most useful
chemical protein cleavage reagent available. It has the 
unique specificity of breaking peptide bonds on the 
carboxyl side of methionine residues. Since methionine 
occurs relatively rarely in proteins, albumin has only 
6 such residues, the resulting fragments are usually 
large and consequently relatively easy to manipulate. 
These peptides are also valuable in the ordering of 
small peptides from enzymic digests.
The reaction is performed in strong acid at 
room temperature with an excess of reagent. Under these 
conditions, methylthiocyanate is formed and methionines 
are converted to a mixture of homoserine and homoserine 
lactone, the two being interconvertible (Ambler, 1965).
In albumin, the met-cys bond at metj2 3  is only 
partially susceptible to cleavage (Doyen and Lapresle,
1979). Methionine is converted to homoserine without 
bond breakage. Taking this into account, eight peptides 
were expected from cleavage of albumin.
Cystine residues are unaffected by CNBr in 
acid and their prior reduction is unnecessary. Oxidation 
of methionine to the sulphone or sulphoxide prevents 
reaction with CNBr. Methionine sulphoxide results from 
autooxidation during protein or peptide isolation and 
can be remedied by pre-treatment with thiols (Westhead, 
1972; Neumann, 1972).
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Fig. 5.4 Reaction of CNBr with methionine residues.
5.1.6 Cleavage at Tryptophan
HSA has a single tryptophan residue at 
position 214 in the sequence. Cleavage at this point 
yields two peptides, readily separable due to large 
size differences. The approximate molecular weight of 
the resultant N-terminal peptide is 24,000 and that of the 
C-terminal peptide, about 42,000. Cleavage at tryptophan 
was carried out for two reasons. Firstly, peptide 
analysis provided confirming evidence regarding the 
region of mutation and secondly, isolation of the 
abnormal peptide followed by further degradation would 
facilitate a more exact location of the amino acid 
substitution.
The cleavage reagents employed for this purpose 
were o-iodosobenzoic acid and N-chlorosuccinimide 
(NCS), both of which cleaved selectively at tryptophan. 
However, yields were low and reaction with o-iodoso-
benzoic acid proved to be non-reproducible.
5.1.6. 1 Reaction with o-.Todosobenzoic Acid
o-Iodosobenzoic acid cleaves on the carboxyl 
side of tryptophan (Mahoney and Hermodson, 1979; 1980). 
The proposed reaction mechanism is shown in Fig. 5.5.
+ O-IOOOSO0ENZOIC 
ACID CcCt
5- IOOOSOBE NZOIC 
ACID
Fig. 5.5 Proposed reaction mechanism of o-iodosobenzoic 
acid at tryptophan.
The first oxidative step leads to the formation 
of the oxindole derivative. This reaction can occur under 
mild oxidative conditions and is therefore probably fairly 
rapid (Savige and Fontana, 1977). The second oxidation 
is rate limiting and is followed by a cyclisation of 
the carbonyl oxygen on the indole nucleus to form an 
iminospirolactone which hydrolyses to the C-terminal
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N-acyldioxindolylalanine, so cleaving the peptide 
chain.
Side reactions are limited to the oxidation of 
methionine to methionine sulphoxide and possible cleavage 
of tyrosyl bonds. Modification and cleavage of tyrosine residues 
has been attributed to o-iodoxybenzoic acid (Fig. 5.6), a 
disproportionation product of o-iodosobenzoic acid 
identified as a contaminant present in most preparations 
of the latter (Mahoney et al., 1981). Pre-incubation of 
o-iodosobenzoic acid with p-cresol causes reduction of 
the contaminant, thereby minimising tyrosine modification.
COOH COOH COOH
i ii hi
Fig. 5.6 Disproportionation of two molecules of o-iodosobenzoic
acid (I) leads to one molecule of o-iodoxybenzoic acid 
(II) and one molecule of o-iodobenzoic acid (III) .
5.1.6.2 Reaction with NCS
N-chlorosuccinimide cleaves on the carboxyl 
side of tryptophan by mild oxidative chlorination of the 
indole nucleus (Schechter et al., 1976). A possible
reaction mechanism is shown in Fig. 5.7.
In aqueous solution under weakly acidic conditions 
(pH 2-5), NCS oxidises the exposed indole rings. Two 
equivalents of active chlorine (Cl+) halogenate the 
indole nucleus which then undergoes spontaneous 
dehalogenation through a series of oxidations and 
hydrolyses, leading to formation of the oxindole. This 
structure promotes bond cleavage.
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NHR
NHR.
Fig. 5.7 Reaction at tryptophan by NCS.
N-terminal tryptophan resists cleavage (Wilcheck 
and Witkop, 1967) and tryptophanyl bonds in native 
proteins are generally inaccessible to this reagent. 
Methionine is oxidised to the sulphoxide and cysteine 
to cystine. Otherwise, other residues remain unaffected 
and no other peptide bond is cleaved.
5.2 EXPERIMENTAL
5.2.1 Performic Acid Oxidation
The performic acid reagent was prepared by 
combining hydrogen peroxide (2 vol., 30%) with formic acid 
(8 vol., 99%) and leaving to stand in a sealed 
container for 2 hours at 25°C. The proportion of performic 
acid reaches a maximum at about this time and decreases 
slowly thereafter. The reagent was then cooled on ice for 
15 minutes.
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Albumin (1-2 mg) was dissolved in formic acid 
(0.5 ml, 99%) and cooled on ice for 15 minutes. The 
performic acid reagent (0.5 ml) was added to the protein 
solution and oxidation proceeded at 0°C for 2.5 hours.
The oxidised protein was precipitated with TCA 
(1.5 ml, 25% w/v) and centrifuged for 5 minutes at 
5,000 r.p.m. The precipitate was washed in three changes 
of ethanol followed by a single wash in diethyl ether 
before being dried in vacuo.
5.2.2 Reduction and S-Carboxymethylation
(Allen, 1980)
Albumin (1-20 mg/ml) was dissolved in trie-HC1 
(0.1 M, pH 8.3) containing urea (8 M, deionised and 
recrystallised) and EDTA (1 mM). Dithiothreitol was 
added to a final concentration of 2 mM. Nitrogen (oxygen- 
free by bubbling through alkaline pyrogallol) was passed though 
the solution and incubation followed at 37°C for 1 hour.
Sufficient iodoacetic acid (50 mM, neutralised with 
NaOH) was added to give a 1.1-fold molar ratio over the 
total protein thiol groups. The vessel was flushed with 
nitrogen and sealed, and alkylation took place in the 
dark at 37°C for 1 hour. A more complete reaction was 
obtained by repeated addition of dithiothreitol (1 mM) 
followed by incubation at 37°C for 1 hour, and then 
re-addition of iodoacetic acid (2 mM) followed by further 
incubation at 37°C for 30 minutes.
2-Mercaptoethanol (1% v/v) was then added to
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remove excess iodoacetic acid and the solution dialysed 
exhaustively against ammonium bicarbonate (50 mM) 
containing thiodiglycol (0.01% v/v) before lyophilisation.
5.2.3 Determination of the N-Terminal Residue
5.2.3.1 Labelling with Dansvl Chloride (Gray, 1972)
Residual acid and possible traces of ammonia
in the albumin samples were removed by dissolving the 
performic acid oxidised protein (50-250 pg) in 
ammonium bicarbonate (100 pi, 0.2 M) containing SDS 
(0.1% w/v) followed by lyophilisation. The sample was 
redissolved in SDS (50 gl, 1% w/v) by heating at 100°C 
for 2-5 minutes. After cooling, N-ethylmorpholine (50 pi) 
was added with thorough mixing and the pH of the solution 
checked with pH paper. Dansyl chloride (75 pi, 25 mg/ml 
in anhydrous dimethylformamide) was introduced and 
any precipitating protein redissolved t>y adding a small volume 
of SDS (1% w/v). Dansylation proceeded for at least 1 hour 
at room temperature away from light.
The labelled protein was precipitated with dry 
acetone (0.5 ml) and the mixture centrifuged for a few 
minutes at 5,000 r.p.m. The compressed precipitate was 
washed once with acetone (0.5 ml, 80% v/v), centrifuged 
again and finally dried in vacuo.
5.2.3.2 Hydrolysis
The dried sample was transferred to a small 
glass test tube (50 mm x 4 mm i.d.) which had been
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pre-cleaned by overnight heating at 500°C. The peptide 
bonds were hydrolysed in HC1 (100 pi, 6.1 M) for 16 hours 
at 105°C after flame-sealing the tube. After hydrolysis, 
the tube was opened and the HC1 removed in vacuo over 
NaOH.
5.2.3.3 Identification of DNS-Amino Acids
The dansyl derivatives were solubilised in acetone 
acetic acid (10 pi, 3:2 v/v) and chromatographed on 
2—dimensional TLC on 5 x 5  cm double—sided polyamide 
plates using a solvent system based on that described 
by Woods and Wang (1967). The sample was applied to one 
corner of the plate and the chromatogram developed in the 
first direction with water: 90% formic acid (200:3 v/v).
The plate was dried, rotated 90°C and run in the second 
solvent, toluene:acetic acid (9:1 v/v). For further 
clarification, a repeat run in the second direction using 
ethyl acetate¡methanol:acetic acid (20:1:1 v/v/v) 
followed by ammonia (1.0 M):ethanol (1:1 v/v) was required.
Control DNS-amino acids, namely DNS-L-aspartic 
acid, DNS-L-arginine, DNS-L-glutamic acid, DNS-e-L-lysine, 
di-DNS-L-lysine and N ,O-di-DNS-L-tyrosine were similarly 
chromatographed on the reverse side of each plate 
and the spots were visualised under u.v. light at 365 nm.
5.2.4 Determination of the C-Terminal Residue
5.2.4.1 Reaction with Carboxypeptidase Y (Lee and
Riordan, 1978)
The enzymic activity (12.5 pmol/mg protein at
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pH 6.75, 25°C) of carboxypeptidase Y (5 yg) was restored 
by incubating at 0°C overnight in water (20 yl). The 
water was added pre-cooled to 0°C. The endopeptidase 
activity of contaminating yeast proteinase A was 
selectively inhibited by pre-incubation with pepstatin A 
(7 yg) in 2-(N-morpholino)-ethane sulphonic acid (MES) 
buffer (20 yl, 10 mM, pH 6.8) for 2 minutes at room 
temperature.
Native albumin (0.5 mg) was dissolved in MES 
buffer (200 yl, 10 mM, pH 6.8) and added to the 
activated enzyme. Digestion was allowed to proceed for 
10 minutes at 37°C, after which time the reaction was 
stopped by freezing and the digest lyophilised. A 
control sample comprised albumin A without added enzyme.
5.2.4.2 Identification of the C-Terminal Residue
The C-terminal residue was identified by 
ascending TLC on silica gel plates using chloroform: 
methanol:30% ammonia (2:1:1 v/v/v) as the solvent system. 
After drying, the chromatogram was sprayed with ninhydrin: 
acetic acid reagent (0.2% ninhydrin w/v in 95% ethanol: 
acetic acid, 20:1 v/v) and the amino acids visualised by 
heating at 60°C for 30 minutes.
The amino acid standards L-leucine and L-glycine 
were chromatographed alongside the albumins for comparison. 
These amino acids form the terminal and penultimate 
residues of albumin A.
5.2.5 Cleavage at Methionine
5.2.5.1 Reaction with Cyanogen Bromide (Allen, 1980)
Normal and mixed albumins were dissolved 
(5 mg/ml) in aqueous formic acid (70% v/v>. Solid 
CNBr (a weight equal to that of protein dissolved in a 
small volume of formic acid (70% v/v>) was added and the 
solution stirred magnetically for 20-22 hours in the 
dark at room temperature (typically 21°C) under oxygen- 
free nitrogen. The mixture was then diluted with water 
(15 vol.) and lyophilised. For complete removal of acid 
and by-products, dilution with water followed by 
lyophilisation was repeated.
The fragments (5 mg/300 pi) were reduced in 
triethanolamine-acetate buffer (0.2 M, pH 8.6) containing 
urea (8 M), methylamine (25 mM, cyanate trap), dithiothreitol 
(60 mM) and EDTA (10 mM) for 4 hours at 37°C (Franklin 
et al., 1980). The peptides were then alkylated to prevent the 
formation of mixed disulphides, by adding iodoacetic 
acid (130 mM, neutralised with NaOH) and reacting for 
30 minutes at room temperature in the dark. The reaction 
was stopped by the addition of excess dithiothreitol.
The samples were diluted with water (5 vol.) and 
precipitated by adding TCA to 20% w/v. The fragments 
were collected by centrifugation, washed with acetone:
HC1 (0.2% w/v) followed by acetone and dried in vacuo.
All solutions contained 2-mercaptoethanol (1% v/v) during 
precipitation.
Peptide analysis is described in Chapter 6.
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5.2.6 Cleavage at Tryptophan
5.2.6.1 Reaction with o-Iodosobenzoic Acid
Reduced and S-carboxymethylated albumin (5 mg) 
was dissolved in a minimum volume of urea (8 M)/dithiothreitol 
(20 mM)/thiodiglycol (1% v/v) by incubation at 37°C for 
about 30 minutes. o-Iodosobenzoic acid (1 mg/100 pi) 
dissolved in acetic acid (80% v/v)/urea (8 M) was pre­
incubated with p-cresol (0.1 mole p-cresol/mole o-iodoso- 
benzoic acid) at room temperature in the dark for at least 
2 hours, and was then added to the albumin in a volume 
equivalent to twice the weight of protein. Reaction took 
place at room temperature in the dark for 24 hours 
and was stopped by adding excess dithiothreitol (5 mg).
The solution was dialysed against acetic acid (10% v/v) 
in the dark at 4°C and lyophilised.
Normal and mixed albumins with no added o-iodoso- 
benzoic acid formed the control samples.
Peptide analysis is described in Chapter 6.
5.2.6.2 Reaction with N-Chlorosuccinimide (Shechter
et al., 1976)
_ QNormal and mixed albumins (1 mg, 1.5 x 10 mol) 
were dissolved in acetic acid (50 pi, 80% v/v) and NCS 
(2 mg/ml) in dimethylformamide was added to a 10-fold 
molar excess over the total tryptophan residues. After 
reaction at room temperature for 40 minutes, excess 
reagent was destroyed with methionine and the 
solution diluted with water (5 vol.). The peptides were 
precipitated by adding TCA to 20% w/v, followed by
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centrifugation. The precipitate was washed with acetone/ 
HC1 (0.2% w/v) and acetone before being dried in vacuo.
Control normal albumin samples contained all 
the reagents except for NCS.
Peptide analysis is described in Chapter 6.
5.3 RESULTS AND DISCUSSION
Partial digestion of albumins Redhill and 
Warwick-2 with carboxypeptidase Y revealed that the 
C-terminal residue of both variants is L-leucine. The 
mobility of the C-terminal amino acids on t.l.c.
(Fig. 5.8) is the same as the mobility of the C-terminal 
residue of albumin A (L-leucine) and of the standard L-amino 
acid. In addition, all the albumin samples released 
glycine which is the penultimate C-terminal residue. No 
other residues were cleaved under the conditions used. The 
successful cleavage of the native protein shows that the 
C-terminal residues are accessible to the enzyme without 
prior dénaturation. The reproducibility of the 
reaction exemplifies the specificity of the enzyme.
The N-terminal residue of albumin Warwick-2 
is L-aspartic acid. This is unchanged from the corresponding 
residue of albumin A. Fig. 5.9 (i) shows the 2-dimensional 
polyamide chromatograms after separation in three solvent 
systems. The DNS-asp of albumin Warwick-2 corresponded 
almost exactly with the standard DNS-asp run on the 
reverse side of the plate and was distinctly separated 
from any DNS amino acids which run close to it during
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Fig. 5.8 Identification of the C-terminal amino acids of 
albumins Redhill and Warwick—2 by thin layer 
chromatography.
A, albumin A/albumin Warwick-2; B, albumin 
Warwick-2; C, albumin A; D, albumin A/albumin 
Redhill; E, albumin Redhill.
t.l.c. The third solvent was required to resolve 
DNS-asp from DNS-OH.
The control experiment using albumin A gave 
the expected L-aspartic acid as the N-terminal residue.
Fig. 5.9 (ii) shows the chromatograms obtained 
for albumin A/albumin Redhill. After running in the 
third solvent system, the DNS-asp spot of albumin A 
was readily visible. However, this solvent is unable
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to resolve DNS-c—lys and DNS—arg. Following chromato­
graphy in the fourth solvent, DNS-arg is clearly resolved 
from DNS-e-lys showing that the N-terminal amino acid of 
albumin Redhill is L-arginine. This indicates strongly 
that albumin Redhill is a proalbumin. The basic 
propeptide contributes to the slow mobility of albumin 
Redhill during electrophoresis at pH 8.6. The two 
dansyl derivatives are also distinguishable on the 
basis of colour. The fluorescence of DNS-arg is slightly 
more yellow than DNS-e-lys which appears slightly blue 
at 365 nm. These colour differences were readily 
observed both in the N-terminal derivatives and the 
standard amino acids. DNS-asp has a yellow fluorescence.
The inconclusive results obtained from partial 
tryptic digestion of albumin Redhill (Section 3.2.8) 
can therefore be clarified and some speculation 
concerning the structure of the propeptide may be permitted. 
The normal propeptide has the sequence arg-gly-val-phe-arg- 
arg. Trypsin is specific for arginyl (and lysyl) peptide 
bonds except where the following residue is proline. If 
the C-terminal residue of the propeptide has been 
substituted by a proline residue, the propeptide would 
not be cleaved except by very prolonged digestion which 
may also fragment the whole protein, and the electrophoretic 
mobility of the variant albumin would remain unchanged, 
as was observed both at pH 5.0 and pH 8.6. Considering 
the nature of the base changes in the genetic code that 
would be required to bring about this change, the 
codons for arginine are CGU, CGC, CGA, CGG, AGA and AGG
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while the codons for proline are CCU, CCA, CCC or CCG. An 
arginine to proline substitution requires only one base 
change and is therefore one of the more likely mutations 
that might occur. Had the propeptide been cleaved, the 
loss of a strongly basic segment of the sequence should 
initiate some change in the electrophoretic mobility, 
even if the mobility of the variant did not revert completely 
to that of albumin A. After treatment with trypsin, the 
variant should migrate more rapidly towards the anode. No 
such change was observed. As mentioned previously 
(Section 3.3), metal binding studies support the evidence 
for a proalbumin.
The combined results obtained from molecular 
weight studies, tryptic digestion and N-terminal residue 
determination strongly suggest that albumin Redhill is 
a proalbumin possessing two sites of mutation, one within 
the propeptide and the other, possibly involving the 
insertion of a short sequence elsewhere in the molecule. 
Albumin Warwick-2 behaves like other monomeric alloalbumins 
having undergone a single amino acid substitution. Since 
this variant is also of the slow type, the mutation must 
also involve some loss of negative charge.
Analysis of the peptides derived from chemical 
fragmentation of albumins Redhill and Warwick-2 are 
discussed separately in the following chapter.
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CHAPTER 6 
PEPTIDE MAPPING
6.1 INTRODUCTION
This chapter details the analytical and 
preparative methods used to compare and isolate the 
peptides derived from the chemical cleavage reactions.
CNBr peptides were analysed using the 
electrophoretic procedure of Franklin et al. (1980) and
by analytical isoelectric focusing in polyacrylamide 
gel. Fragments resulting from o-iodosobenzoic acid 
cleavage were examined using a similar electrophoretic 
system and also by SDS-PAGE (Swank and Munkres, 1971) 
and SDS-disc PAGE (Brown et al., 1967), whereas NCS 
peptides were resolved by SDS-disc PAGE (Laemmli, 1970).
6.1.1 Analysis of CNBr Peptides by PAGE (Franklin
et al., 1980)
Peptides were resolved on 12% polyacrylamide 
gels containing 5 M urea, 5% acetic acid and 6 mM 
Triton X-100. This system gave highly reproducible 
peptide maps and is sensitive to small changes in the 
ionic charge of the peptides. The cationic fragments 
are differentially retarded depending on their ability 
to bind the non-ionic detergent and to form micelles 
between the detergent and the hydrophobic regions of the
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peptide chain. The resultant mobility, therefore, arises 
through a combination of the molecular size, net charge and 
degree of hydrophobicity of the protein (Zwiedler and 
Cohen, 1972). Unlike other, conventional electrophoretic 
systems, these gels were able to resolve neutral amino 
acid substitutions. Improved resolution and clarity of 
the peptide maps was obtained on gels measuring 47 cm in 
length as opposed to the usual length of 16 cm.
The peptides were identified using Franklin’s
notation.
6.1.2 Analysis of CNBr Peptides by Analytical
Isoelectric Focusing
Isoelectric focusing has rarely been used 
for separating peptides since they often have no clearly 
defined isoelectric points. A further problem is that 
peptides have very similar properties to the carrier 
ampholytes in that both are amphoteric and have 
comparable molecular weights. Therefore, although peptides 
may focus well, their detection and recovery may be difficult. 
Small peptides are poorly fixed in TCA and tend to be 
washed out of the gel along with the ampholytes.
The solubility of peptides in aqueous solution 
is usually low and various additives are incorporated into 
the gel to preserve the solubility of focused bands.
To this end, 5 M urea was included in the gel and 
artefacts due to oxidation of methionine residues 
(cysteine residues were already stabilised by
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carboxymethylation) were counteracted by including 
ascorbic acid. This anti-oxidant has an additional 
advantage over thiodiglycol, 2-mercaptoethanol and 
dithiothreitol in that it prevents possible modification 
of tyrosine residues (Jacobs, 1973).
Isoelectric focusing was carried out with a 
view to separating the CNBr peptides by chromatofocusing. 
The large peptides presented few problems during IEF. 
Reproducible band patterns were obtained using conventional 
focusing procedures in the range pH 3-10.
6.1.3 Preparative Isolation of Peptides
Established procedures for the preparative 
purification of peptides include gel filtration, ion- 
exchange chromatography and preparative electrophoresis. 
Considering the proportionally minute difference between 
the abnormal peptides and the corresponding peptides 
from albumin A, and also the difficulty in separating the 
whole albumins by chromatographic methods, it was not 
expected that the peptides would be separable by 
chromatography. The only sufficiently discriminating method 
was the electrophoretic system of Franklin et al. Also, 
with this system, the identity of the peptide obtained 
was certain.
The reproducible, well-defined band patterns 
obtained with analytical IEF (Section 6.2.2) indicated 
that the CNBr peptides had characteristic, widely 
distributed, and reproducible isoelectric points.
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Chromatofocusing was not expected to be able to isolate 
individual peptides since the isoelectric points of 
some of the peptides were very closely spaced. The 
rationale behind the procedure was to obtain a degree 
of separation such that the abnormal peptides were 
separated from some of the normal ones, facilitating 
the subsequent purification of the abnormal fragments.
6.2 EXPERIMENTAL
6.2.1 Peptide Mapping of CNBr Peptides by PAGE
(Zwiedler, 1978; Franklin et at., 1980)
Gels (16 x 16 x 0.15 cm) containing 12% 
acrylamide, urea (5 M), acetic acid (5%) and Triton 
X-100 (6 mM) were overlayered with acetic acid (5% v/v) 
containing urea (5 M) and Triton X-100 (6 mM) and pre- 
electrophoresed at 130 V constant voltage for 4 hours or 
until a minimum current had been reached (typically 
12 mA). Pre-electrophoresis was continued for a further 
30 minutes at 130 V under acetic acid (5% v/v) 
containing urea (5 M), Triton X-100 (6 mM) and 
2-mercaptoethanol (0.5 M). Acetic acid (5%) formed 
the electrode buffer.
The peptides were dissolved in a suitable 
volume of urea (8 M)/thiodiglycol (1% v/v)/dithiothreitol 
(20 mM) and reduced for 90 minutes at 37°C. Basic 
fuchsin (5 m1, 1% w/v in water) was included as the
tracker dye. Electrophoresis was carried out at
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130 V for 16 hours with acetic acid (5% v/v) as the 
electrode buffer.
For better resolution, larger gels (20 x 47 x 
0.15 cm) were used. Pre-electrophoresis was at 340 V for 
24 hours, followed by electrophoresis of the peptides at 300 V 
for 48 hours.
6.2.1.1 Detection of the Peptides
Gels were simultaneously fixed and stained 
in PAGE Blue G-90 (0.2% w/v) in acetic acid (10% v/v)/ 
methanol (45% v/v) and destained by diffusion in acetic 
acid (10% v/v)/methanol (45% v/v) at 40°C.
6.2.2 Isoelectric Focusing of CNBr Peptides
Electrofocusing gels (T = 5%, C = 3%) containing 
Pharmalyte pH 3-10, urea (5 M), methylamine (25 mM, cyanate 
t-rap) and L—ascorbic acid (0.1 mM) were cast into tubes 
(9 x 0.6 cm i.d.) as previously described (Section 3.2.9.1). 
Persulphate and any cyanate ions were removed by prefocusing 
at 1 mA/gel for 30 minutes.
CNBr peptides were dissolved in urea (8 M)/thiodiglycol 
(1% v/v)/dithiothreitol (20 mM) and reduced for 90 minutes 
at 37°C. An equal volume of a solution containing 
Pharmalyte pH 3-10 (diluted 1:7.5 in water)/sucrose (30% w/v)/ 
methyl red was added and approximately 250 ug of peptides 
was applied per gel. Focusing was at 1-2 mA/gel for 3 hours 
with cooling. The electrolytes comprised phosphoric acid 
(1.0 M) at the anode and NaOH (1.0 M) at the cathode. Both
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solutions contained ascorbic acid (0.1 mM) and were 
degassed before use.
6.2.2. 1 Fixing, Staining and Destaining
(i) With PAGE Blue G-90 (Righetti and Drysdale, 1974) 
Following overnight fixing in methanol (30% 
v/v)/sulphosalicyclic acid (3.5% w/v)/TCA 
(11.5% w/v), gels were immersed for 4-6 hours 
in a solution of PAGE Blue G-90 (0.05% w/v) 
containing copper sulphate (0.1% w/v) in 
acetic acid (19% v/v)/ethanol (25% v/v).
Gels were then destained for 4 hours in the 
same solution but containing only 0.01% w/v of the 
dye, and finally in aqueous acetic acid (10%)/ 
ethanol (10%) at 40°C. The inclusion of copper 
sulphate in the stain reduces the background 
colouration.
(ii) With FAST GREEN FCF (Riley and Coleman, 1968)
This less sensitive stain was useful for 
depicting major bands. Immediately after focusing, 
gels were fixed in sulphosalicyclic acid (5% 
w/v)/TCA (16.7% w/v) and then stained for 6 
hours in Fast Green FCF (0.25% w/v) dissolved in 
acetic acid (10% v/v)/ethanol (30% v/v).
Destaining was at 40°C in acetic acid (10% v/v)/ 
ethanol (10% v/v).
6.2.2.2 Measurement of the pH Gradient
Blank gels containing Pharmalyte but no sample
were run simultaneously. After focusing, gels were 
cut into 5 mm lengths and each segment eluted in 
degassed water (1.0 ml) for several hours in a sealed 
vial. The pH of each solution was then measured 
with a pH microelectrode.
6.2.3 Analysis of Tryptophanyl Peptides
6.2.3.1 o-lodosobenzoic Acid Peptides
(i) By Urea/Acid/Triton X-100 PAGE (Zwiedler, 1978)
Gels (16 x 16 x 0.15 cm) contained 10% acrylamide, 
urea (5 M), acetic acid (5%) and Triton X-100 
(6 mM). Sample preparation and pre-electrophoresis 
were carried out as described for CNBr peptides 
(Section 6.2.1). 250 pg of peptides were applied 
to each sample well and electrophoresis was 
carried out at 130 V for 16 hours. Gels were 
stained as for CNBr peptides (Section 6.2.1.1).
(ii) By SDS-iris-phosphate PAGE (T = 7.5%, C = 3.3%) 
(Swank and Munkres, 1971)
Gels (14 x 0.6 cm i.d.) contained phosphoric 
acid (0.1 M), SDS (0.1% w/v), urea (5 M) and 
trio to pH 6.8
Peptides were dissolved in SDS (1% w/v)/urea 
(8 M)/2-mercaptoethanol (1% v/v)/phosphoric 
acid (0.01 M) adjusted to pH 6.8 with trie, 
heated for 10 minutes at 60°C and stored 
overnight at room temperature prior to electro­
phoresis. 125 pg of peptides (in bromophenol
(iii)
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blue/sucrose (40% w/v)) were applied per gel 
and electrophoresis was carried out at 4 raA/ 
gel for 12 hours with phosphoric acid (0-1 M)/
SDS (0.1% w/v) adjusted to pH 6.8 with trie 
as the electrode buffer.
Staining and Destaining
Gels were fixed and stained in PAGE Blue G-90 
(0.25% w/v) in methanol (45% v/v) and acetic 
acid (10% v/v). Destaining was at 40°C in 
methanol (5% v / v ) /acetic acid ( 7 . 5 ° ' V / v )  (Weber 
et al. , 1972).
By SDS-disc PAGE (Brown et al., 1967)
Gels (14 x 0.6 cm i.d.) were a modification 
of Laemmli's gels, containing 5 M urea. The 
separating gel (T = 7.5%, C = 2.7%) contained 
trie-HCl (0.375 M, pH 8.9), urea (5 M) and SDS 
(0.1% w/v) and the stacking gel (T = 3%, C = 2.7%) 
contained fcris-HCl (0.125 M, pH 6.8), urea (5 M) 
and SDS (0.1% w/v). The electrode buffer was 
trie (0.05 M)-glycine (0.38 M) containing SDS 
(0.1%), final pH 8.3. Samples were dissolved in 
trie-HCl buffer (0.04 M, pH 6.8) containing urea 
(8 M). Electrophoresis was carried out at 
1 mA/gel during stacking and then at 3 mA/gel 
for 5*i hours.
Fixing, staining and destaining was as above 
(Weber et al., 1972).
6 .2 .3.2 N-Chlorosuccinimide Peptides by 
SDS-disc-PAGE (Laemmli, 1970)
The separating gel contained 10% acrylamide 
(C = 2.7%). Peptides were dissolved in tris-HCl 
(0.0625 M, pH 6.8) containing glycerol (10%), SDS 
(2% w/v), 2-mercaptoethanol (5% v/v) and bromophenol 
blue (0.01% w/v), and heated at 100°C for 2 minutes.
200 ug of peptides was applied to each sample well and 
electrophoresis was carried out at 60 V constant 
voltage for 16 hours. Commercial molecular weight markers 
ranging from 12,300 to 78,000 were run alongside the 
peptides to aid identification.
Staining and Destaining
The peptides were detected with PAGE-Blue 
G-90 as described for o-iodosobenzoic acid peptides 
(Section 6.2.3.1(11).
6.2.4 Preparative Isolation of CNBr Peptides
6.2.4.1 By Acid/Urea/Triton X-100 PAGE
Preparative gels had a similar composition 
to the analytical gels, and were of dimensions 20 x 47 x 
0.3 cm.
Immediately after electrophoresis, the gel was 
superficially stained (about 1 hour) in PAGE Blue G-90 
(0.2% w/v) dissolved in water. Excess stain was removed 
by washing in water. The peptides were excised from the 
gel (Gibson and Gracey, 1979) and finely homogenised 
in an equal volume of formic acid (60% v/v) using a
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glass homogeniser with a mechanically driven teflon pestle, 
followed by extrusion through a glass syringe. The peptides 
were eluted from the gel by magnetic stirring at 4°C 
for 6 hours. The acrylamide fragments were removed 
by centrifugation and the supernatant decanted and 
lyophilised. The gel was washed twice with formic acid 
(60%) to ensure maximum recovery.
The dye was removed by adding HC1 (6 M) until 
the dry protein had dissolved. n-Octanol (2 vol.) was 
added with thorough mixing and the two phases separated 
by centrifugation. The blue organic layer was removed and 
the aqueous layer extracted twice more in a similar 
manner. The final acid phase was diluted with an equal 
volume of water and lyophilised.
6.2.4.2 By Chromatofocusing
Chromatofocusing of CNBr peptides from normal 
albumin in the pH range 7-4 was carried out as 
previously described (Section 4.6). A column (1 x 27 cm) 
of PBE 74 was equilibrated with imidazole-HCl buffer 
(0.025 M, pH 7.4) containing urea (5 M) , ascorbic acid 
(0.1 mM) and methylamine (25 mM). CNBr fragments (10 mg) 
were reduced for 90 minutes at 37°C in urea (8 M)/ 
thiodiglycol (1% v/v)/dithiothreitol (20 mM) before being 
applied to the column. Elution was at a flow rate of 
18.0 ml/hour using Polybuffer 74-HC1 (0.0094 mmol/pH unit/ 
ml, pH 4.0) containing urea, antioxidant and cyanate 
scavenger as for the starting buffer. The pH of the 
fractions eluting either side of the protein peaks
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was measured and the eluate was monitored at 280 nm.
6.3 RESULTS AND DISCUSSION
Specific cleavage at methionine using cyanogen 
bromide gave highly reproducible peptide maps on urea/ 
acid/Triton X-100 PAGE. Fig. 6.1 shows the fragmentation 
patterns of albumin A, albumin A/albumin Redhill and 
albumin A/albumin Warwick-2. The peptides were assigned 
according to Franklin et al. (1980): on the basis of
A B C D E F G H  I
Fig. 6.1 Peptide analysis of the CNBr fragments of albumin 
by acid/urea/Triton X-100 PAGE. A, albumin A from 
serum containing albumin Warwick-2i Band C,
Albumin A/albumin Warwick-2) D, F and G, albumin A/ 
albumin Redhill) E, albumin A from serum containing 
albumin Redhill) H and I, albumin A.
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was measured and the eluate was monitored at 280 nm.
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Specific cleavage at methionine using cyanogen 
bromide gave highly reproducible peptide maps on urea/ 
acid/Triton X-100 PAGE. Fig. 6.1 shows the fragmentation 
patterns of albumin A, albumin A/albumin Redhill and 
albumin A/albumin Warwick-2. The peptides were assigned 
according to Franklin et al. (1980): on the basis of
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Fig. 6.1 Peptide analysis of the CNBr fragments of albumin 
by acid/urea/Triton X-100 PAGE. A, albumin A from 
serum containing albumin Warwick-2) Band C,
Albumin A/albumin Warwick-2i D, F and G, albumin A/ 
albumin Redhill) E, albumin A from serum containing 
albumin Redhill) 11 and I, albumin A.
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molecular weight and amino acid composition, being 
numbered in accordance with their order in the known 
sequence of albumin. Table 6.1 gives the mobilities 
of the peptides measured relative to the mobility 
of the basic fuchsin tracker dye.
Table 6.1 Fragments obtained by reaction with CNBr;
analysis by acid/urea/Triton X-100 PAGE 
(Franklin et al., 1980)
Peptide Residue Number
Relative Mobility 
(% mobility basic 
fuchsin)
2 + 3 88-298 0.29
3 124-298 0.33
3 m 124-298 0.35
i 1-87 0.39
1 m 1-87 0.41
1 (albumin Redhill 
and albumin Warwick-2) 1-87 0.42
5 m 330-446 0.48
5 330-446 0.49
6 447-548 0.53
7 549-585 0.59
Relative mobility is expressed as:
distance migrated by protein____
distance migrated by tracker dye
For all albumin samples, fragments 1, 3 and 5 
were present as double bands. The minor bands were 
labelled ' m ', referring to peptide modifications 
probably arising from oxidation of unreacted cysteine
or the alkylation of lysine by excess iodoacetic acid
during reduction and carboxymethylation. Fragment 7
was present faintly but fragment 4 could not be identified.
For both albumins Redhill and Warwick-2, a 
faster migrating fragment corresponding to the N-terminal 
CNBr peptide was present. This band was not visible in 
the peptide maps of albumin A indicating that both 
variants possess a site of mutation in the N-terminal region 
of the molecule, between residues 1 and 87. The faster 
mobility is coincident with the finding of a basic propeptide 
in albumin Redhill. The variant peptides are indistinguishable 
from each other on this gel system and an alteration 
in the Triton binding conditions may be required to 
distinguish them.
The similarity between the peptide maps of 
albumin Redhill and albumin A suggests that the second 
mutation involving the increased molecular weight of the 
variant does not interfere with cleavage at methionine 
residues and may therefore lie within one CNBr fragment 
and not span a greater number of peptides.
For albumin Warwick-2, the faster migration of 
the variant peptide at pH 3.0 indicates a loss of negative 
charge. Consequently, a change from an acidic or neutral 
residue is suspected, analogous to fragment 7 of albuminsB 
and Mexico-2 (Section 1.8.2.12 and 1.8.2.13). No other 
novel peptides were detected for either variant on this 
gel system.
Peptide mapping using the mixed albumins was 
more informative than studies involving the variants
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alone since preparations of the pure variants tended to 
give less well-resolved peptide maps, the probable cause 
being amino acid modification during the long chromatographic 
and electrophoretic purification procedures. Also, 
identification of the novel peptides was simplified if the 
normal peptide was present as a reference.
Isoelectric focusing of the CNBr peptides 
exemplified the difference between albumins Redhill and 
Warwick-2. The band patterns for all samples were 
closely reproducible and span a wide pH range, from 
pH 7.35 to pH 4.05. Normal albumin gave eight major, 
well separated bands which were more evident after 
staining with Fast Green FCF than with PAGE Blue G-90.
The major bands were interspersed with many closely 
spaced minor bands which stained more intensely with the 
more sensitive PAGE Blue, obscuring the main bands to 
some extent and complicating the interpretation of the 
peptide maps. The pi's were as follows, as measured 
using the pH gradient curve shown in Fig. 6.2, pH 7.35,
7.05, 6.85, 6.35, 6.25, 6.05, 5.95, 5.9, 5.7, 5.5, 5.2,
5.0, 4.9, 4.8, 4.7, 4.55, 4.45, 4.05. The major bands 
are underlined.
Albumin A/albumin Redhill fragments also showed 
the same eight major bands corresponding to the expected 
number of CNBr peptides, but no differences between the 
isoelectric patterns of albumin Redhill and albumin A 
were apparent. The variant peptides may have been obscured 
by the multitude of minor bands or become isoelectric 
outside the pH range employed in this analysis. The
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Fig. 6.2 Isoelectric focusing of CNBr peptides in the pH 
range 3-10: pH gradient curve.
minor bands probably occurred as a consequence of amino 
acid modifications: oxidation of non-alkylated cysteine 
residues, deamidation of asparagine and glutamine or 
carbamylation of amino groups by residual cyanate, or 
may be due to the natural heterogeneity inherent in 
albumin preparations.
Albumin Warwick-2 clearly showed an additional
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acidic peptide with a pi of 4.3.
Fig. 6.3 shows the peptide maps stained with 
Fast Green FCF. The pi of the abnormal peptide is more 
basic than the corresponding normal peptide, there being a 
difference between them of 0.25 pH units. This agrees with 
the slower mobility of the native variant at pH 8.6 and 
5.0 and the faster mobility of the N-terminal CNBr peptide 
at pH 3.0.
Since isoelectric focusing of the CNBr peptides 
resulted in so many bands, this method was not very useful
A B O D E
Fig. 6.3 Isoelegtric focusing of CNBr peptides in the pH 
range 3-10, A, albumin A> B and C, albumin A/ 
albumin Redhill) D and E, albumin A/albumin 
Warwick-2.
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Fig. 6.3 shows the peptide maps stained with 
Fast Green FCF. The pi of the abnormal peptide is more 
basic than the corresponding normal peptide, there being a 
difference between them of 0.25 pH units. This agrees with 
the slower mobility of the native variant at pH 8.6 and 
5.0 and the faster mobility of the N-terminal CNBr peptide 
at pH 3.0.
Since isoelectric focusing of the CNBr peptides 
resulted in so many bands, this method was not very useful
A B C D E
Fig. 6.3 Isoelegtric focusing of CNBr peptides in the pH 
range 3-10, A, albumin A; B and C, albumin A/ 
albumin Redhill; D and E, albumin A/albumin 
Warwick-2.
for identifying the abnormal peptides. The only 
assignable peptide was that derived from the N-terminus 
and previously identified as containing mutations by 
acid/urea/Triton X-100 PAGE.
Specific cleavage at tryptophan with o-iodosobenzoic 
acid and N-chlorosuccinimide gave further information 
concerning the location of the second mutation in 
albumin Redhill.
All three gel systems employed to analyse the 
fragments obtained from o-iodosobenzoic acid cleavage 
revealed that this reagent cleaved the albumin specifically 
at tryptophan. However, repeated attempts showed the 
reaction to be non-reproducible and subsequent fragmenta­
tion patterns were variable.
Fig. 6.4 shows the peptide maps obtained by 
extended electrophoresis on 10% acid/urea/Triton X-100 
gels. Control experiments with no included reagent 
showed that no anomalous peptides occurred as a result 
of random, non-specific hydrolysis in the solvent 
(Brown et al. , 1967) . This gel system was unable to 
resolve the abnormal peptides from their normal analogues.
The tryptophanyl peptides are much larger than the CNBr 
peptides separated in the same system, and a contributory 
factor to the lack of resolution may be that the mutation 
is proportionally much smaller relative to these larger 
peptides. Albumin A, albumin A/albumin Redhill and 
albumin A/albumin Warwick-2 gave identical fragmentation 
patterns comprising three bands which corresponded to 
the uncleaved albumin, the C-terminal peptide and the
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Fig. 6.4 Analysis of o-iodosobenzoic acid peptides by acid/urea/ 
Triton X-100 PAGE (Franklin et al., 1980).
A , pure albumin A: B, albumin A; C, albumin A/ 
albumin Warwick-2;D, albumin A/albumin Redhill.
lower molecular weight N-terminal peptide (Table 6.2).
It was necessary to overload each gel in order to see 
the peptides clearly since cleavage yields were quite 
low.
The SDS-tris-phosphate gels (Swank and Munkres, 
1971) and SDS-disc gels (Brown et al., 1967) were able 
to resolve the variant C-terminal peptide of albumin 
Redhill on the basis of molecular weight. Fig. 6.5 
shows the band patterns obtained using SDS-trio-phosphate
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Fig. 6.4 Analysis of o-iodosobenzoic acid peptides by acid/urea/ 
Triton X-100 PAGE (Franklin et al., 1980).
A, pure albumin A; B, albumin A; C, albumin A/ 
albumin Warwick-2;D, albumin A/albumin Redhill.
lower molecular weight N-terminal peptide (Table 6.2).
It was necessary to overload each gel in order to see 
the peptides clearly since cleavage yields were quite 
low.
The SDS-tris-phosphate gels (Swank and Munkres, 
1971) and SDS-disc gels (Brown et al., 1967) were able 
to resolve the variant C-terminal peptide of albumin 
Redhill on the basis of molecular weight. Fig. 6.5 
shows the band patterns obtained using SDS-trie-phosphate
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uncleaved albumin 
C - t e r m i n a l  peptides
N -t e r m i n a l  peptides
Fig. 6.5 Analysis of o-iodosobenzoic acid peptides by SDS-tris- 
phosphate PAGE (Swank and Munkres, 1971).
A, standard molecular weight markers; B, uncleaved 
albumin A (control); C, albumin A; D, albumin A/ 
albumin Redhill; E, albumin A/albumin Warwick-2.
gels. The molecular weights of the peptides bear no 
resemblance to the molecular weights of the standard 
markers. The C-terminal peptide of albumin Redhill has 
a higher molecular weight than the corresponding peptide of 
albumin A. The two peptides are well-resolved, being 
visible as distinct bands of equal intensity on both 
electrophoretic systems. The increased molecular weight 
previously observed during conventional molecular weight 
determination (Section 3.2.7) therefore lies in the
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C-terminal region of the variant albumin, between residues 215 
and 585. Thus, albumin Redhill has two separate regions 
of mutation. The abnormal peptide in albumin Warwick-2 
was indistinguishable on all the gel systems employed, 
indicating a smaller degree of mutation, too minute to 
cause a detectable change in molecular size, reminiscent 
of a single amino acid substitution.
The faint band visible below the N-terminal 
peptide in the peptide maps of both variants on the 
SDS-tr-£s-phosphate system was not present on the SDS-disc- 
PAGE system. The intensity of this band is much lower than 
the intensity of the main band and may represent a low 
molecular weight fragment arising from a small degree 
of cleavage at tyrosine residues. It is unlikely that 
the mutation occurring in the N-terminal region of 
albumin Warwick-2 involves a reduction in size; albumin 
Redhill has an increased molecular size in this region and 
shows the same faint band. Furthermore, mutations 
involving a deletion of part of the sequence have not 
been discovered in any other variant studied in this 
depth, and no low molecular weight bands were observed 
during studies with the native proteins. Alternatively, 
the additional band may therefore be an artefact arising 
from an altered binding capacity of the variant 
albumins for SDS. The primary structure of the protein 
influences its ability to bind SDS, possibly involving 
electrostatic attractions. The N-terminal peptides of 
both variants possess additional positive charge.
Electrostatic attraction may cause more of the anionic *
*
¡5$
Table f i. 3 .inn lysis bvFragments obtained by reaction with o-iodosobcnzoic acid; 
SOS-PAGE
Sample Relative mobility mobility bromophcnol blue) Identity of protein band
Swank and Drown c t »</.
Munkrcs (1971) ( 19f.7)
Standard molecular 0.22 0.36 Ovotransfcrrin
•weight markers 0.25 0.42 DSA
0.39 0.72 Ovalbumin
0.59 0.94 Chymotrypsinooen A
0.74 0.98 Myoglobin
0.80 - Cytochrome C
Albumin A 
(control)
0.21 0.28 Une leaved albumin
Albumin A ♦ 
o-iodosobenzoic 
acid
0.21 
0.29
0.28
0.43
Uncleaved albumin
C-terminal peptide 
(residues 215-585)
0.55 0.78 N-terminal peptide 
(residues 1-214)
Albumin A/ 0.20 0.29 Uncleaved albuminalbumin Redhill ♦ 
o-iodosobenzoic 0.26 0.42 C-terminal peptide
acid (albumin Redhill)
0.29 0.44 C-tcrminal peptide 
(albumin A)
0.53 0.78 N-terminal peptide 
(albumin A/albumin Redhill)
Albumin A/ 0.21 0.28 Unclcavcd albuminAlbumin Warwick-2 ♦ 
o-iodosobenzoic 0.29 0.43 C-tcrminal peptideacid (albumin A/albumin Warwick-2
0.55 0.77 N-tcrminal peptide 
(albumin A/albumin Warwick-2
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SDS to bind to this region, thus increasing the overall 
negative charge on the peptide. During electrophoresis, 
the variant peptides migrate more rapidly to the anode 
giving a false impression of low molecular weight bands.
Table 6.3 gives the relative mobilities of the tryptophanyl 
peptides in both the Swank and Munkres and Brown gel systems. 
There is no comparison between the mobilities of the peptides 
in the two systems but the fragmentation patterns give the 
same information.
Fig. 6.6 shows the fragmentation patterns 
obtained after reaction with N-chlorosuccinimide. This 
reagent proved to be more reliable than o-iodosobenzoic 
acid and subsequent reactions gave similar peptide maps.
But, like o-iodosobenzoic acid, yields were rather low and 
it was necessary to overload the gels in order to see 
the peptides clearly.
Fig. 6.6 Analysis of N-chlorosuccinimide peptides by SDS-PAGE 
(Laemmli, 1970).
A and G, standard molecular weight markers;
B, albumin A/albumin Warwick-2; C, albumin A/albumin 
Rcdhill;DAE, albumin A; F, uncleaved albumin A (control).
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Table 6.3 gives the relative mobilities of the tryptophanyl 
peptides in both the Swank and Munkres and Brown gel systems. 
There is no comparison between the mobilities of the peptides 
in the two systems but the fragmentation patterns give the 
same information.
Fig. 6.6 shows the fragmentation patterns 
obtained after reaction with N-chlorosuccinimide. This 
reagent proved to be more reliable than o-iodosobenzoic 
acid and subsequent reactions gave similar peptide maps.
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uncleaved albumin 
C - t er mi na l  peptides
N - t e r mi n a l  pepti des
Fig. 6.6 Analysis of N-chlorosuccinimide peptides by SDS-PAGE 
(Laemmli, 1970) .
A and G, standard molecular weight markers;
B, albumin A/albumin Warwick-2; C, albumin A/albumin 
Rcdhi 11 ; 0 ft E, albumin A; F, uncleaved albumin A (control).
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Table 6.4 Fragments 
SDS-PAGE
obtained by reaction with 
(Laemmli, 1970)
N-chlorosuccinimide; analysis by
Relative mobility Identity of 
protein bandSample (% mobility bromo- phenol blue) weight
Standard molecular 0.21 Ovotransferrin 76-78,000
weight markers 0.24 DSA 66,200
0.41 Ovalbumin 45,000
0.57 Chymotrypsinogen A 25,700
0.86 Myoglobin 17,200
0.90 Cytochrome C 12,300
Albumin A 0.27 Uncleaved albumin
(control)
Albumin A ♦ 0.27 Uncleaved albumin
NCS 0.39 C-terminal peptide 
(residues 215-585)
47,000
0.59 N-terminal peptide 
(residues 1-214)
28,800
Albumin A/ 0.26 Uncleaved albuminalbumin Redhill ♦ .
NCS 0.36 C-terminal peptide (albumin Redhill)
49,900
0.39 C-terminal peptide 
(albumin A)
47,000
0.59 N-terminal peptide 28,800
0.60 N-terminal peptide 
(albumin Redhill?)
27,700
Albumin A/ 0.26 Unclcaved albuminalbumin Warwick-2 ♦ _ __
NCS 0.39 C-terminal peptide 47.000 (albumin A/Warwick-2)
0.59 N-terminal peptide 28,800
0.60 N-termlnal peptide 
(albumin Warwick-27)
27,700
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In the Laemrali gel system, the molecular
talysis by weight of the albumin bands correlated well with the
standard markers. Table 6.4 shows the relative mobilities,
Molecular
molecular weights and identification of the peptides.
weight The molecular weight of the C-terminal peptides of
76-78,000 albumin Redhill and albumin A differed by a factor of
66,200
45,000
2,900 in this system. The discrepancy between these
25,700 measurements and the weight calculated for the native
17,200
12,300 protein (a difference of 2,200) may be a manifestation of the
proportional size of the mutation relative to the size of the
protein chain in which it is contained or be due to the
47,000
different mobilities on different concentrations of
28,800
acrylamide gel. The bands representing the N-terminal
peptide in both variants are double and of near equal
intensity. The most probable explanation for the
49,900 duality of these bands lies in the binding of SDS as
47,000 previously described, especially since they run so close
28,800
27,700 together.
The difference in molecular weight between
47,000 the C-terminal peptides of albumin Redhill and
28,800 albumin A and between the whole, native albumin is
27,700 much larger and the equal intensity of the bands is
constant throughout the various gel systems, unlike
the varying intensities observed with the N-terminal
peptide bands. This strongly suggests that the slower
migrating band is not artefactual and represents a
true difference in the size of the proteins in this
region.
Cleavage with NCS confirms that albumin Redhill
has a mutation in both the N- and C-terminal regions
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whereas albumin Warwick-2 has one N-terminal mutation.
Specific cleavage of normal and variant albumins 
at methionine and tryptophan followed by several methods 
of peptide analysis has shown that albumin Redhill and 
albumin Warwick-2 are structurally different, both to 
albumin A and to each other. Albumin Warwick-2 has 
undergone an amino acid substitution within the first 
87 residues from the N-termianl end. Albumin Redhill 
is a proalbumin with an additional mutation between 
residues 215 and 585 involving an insertion of about 
ten to twelve residues.
Preparative isolation of the CNBr peptides from 
acid/urea/Triton X-100 gels was less successful than 
originally hoped from the success of the analytical 
gels. Much of the resolving power and clarity was lost 
on the larger preparative scale. The normal fragments 
separated well enough to be excised as separate bands 
whereas the variant N-terminal peptides tended to merge 
with the normal peptides owing to the diffuse nature of the 
bands. Difficulty in obtaining clear backgrounds with 
diffusion destaining in water reduced the visibility of 
the abnormal bands and prolonged destaining increased the 
possibility of losing some of the non-fixed peptides by 
free diffusion into the destaining solution. Prior 
fixing in TCA was not favoured since prolonged immersion 
in strong acid may catalyse the deamidation or some 
hydrolysis of asparagine and glutamine residues, 
resulting in the formation of their corresponding acids. 
This may cause errors in sequencing later on.
Chromatofocusing of CNBr peptides from albumin A 
resolved the peptides into two peaks. The first group 
eluted within the pH range 7.59 to 7.39 and the second 
group between pH 5.88 and pH 3.90. Analysis of these 
peaks and further use of this technique was hindered 
by there being no satisfactory method for removing 
Polybuffer and some difficulty experienced in dialysing out 
the large quantities of urea employed to maintain the 
solubility of the peptides during chromatography, owing 
to the danger of losing small peptides through the 
dialysis membrane. The molecular weight of some of 
the smaller peptides is too close to that of Polybuffer 
to enable separation by gel filtration; the minimum 
weight that can be separated from Polybuffer by column 
chromatography is 25,000 and all of the albumin CNBr peptides 
are smaller than this. Similar difficulties were foreseen 
with ammoniun sulphate precipitation and hydrophobic 
interaction chromatography, the other suggested methods.
The peptides are probably too small to be precipitated 
with ammonium sulphate and removing the large quantities 
of this salt required in both methods would meet with the 
same problems involved in separating the protein from 
urea.
A more quantitative method for the preparative 
isolation of the CNBr peptides is required and further 
investigations are at present being carried out 
by Mr. P. Matejtschuk in the Department of Chemistry and 
Molecular Sciences at the University of Warwick, using 
HPLC as a possible solution to this problem.
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Further to the fragmentation studies, samples 
of purified albumin A and albumin Redhill have been sent 
to the S.E .R.C.-funded protein sequencing unit at the 
University of Leeds, where amino acid sequencing studies 
are at present in progress.
CHAPTER 7
LIGAND BINDING STUDIES
7.1 INTRODUCTION
The relationship between amino acid sequence 
and ligand binding properties was investigated using 
nickel, copper, palmitate and bilirubin. The binding 
regions for these ligands are well established 
(Section 1.7). The relative binding capacity of albumins 
Redhill and Warwick-2 compared to the capacity of 
albumin A provided additional information concerning the 
site of amino acid substitution.
7.1.1 Nickel and Palmitate
The binding capacity of the variant albumins for 
the radiolabelled ligands ^nickel and I *^C]-palmitate 
relative to that of albumin A was assessed by cellulose 
acetate electrophoresis-autoradiography (Brennan and 
Carrell, 1980).
7.1.2 Copper
Copper binding was measured using gel filtration 
(Hummel and Dreyer, 1962). The method is based on the 
following general principle. The protein is dissolved 
in a solution of a ligand to which it binds. The
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concentration of free ligand is thereby reduced by an 
amount equivalent to the protein-ligand complex formed.
The solution is applied to a Sephadex column equilibrated 
with the same solution of ligand as was used to dissolve 
the protein, and thereafter, eluted with this solution.
The concentration of ligand in the eluate is measured.
As the protein moves down the column it continues to 
remove ligand from the solution and elutes in the void 
volume. The amount of ligand localised in the complex, 
therefore, rises above that present in the eluant and 
correspondingly, at some point after the protein peak, the 
concentration of ligand in the eluate decreases, forming 
a trough in the elution profile which extends to the 
salt volume of the column. The quantity of free ligand 
removed from the solution is equal to the excess 
concentration of ligand associated with the protein.
7.1.3 Bilirubin
The binding of bilirubin was examined by fluorescence 
quench titration (Levine, 1977). Albumin, like most proteins 
exhibits an intrinsic fluorescence due to absorption in 
the ultraviolet of the aromatic amino acids tryptophan and 
tyrosine. Tryptophan contributes a greater part of the 
fluorescence owing to its higher extinction coefficient 
whereas the fluorescence contribution of phenylalanine 
is negligible. Bilirubin absorbs strongly in the region 
of albumin emission so that binding of bilirubin is 
accompanied by a loss in intrinsic albumin fluorescence
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due to energy transfer from the excited state tryptophan 
to the bound ligand (Chignell, 1972; Chen, 1973). To 
prevent the obscuring of binding sites any endogenous 
metal ions were removed from albumin by treatment with 
Chelex 100 before nickel and copper binding. Defatted 
albumin was used to study palmitate and bilirubin binding.
7.2 EXPERIMENTAL
7.2.1 Removal of Trace Metals from Serum
Small columns (6 x 0.9 cm i.d.) of de-fined 
Chelex 100 (Na+ form) were neutralised with four bed 
volumes of sodium acetate buffer (0.5 M, pH 6.5) 
followed by equilibration with five bed volumes of 
water. Sera (100 ul) were applied to individual columns 
and eluted with water at a slow flow rate. The protein 
peaks were collected directly into round bottomed flasks 
(25 ml) and lyophilised.
7.2.2 Nickel Binding (Brennan and Carrell, 1980)
The lyophilised sera were reconstituted with 
water (100 pi). (^ Ni]-nickel chloride (1 mCi) in HC1 
(0.2 ml, 0.1 M) was diluted with water (0.8 ml) and 
an aliquot (1 ul, 1 pCi) was added to serum (30 pi). 
Following incubation at 37°C for 1 hour, the albumins were 
separated by cellulose acetate electrophoresis in barbitone 
buffer (0.075 M, pH 8.6) at 8 V/cm for 4 hours. The
electrophoretogram was dried in warm air and subjected 
to autoradiography using LKB Ultrofilm under slight 
pressure at room temperature for 2 4 hours. The film 
was then developed in commercial developer and fixer 
(5 minutes each solution).
To facilitate interpretation of the 
autoradiograph, the electrophoretogram was subsequently 
stained with Ponceau S for comparison.
The control was normal serum with no radiolabelled
nickel.
7.2.3 Palmitate Binding (Brennan and Carrell, 1980)
14l-[ C)-Palmitate was supplied as a solution
in toluene (500 p1, 50 pCi). The lyophilised, defatted
normal and mixed albumins (4.2 mg) were dissolved in
14water (100 pi) and undiluted l-[ C)-palmitate was added 
(1 pi, 0.1 pCi per 30 pi of albumin solution).
Incubation, electrophoresis and autoradiography followed 
as previously described. The control was normal albumin 
with no added radiolabelled ligand.
7.2.4 Copper Binding (Hummel and Dreyer, 1962)
Defatted normal and mixed albumins (5.0 mg), 
free of trace metals by pre-treatment with Chelex 100, were 
dissolved in trio-HC1 buffer (500 pi, 0.02 M, pH 8.0) 
containing Cu*11* ions (3 pg/ml) and applied to a 
column (1.6 x 46.5 cm) of Sephadex G-50 pre-equilibrated
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with the same copper containing buffer. The column was 
eluted with this buffer at a flow rate of 17 ml/hr and 
small fractions of equal volume (1.5 ml) were collected.
The eluate was primarily monitored at 280 nm. The 
copper content of the individual fractions was subsequently 
determined by atomic absorption spectroscopy using a 
Varian Techtron Spectrophotometer. All measurements 
were made at 325.1 nm employing the same instrument 
conditions: Lamp current 3 mA, fuel 3.0, oxidant 7.5
and band width 0.2 nm.
7.2.5 Bilirubin Binding (Levine, 1977)
The titration involved adding aliquots of 
bilirubin to the albumin solution and measuring the 
decrease in protein fluorescence after each addition.
Bilirubin (20.8 uM) was initially solubilised 
in a minimum volume of NaOH (0.1 M) containing EDTA 
(0.1 mM) and subsequently buffered with tvia-HC1 (0.1 M, 
pH 7.4). Aliquots (10 mD  of this solution were added 
to defatted albumin (1.04 pM in tria buffer, 2.0 ml) 
in a 3 ml quartz fluorescence cuvette with a path 
length of 1 cm, and mixed by inversion five times. A 
similar cuvette containing buffer only served as the 
blank and was checked frequently.
The excitation filter had a maximal transmission 
at 294 nm while the emission maximum was 343 nm. The 
half band width for both filters was 10 nm. All studies 
were performed at ambient temperature in subdued lighting
and glassware was siliconised with dimethyldichlorosilane 
solution (2% in 1,1,1-trichloroethane) to prevent 
adsorption of bilirubin. The shutter allowing light to 
strike the test solution was opened only when reading 
fluorescence to avoid photodecomposition of bilirubin.
7.3 RESULTS AND DISCUSSION
The results obtained from the binding of copper 
and nickel substantiate previous evidence that albumin 
Redhill is a proalbumin. The mutation within the 
N-terminal sequence lies within the primary binding site 
for these two metals, namely the N-terminal tripeptide, 
whereas the single site of mutation within albumin 
Warwick-2 lies elsewhere between residues 1 and 87.
Comparing the autoradiograph of serum containing
6 3albumin Redhill incubated with Ni, and the corresponding 
cellulose acetate electrophoretogram, the autoradiograph 
shows only the faster migrating albumin A band.
Albumin Redhill failed to give a band on the film. This 
shows that albumin Redhill is unable to complex nickel 
in the normal manner, or binds so little that any 
residual capacity is undetectable by this method. Fig. 7.1 
shows the autoradiographs for all sera and the cellulose 
acetate electrophoretogram stained with Ponceau S is 
included in Fig. 7.2 for comparison. Control normal serum 
showed no background radioactivity and there was no 
detectable nickel uptake by the globulins.
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A B C D  E F
F ig . 7.1 N ickel b in d in g : autoradiograph. E and F, albumin 
W arwick-2j C and D albumin R e d h illi  A and p, 
normal serum.
A B O D E  F
Fig. 7.2 Nickel binding: cellulose acetate electrophore- 
togram. A and B, albumin Warwick-2; C and D, 
albumin Redhilli E and F, normal serum.
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Fig. 7.1 Nickel binding: autoradiograph. E and F, albumin 
Warwick-2> C and D albumin Redhill; A and P, 
normal serum.
A B C D E F
Fig. 7.2 Nickel binding: cellulose acetate electrophore- 
togram. A and B, albumin Warwick-2| C and D, 
albumin Redhill) E and F, normal serum.
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Fig. 7.3 Copper binding: elution profile of albumin 
Warwick-2 by atomic absorption spectroscopy.
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As previously described (Section 1.7.4.3), 
nickel^11' binds to albumin at one primary site constituting 
the N-terminal tripeptide NF^-asp-ala-his. The binding of 
nickel to albumin variants has been demonstrated as 
being a test for proalbumins (Brennan and Carrell, 1980). 
Proalbumin Christchurch showed a similar lack of affinity 
for nickel. The reduced capacity arises from the 
unavailability of the a-amino group necessary to complete 
the chelate structure, which has been blocked by the 
C-terminal residue of the propeptide. The reduced 
affinity for copper and nickel is strong evidence for 
the presence of an N-terminal propeptide in albumin 
Redhill.
Conversely, both albumin bands in the serum 
containing albumin Warwick-2 were visible on the film.
A densitometric tracing of both bands revealed that 
the relative proportions of nickel bound by each albumin 
corresponded to the relative proportion of each albumin 
in the serum, showing that albumin Warwick-2 binds nickel 
normally and that the mutation lies further into the 
sequence between residues 1 and 87. The propeptide of 
this variant is cleaved normally in vivo.
The proposed regions of mutation were confirmed 
by the copper binding experiments. Fig. 7.3 shows a 
typical elution profile (albumin Warwick-2) derived 
from the copper content of the eluate as measured by 
atomic absorption spectroscopy. The first peak corresponds 
to the albumin-copper complex eluting in the void volume 
(27.0 ml as determined with Blue Dextran). The trough
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represents the copper depleted eluate approximating to 
the salt volume of the column. The relative areas under 
the albumin-copper peaks were calculated by taking a 
standard area under the baseline equivalent to a standard 
weight of copper. The peak areas for albumin A and 
albumin A/albumin Warwick-2 were equal and represented 
5.48 pg of copper bound per 5.0 mg of the defatted 
protein, whereas an equal weight of albumin A/albumin 
Redhill bound only 3.92 pg of copper.
As described previously (Section 1.7.4.2) the 
primary copper(II) binding site lies within the N-terminal 
tripeptide and the quantity of copper bound by the
variant albumins relative to albumin A shows that 
albumin Warwick-2 binds this ligand normally at this 
site whereas albumin Redhill has a markedly reduced 
capacity. However, this variant does show some affinity 
for copper, possessing approximately 28% of the binding 
affinity of albumin A. This copper must be bound at the 
secondary sites which are unaffected by the alteration in 
the amino acid sequence.
The abnormality in the C-terminal region of albumin 
Redhill was investigated using palmitate. The primary 
binding site for this ligand lies between residues 377 
and 503 (Section 1.7.2.5). Autoradiography showed that 
both variants bound palmitate normally. This was 
expected for albumin Warwick-2 since no evidence for a 
mutation in the C-terminal region of the molecule had 
been found. The C-terminal mutation evident in 
albumin Redhill did not affect the binding of palmitate
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and hence it is unlikely that the mutation is located in 
this region.
Fig. 7.4 shows the fluorescence titration curve 
for bilirubin binding. The initial, steepest part of 
each curve represents the binding of one mole of 
bilirubin per mole of albumin at the primary binding 
site (residues 186-238, Section 1.7.3.2). The curves 
for albumin A, albumin A/albumin Redhill and albumin A/ 
albumin Warwick-2 all coincide in this region indicating
100
t:________________________________
°  I O
M O L A R  R A T IO  I [b t lu ubin j  /JalbuminJ I
Fig. 7.4 Bilirubin binding: fluorescence titration curve.
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that the sequence of both variants is unchanged within the 
primary bilirubin binding site. In contrast, the curves 
for both variants depart from the albumin A curve where 
bilirubin begins to bind at the secondary sites, showing 
that the mutation in both variants, although different, 
affects the binding of this ligand at these low 
affinity sites. Gitzelmann-Cumarasamy et al. (1976) 
localised one of the secondary sites to residues 446 to 547 
and the C-terminal mutation in albumin Redhill may lie 
within this sequence. However, since palmitate (377-503) 
binding is not affected, and no binding studies involving 
residues 547 to 585 were carried out, residues 503 to 585 
may contain the abnormality. In addition, bilirubin has 
been shown to bind strongly to the N-terminal region of 
the albumin molecule (residues 1-124, Hutchinson and 
Mutopo, 1979). The N-terminal mutation in both 
variants may contribute to the reduced binding of 
bilirubin in this region.
The C-terminal mutation in albumin Redhill 
appears to involve an insertion of a short sequence, 
possibly localised in CNBr fragments 6 (447-548) or
7 (549-585). This difference was not resolved on 
acid/urea/Triton X-100 PAGE suggesting that the Triton 
binding properties were not affected by these additional 
residues .
The mutation is neither spontaneous nor does 
it lead to an alteration in the reading frame of the 
mRNA during translation. An insertion of base pairs into 
a gene in any number other than an exact multiple of three 
causes a shift in the reading frame, leading to a
183
considerable alteration in the amino acid sequence 
following the position of insertion, which continues until 
a termination codon is reached. This has not happened 
in the albumin Redhill gene since the C-terminal and 
penultimate amino acid residues are identical to those 
of albumin A. Therefore, the mutation may have arisen 
via the unequal crossing over of homologues within the 
albumin gene prior to gene segregation. The extreme 
accuracy of most crossing over events depends upon the 
correct juxtaposition of the complementary homologues. 
However, the rare occurrence of misjoining between 
nearby regions of nucleotide homology within the gene 
can lead to a duplication (or deletion) of the sequence 
lying between the homologous regions. The mutation in 
albumin Redhill may have originated as a result of 
such an unequal crossover; the mismatching of short 
homologous nucleotide sequences positioned approximately 
ten to twelve residues apart within the albumin gene 
may have caused the duplication of the intervening 
sequence. The duplicate sequences would lie in tandem 
and account for the increase in molecular weight consistently 
observed in this region.
A similar mutation is observed in the 8-chain 
of human haemoglobin. Two nearby regions of eight- 
nucleotide homology (residues 90-92 and 95-97) mispair 
resulting in either the deletion or duplication of 
residues 91-95. Human haemoglobin is very susceptible to 
mutation and many types have been identified. Mutations 
of this nature in an individual are not the result of new
mutations in that person, rather they have been inherited 
from the previous generation and may have originated many 
generations in the past.
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Summary Albumin Redhill, a variant human albumin 
with the same C-terminal amino acid as Albumin A but 
with arginine at the N-terminus has been isolated by 
chromatofocussing from the sera of an English family. 
Thus, Albumin Redhill contains two sites of mutation 
in its protein chain and is probably a proalbumin.
The ability of Albumin Redhill to bind Ni(II) or 
Cu(II) ions is considerably less than that of Albumin A.
Keywords human albumin, variant, metal-binding, 
purification, proalbumin.
INTRODUCTION
Bisalbuminaemia, the presence of two electrophoretically
distinct albumins in serum, is well documented. While
numerous examples have been reported in humans 11], the
structures and properties of these variant albumins are
largely unknown. For example, the complete amino acid
sequences of only five variant albumins are known [2-6]
and one partial structure has been reported [7]. Abnormal
albumins have been identified by their dye-binding
properties [8); unusual ligand binding properties of
abnormal albumins have also been reported [9,10].
However, no systematic studies have been carried out on the
relationship between the amino acid sequence of an
albumin and its ligand-binding properties, mainly on
account of difficulties in obtaining pure samples of
abnormal albumins. We now wish to report initial
observations on the structure and ligand-binding
properties of an albumin which has been isolated from
the sera of a mother and son living in the neighbourhood
of Redhill, Surrey, U.K.
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CASE REPORTS
CASE 1
This patient is a 69 year old woman with a clinical 
history of recurrent psychiatric illness, first presenting 
itself when she was 21 years of age. She had a 
hysterectomy and prolapse repair in 1973. In May 1976 
she was shown by routine protein electrophoresis to have 
bisalbuminaemia. Since 1976 she has had many lengthy 
admissions to a psychiatric hospital on account of depression, 
although in between these episodes there have been periods 
of normality. Hypomanic attacks have also occurred during 
which she has not only talked incessantly but also has 
slept poorly. A high intake of alcohol has also occurred. 
Medication over the past 27 years has included amitriptyline, 
amylobarbitone, chlordiazepoxide, chlorpromazine, 
desipraraine, haloperiodol, imipramine, nortriptyline, 
orphenadrine, perphenazine, thioridazine and trifluoperazine. 
She has also had courses of electroconvulsive therapy.
CASE 2
This patient is the 52 year old son of Case 1. He 
is mentally normal. He had a cholecystectomy in 1968 fc gall­
stones, herpes in 1971, and a chest infection in 1972. At 
about the same time he had pain in the left leg; an X-ray 
of the spine and hips at that time, however, revealed only
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minor spondylitic changes. Recurrence of pain in the 
left leg was noted for a few weeks in 1982. The only 
medications which the patient has received are vitamin B 
compound, and amoxycillin for an infected finger.
The above reports summarise the main clinical data 
of the two patients. It is not implied, however, that 
any of the features quoted are necessarily related to the 
presence of Albumin Redhill; the documentation is 
provided simply to enable clinical comparison with any 
other cases which may come to light in the future.
MATERIALS AND METHODS
Blood was collected without addition of anticoagulant 
from both mother and son. The serum obtained by centrifugation 
was electrophoresed at pH 8.6 in 0.075 M sodium barbiturate 
buffer on a cellulose acetate membrane. After staining with 
Ponceau S, the presence of Albumin A was confirmed, but in 
addition, there was an approximately equal amount of another 
albumin with a relative mobility of 91 (alb A = 100).
Isolation
The two albumins were precipitated from the serum 
by means of addition of ammonium sulphate( 11) . The albumin- 
containing fraction was desalted on a column of Sephadex G-100 
(1.5 x 95 cm) using tris-HCl (0.01 M pH 7.0, containing 
0.05 M NaCl) as eluting buffer. The albumin-containing 
fractions were pooled, dialysed against water and then lyophilisec 
The mixed albumins (25 mg) in histidine-HCl buffer (1 ml,
0.025 M, pH 6.2) were applied to a column (1 x 26 cm) of 
Polybuffer PBE 94 exchanger (Pharmacia (Great Britain)
Ltd.) which had previously been equilibrated with the
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histidine-HCl buffer; the column was then eluted with 
Polybuffer 74 <diluted 1 to 8 with water and brought to 
pH 4.0 with 1 M HC1). The fractions which contained 
albumin eluted last and were pooled and then lyophilised; 
the residue was dissolved in the minimum amount of tris-HCl 
buffer (described above), and was then applied to a column 
of Sephadex G-100 (1.5 x 95 cm), which was, in turn, eluted 
with tris-HCl buffer. The fractions which contained 
Albumin Redhill were pooled, dialysed against water and 
lyophilised. Electrophoresis on cellulose acetate showed 
that the Albumin Redhill was contaminated with Albumin A.
Pure Albumin Redhill was obtained after a second cycle of 
chromatofocussing. The molecular weight of Albumin Redhill 
was found to be 67,600, as determined by SDS-polyacrylamide 
gel electrophoresis(12] ; Albumin A had a molecular weight of 
65,400 by this technique. The isoelectric point of Albumin 
Redhill was 4.75 (Albumin A pi = 4.93). Immunodiffusion on 
microscope slides [13] against antiserum to human albumin 
(Miles Laboratories Ltd.) showed a single, strong 
precipitation line.
Ligand-binding
(a) Nickel
[63Ni]-Nickel chloride (1 mCi) (Amersham International) 
was diluted to 1 ml with water and an aliquot (1 ul) was 
added to serum (30 ill) which had been treated with 
Chelex 100 (Biorad Laboratories); the mixture was 
incubated at 37°C for 60 minutes. Electrophoresis 
of the mixture on cellulose acetate at 8 v/cm for 4 
hours using sodium barbiturate buffer (0.075 M, pH 8.6)
followed by autoradiography using LKB Ultrofilm (3H) 
for 24 hours, showed that while Albumin A in the 
serum bound 63Ni ions. Albumin Redhill did not.
(b) Palmitate
The experiment described above was repeated 
14using C-palmitate (Amersham International, 0.1 yCi,
1 vil) in place of [^ 3Ni)-nickel chloride. Autoradiography 
revealed that both Albumin A and Albumin Redhill bound 
palmitate to an approximately equal extent.
<c) Copper
This was determined on the defatted albumin using 
gel filtration [14] on a column (1.6 x 46.5 cm) of 
Sephadex 050 equilibrated with tris-HCl buffer (0.02 M, 
pH 8.0 containing 3 ug/ml Cu(II) ions). The column 
was eluted with the same buffer and the copper content 
of individual fractions determined by atomic absorption 
spectroscopy. Albumin A (5 mg) bound 5.48 yg of copper(II) 
ions under these conditions, whereas an albumin fraction 
(5 mg) containing approximately equal amounts of 
Albumin A and Albumin Redhill bound 3.92 yg of 
copper(II) ions. Hence, Albumin Redhill binds 
approximately 28% of the copper(II) ions that are 
bound by Albumin A.
C- and N-Terminal Amino Acids
The N-terminal amino acid of Albumin Redhill was 
shown, by the reaction with dansyl chloride followed 
by acid hydrolysis, to be arginine [15]. The C-terminal
amino acid was shown, by partial hydrolysis of Albumin Redhill 
with carboxypeptidase Y, to be leucine [16].
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Cleavage of Albumin Redhill by N-Chlorosuccinimide
Mixed Albumins A and Redhill were cleaved with N-chloro- 
succinimide [17]. After the reaction was complete, the 
peptides were precipitated by the addition of 5 volumes of 
water, followed by 5 volume of 25% trichloroacetic acid/
1% 2-mercaptoethanol. The precipitated peptides were washed 
with acetone/0.2% HC1/1% 2-mercaptoethanol, followed by 
acetone/1% 2-mercaptoethanol and then dried in vacuo. 
SDS-Polyacrylamide electrophoresis[12] showed that Albumin Redhill 
had an N-terminal peptide, which migrated faster than that of 
Albumin A, while the C-terminal peptide migrated more slowly 
than that of Albumin A.
RESULTS AND DISCUSSION
Albumin Redhill has been isolated in pure form by 
chromatofocussing, a technique which has previously been 
used to purify Albumin Kashmir [18]. Albumin Redhill differs 
from other albumin variants which have been described so 
far, in that there appear to be two sites of mutation in 
the protein, rather than one. Cleavage of Albumin Redhill 
by N-chlorosuccinimide, at the single tryptophan residue 
trp214, reveals that both peptides thus produced differ 
from those obtained from Albumin A under identical conditions.
Albumin Redhill has arginine as its N-terminal amino 
acid, and could well be a proalbumin particularly as 
its molecular weight as determined by SDS-polyacrvlamide 
gel electrophoresis is greater than that of Albumin A. 
Confirmation that there is a mutation near the N-terminus 
of Albumin A is provided from metal ion-binding studies.
Albumin Redhill in serum docs not bind [63Ni)-nickel(II) 
ions and the binding of copper(II) ions to the defatted 
albumin is significantly less than that
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observed with Albumin A under the same conditions. The 
C-terminal amino acid of Albumin Redhill is leucine, 
as for Albumin A [10]. The variant albumin binds palmitate 
in the normal manner, indicating that the third binding 
domain of the albumin is unaffected. Albumin Redhill 
binds a number of ligands (bromophenol blue, bromocresol 
green, Ponceau S. Congo Red and bilirubin) less 
effectively than Albumin A [20], suggesting that the 
second mutation site may be near the binding domain 
for these ligands.
Albumin Redhill has a lower isoelectric point than 
Albumin A (4.75 vs 4.93), and Albumin Redhill is eluted 
after Albumin A on chromatofocussing, confirming that it 
has the lower pi. Albumin Redhill migrates more slowly 
than Albumin A on electrophoresis at pH 8.6; a contributory 
factor may bethe greater molecular weight of Albumin Redhill.
Further studies are in progress on Albumin Redhill, 
particularly the determination of its total amino acid 
sequence.
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